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Summary 
 
Differences in size are often the most distinctive features between individuals and species. 
The size of an animal depends mainly on the size and number of the cells it contains. 
Therefore, the control of cell, organ, and body growth is of fundamental importance to the 
development of any organism. How cells know when they have to grow or divide, and when 
they have to stop growing, remains obscure. The evolutionarily conserved insulin receptor 
(InR) and Target of Rapamycin (TOR) signaling cascades have been found to integrate 
various signals like nutrients, growth factors, and oxygen levels to regulate protein synthesis, 
metabolism, reproduction, and lifespan. Deregulated activity of both pathways results in 
severe metabolic- and growth anomalies like diabetes, inflammation, and cancer. Since 
mutations in the two only known negative regulators, PTEN or TSC, of the InR/TOR 
cascades are implicated in the development of a wide variety of human tumors, all inhibitors 
of these pathways can be considered as putative tumor suppressors. Therefore, to better 
understand the development of cancer and to identify potential therapeutic targets, it is 
essential to identify all the gene products involved in the regulation of the two cascades.  
This PhD thesis describes the functional characterization of a novel negative regulator of the 
insulin signaling pathway, the Imaginal morphogenesis protein-Late2 (Imp-L2). Imp-L2 has 
been identified in an enhancer/promotor (EP) based overexpression screen searching for 
suppressors of the hyperplasic eye phenotype induced by ectopic expression of the InR in the 
developing eye. Imp-L2 is a secreted member of the immunoglobulin (Ig) superfamily, which 
inhibits growth non-autonomously by suppressing insulin signaling in Drosophila. Like its 
ortholog the putative vertebrate tumor suppressor insulin-like growth factor-binding protein-
related Protein-1 (IGFBP-rP1), Imp-L2 binds at least one of the seven Drosophila insulin-like 
peptides (Dilps) and counteracts its activity, thereby providing a way of compensating 
hyperinsulinemia. Under adverse nutritional conditions, Imp-L2 is upregulated and necessary 
for larval survival by attenuating insulin signaling activity. Additionally, Imp-L2 is also 
induced under lowered oxygen levels (hypoxia). This indicates that Imp-L2 functions as a fast 
inhibitor of insulin activity under unfavorable environmental conditions.  
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Zusammenfassung 
 
Unterschiedliche Grösse ist oft das auffälligste Merkmal zwischen einzelnen Individuen und 
Spezies, weshalb die Kontrolle von Zell-, Organ- und Körperwachstum von fundamentaler 
Bedeutung für die Entwicklung eines Organismus ist. Es ist jedoch unklar, woher die Zellen 
wissen, wann sie wachsen oder sich teilen sollten, und wann das Wachstum wieder gestoppt 
werden muss. Die beiden evolutionär konservierten Signalkaskaden, der Insulin Rezeptor 
(InR) und der Target of Rapamycin (TOR) Signalweg, integrieren verschiedenste Signale wie 
Nahrungsangebot, Wachstumsfaktoren und Sauerstoffangebot, um Proteinsynthese, 
Metabolismus, Reproduktion und Lebensdauer zu steuern. Deregulierte Aktivität beider 
Signalwege führt zu schweren Metabolismus- und Wachstumsanomalien wie zu Beispiel 
Diabetes, chronischen Entzündungen und Krebs. Da Mutationen in den einzigen zwei 
bekannten negativen Regulatoren der InR/TOR-Kaskade, PTEN und TSC, an der 
Entwicklung einer grossen Anzahl menschlicher Tumore beteiligt sind, können alle 
Inhibitoren dieser Signalwege als potentielle Tumor-Suppressoren betrachtet werden. Um die 
Entstehung von Krebs besser verstehen zu können und mögliche Therapien dagegen zu 
entwickeln, ist es deshalb essentiell, alle Gene zu identifizieren die an der Regulierung dieser 
zwei Signalkaskaden beteiligt sind.  
In der vorliegenden Doktorarbeit wird die funktionelle Charakterisierung eines neuen 
negativen Regulators des Insulin-Signalweges, des Imaginal morphogenesis protein-Late2 
(Imp-L2), beschrieben. Imp-L2 wurde in einem enhancer/promotor (EP) Überexpressions-
Screen gefunden, in welchem Suppressoren, des durch ektopische InR-Expression 
verursachten „Grosse-Augen“ Phänotyps gesucht wurden. Imp-L2 ist ein sekretiertes Mitglied 
der Immunoglobulin (Ig) Familie, welches das Wachstum in Drosophila nicht-autonom, 
durch Runterregulierung des Insulin Signalweges inhibiert. Wie sein Ortholog, Insulin-like 
growth factor-binding protein-related Protein-1 (IGFBP-rP1), ein potentielle Tumor-
Supressor in Vertebraten, bindet Imp-L2 wenigstens eines der sieben Drosophila insulin-like 
peptides (Dilps) und hemmt dessen Funktion. Dadurch kann Imp-L2 stark erhöhte Insulin 
Pegel kompensieren. Unter ungünstigen Nahrungsbedingungen wird die Expression von Imp-
L2 induziert, was fürs Überleben der Larven und die nötige Abschwächung des Insulin 
Signals essentiell ist. Zusätzlich wird Imp-L2 auch unter tiefen Sauerstoff-Bedingungen 
(Hypoxische Bedingungen) raufreguliert. Dies alles deutet darauf hin, dass Imp-L2 als 
schneller Inhibitor der Insulin Aktivität unter ungünstigen Umweltbedingungen verwendet 
wird.  
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Introduction 
 
Growth is determined by a wide variety of cues 
 
Cell growth, defined as an increase in mass, is a highly regulated process, being subject to 
both temporal and spatial controls. It is usually coupled with cell division - an increase in cell 
number - to give rise to an organ or organism of characteristic size. Differences in size are 
often the most distinctive features between, but also within different species, yet we still know 
little about the genetic basis of size regulation (Conlon and Raff 1999). How is it possible that 
animals of the same class, like the two fishes whale shark (12.65m) and dwarf goby (8.6mm) 
vary 1500 fold in size? The size of an animal, organ, or appendage depends on the number 
and size of the cells it contains as well as on the amount of extracellular matrix and fluid.  
Although cell proliferation (increase in cell number controlled by cell division and 
programmed cell death) and cell growth (increase in cellular size) are often coupled 
processes, they must be considered separately, because cells can either grow to different sizes 
or divide without growth to produce larger numbers of smaller cells. The observation that 
individuals of the same species and genotype tend to grow to a highly predictable size 
suggests that growth is under genetic control. The size of a cell is largely proportional to the 
amount of DNA it contains (Stocker and Hafen 2000). In insects like Drosophila, cells of the 
so-called endoreplicative tissues grow by replicating their DNA without intervening mitosis 
thereby reaching huge sizes in comparison with epithelial cells, and ploidies from 16C to 
2048C (Edgar and Orr-Weaver 2001).  
However, growth and final body size are also influenced by external factors like temperature, 
nutrition or oxygen levels of the environment. For example, rearing flies under crowding, low 
oxygen (hypoxic), or starvation conditions results in a developmental delay and in the 
generation of tiny animals. Moreover, flies reared at lower temperature display enlarged body 
structures compared to control animals reared at higher temperature due to cell size increases 
(French et al. 1998; Azevedo et al. 2002).  
Within the last thirty years a considerable amount of progress about the control mechanisms 
of the cell cycle has been made. However, the understanding of cell growth, especially how 
cells integrate extrinsic and intrinsic stimuli to adapt metabolism and growth, lagged behind. 
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Cell growth does not depend on progression through the cell division cycle, as mutations that 
block cell cycle progression tend not to arrest cell growth (Johnston et al. 1977; Weigmann et 
al. 1997; Neufeld et al. 1998). Moreover, some cells as nerve and muscle cells, grow mainly 
after they have permanently withdrawn from the cell cycle, others, such as Drosophila 
imaginal disc cells, grow before they enter the cell cycle (Madhavan and Schneiderman 
1977). However, how cell growth is coupled with the cell cycle has remained elusive. A 
solution to couple these two processes directly might be to connect the synthesis of factors 
rate-limiting for cell cycle progression and the translational capacity. In yeast, the G1 cyclin 
Cln3p determines the critical growth-rate threshold for division. Due to the presence of an 
upstream open reading frame (uORF) in the mRNA of Cln3p, under adverse nutritional 
conditions, Cln3p is only poorly translated. Conversely, when nutrients are sufficiently 
abundant, the inhibiting effect of the uORF is overcome, and the cell enters S-phase 
(Polymenis and Schmidt 1997).  
 
Two major regulators of the complex growth process, controlling both cell number and cell 
size, are the evolutionarily conserved insulin receptor (InR) and Target of Rapamycin (TOR) 
pathways. Both pathways are necessary to couple environmental factors such as nutrients or 
oxygen levels directly to the growth rate of a cell. The high evolutionary conservation of InR 
and TOR signaling in higher eukaryotes can also be used for medical research. Deregulation 
of insulin signaling causes severe diseases such as diabetes, cancer, and inflammation (Hill 
and Hemmings 2002; Bjornsti and Houghton 2004; Sansal and Sellers 2004). In fact, the 
tumor suppressor PTEN is frequently lost in a variety of cancer types (Cantley and Neel 1999; 
Simpson and Parsons 2001). Therefore, the identification of novel signaling components in 
model organisms, such as C. elegans and Drosophila melanogaster, might enhance the 
understanding of human diseases and eventually lead to novel therapeutic interventions.  
 
 
The Insulin/IGF signaling pathway 
 
Vertebrate insulin and insulin-like peptides 
 
The insulin/insulin-like growth factor (IGF) signaling (IIS) cascade is an ancient pathway that 
is well conserved between vertebrates and invertebrates. Extensive studies of this pathway 
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have shown that IIS is split into complementary and interacting subsystems that govern 
growth, metabolism, reproduction, and longevity (Nakae et al. 2001; Saltiel and Kahn 2001).  
Insulin, which is produced by β-cells of the endocrine pancreas, on one hand increases the 
storage of glucose, fatty acids, and amino acids in adipose tissue and muscle, and on the other 
hand inhibits hepatic glucose production. Thus, insulin serves as the primary regulator of 
blood glucose concentration, which remains always in a narrow range between 4 and 7mM in 
normal human individuals (Saltiel and Kahn 2001). Glucose is metabolized by all tissues, but 
is a critical metabolic fuel for the nervous system including the brain (McCall 1993). Since 
the brain is unable to metabolize fatty acids, under physiological conditions, it depends almost 
exclusively on the metabolism of glucose (∼85% of which is terminally oxidized) for its 
energy production. Glucose oxidation normally accounts for virtually all of the oxygen 
consumed by the brain; the brain respiratory quotient is nearly 1.0 (Sokoloff 1989). Thus, 
even though other fuels, such as ketone bodies (water-soluble fatty acid equivalents that are 
produced by the liver, namely acetone, acetoacetate, and hydroxybutyrate), can partially 
substitute as a brain energy source when their circulating levels rise high enough for them to 
enter the brain in quantity, as ketone bodies do during fasting (Owen et al. 1967; Hasselbalch 
et al. 1995), availability of glucose is critical for the survival of the brain, and therefore for the 
whole individual. Impaired insulin signaling leads to a massive increase of blood glucose 
levels resulting in a pathological condition called Diabetes mellitus. The chronic 
hyperglycemia resulting from diabetes is associated with long-term damage, dysfunction, and 
failure of various organs, especially the eyes, kidneys, nerves, heart, and blood vessels. 
Diabetes mellitus is a fast spreading disease that currently afflicts around 150 million people 
world wide and is predicted to increase to 300 million people by the year 2025 (Green et al. 
2003). According to the Report of the Expert Committee on the Diagnosis and Classification 
of Diabetes mellitus (Gavin et al. 2000), diabetes can be classified etiologically into four 
major types: type I diabetes, type II diabetes, other types, and gestational diabetes. However, 
type I and type II constitute the two major forms and afflict almost 90% of the total diabetic 
population. Type I Diabetes mellitus, previously termed Insulin Dependent Diabetes Mellitus 
(IDDM), accounts for less than 10% of all cases. It results from a complete autoimmune 
destruction of the β-cells in the pancreas, caused by either environmental or genetic factors. 
Type II diabetes, formerly termed Non-Insulin Dependent Diabetes Mellitus (NIDDM), 
results from a combination of resistance to insulin action and an inadequate compensatory 
insulin secretory response by the pancreatic β-cells. An estimated 100 million people world-
wide of a wide range of ethnic groups and all social and economic levels suffer from this type 
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of diabetes (Green et al. 2003). Epidemological and twin studies indicate a polygenic 
predisposition for type II diabetes (Froguel et al. 1993). However, environmental factors such 
as obesity and sedentary life style can aggravate genetically determined insulin resistance.  
Besides its role as main regulator of blood glucose, insulin also stimulates cell growth and 
differentiation by promoting the storage of substrates in fat, liver and muscle by stimulating 
lipogenesis, glycogen-, and protein synthesis, and inhibiting lipolysis, glycogenolysis and 
protein breakdown (Saltiel and Kahn 2001). However, in vertebrates, circulating IGFs, which 
are phylogenetically closely related to insulin (Plisetskaya 1989), are the key regulators of 
IIS-dependent growth effects. Circulating IGFs are mainly produced by the liver upon 
induction of growth hormone (GH) (Lund 1999) and are essential for regulating growth and 
body size both pre-natally (IGF-1 and IGF-2) and post-natally (IGF-1)(Efstratiadis 1998; 
Nakae et al. 2001). Because many components from the IIS pathway have been isolated as 
retroviral oncogenes and as tumor-suppressor genes from mammalian systems, it has been 
suggested that deregulation of the IIS system can lead to cancer (Valentinis and Baserga 
2001; Vogt 2001). Proto-oncogene activation and loss-of-tumor-suppressor gene function lead 
to the initiation and progression of a variety of cancers, yet the basis for their tumorigenicity 
is often unknown because multiple genetic lesions are required to undermine the anti-
proliferative checkpoints of a cell (Vogelstein and Kinzler 1993; Hanahan and Weinberg 
2000).  
Apart from insulin and the IGFs, the insulin superfamily consists of at least five more 
members, namely relaxin, insulin-3, -4, -5, and -6 (Nakae et al. 2001). Relaxin, a hormone 
important for the growth and remodeling of reproductive and other tissues, does probably not 
signal through the canonical tyrosine kinase receptors (see below), but by the two G-protein 
coupled receptors LGR7 and LGR8 (Hsu et al. 2002). Insulin-3 is responsible for testicular 
descent through virilization, outgrowth of the embryonic gubernaculum, and gets specifically 
downregulated by estrogens (Nef et al. 2000). Insulin-4 is believed to play an important role 
in trophoblast development and regulation of bone formation (Chassin et al. 1995; Laurent et 
al. 1998). Insulin-5 is expressed in the hypothalamus and the pituitary gland, and is probably 
involved in thymic development and regulation (Conklin et al. 1999; Dun et al. 2006). 
Insulin-6 is known to be expressed at high levels in testes, but its function is so far unknown 
(Lok et al. 2000).  
All in all, there exist at least eight different insulin-like proteins in vertebrates, which carry 
out a wide variety of functions. How exactly the IIS system regulates, coordinates, and 
integrates all these processes remains at a rudimentary stage of understanding. One approach 
 10 
to understand this orchestration is to utilize the fruit fly Drosophila melanogaster, in which 
IIS is, despite the ∼700 million year evolutionary divergence, astonishingly well conserved 
(Oldham and Hafen 2003).  
 
 
The IGF-Binding Protein (IGFBP) Superfamily 
 
In biological fluids of vertebrates, IGFs are normally bound to IGFBPs. There are, at present, 
six well-characterized mammalian IGFBPs, designated IGFBP-1 through -6, which have 
higher affinities for IGFs than for the IGF-1 receptor (IGF-1R) and are present in molar 
excess relative to the sum of the concentrations of IGF-1 and -2 (Hwa et al. 1999). Therefore, 
the variables that control the molar concentration of each binding protein in extracellular 
fluids are important determinants of IGF action. IGFBP-3, which the most abundant of the 
IGFBPs, transports >75% of serum IGF-1 and -2 (Burger et al. 2005). The functions of the 
IGFBPs can be divided into four major areas. The first is their role as transport proteins for 
the IGFs in plasma, which also serve to control the efflux of IGFs from the vascular space. A 
second function of the IGFBPs is to regulate the half-lives and metabolic clearance rates of 
IGF-1 and -2. The third function is to provide a means of tissue- and cell-type-specific 
localization of the IGFs, and the fourth is to directly modulate the interaction of IGFs with 
their receptors (Clemmons 1999). Although a huge amount of both in vitro and in vivo studies 
have been conducted, it still remains elusive whether IGFBPs inhibit or augment IGF actions. 
A possible explanation is that the different cell lines used react in distinct ways to the 
presence of IGF/IGFBP complexes, because some secrete for instance certain proteases 
known to cleave IGFBPs, thereby decreasing their affinity for IGFs. Another explanation lies 
within the dual nature of the IGFBPs, which on one hand binds IGFs better than the receptors 
do, and on the other hand increases the half-life of the IGFs, thereby prolonging their presence 
in the system. Therefore, IGFBPs have the potential to either restrict or increase IGF activity.  
The primary structures of mammalian IGFBPs contains three distinct domains of roughly 
equivalent sizes: the conserved N-terminal domain, the highly variable midregion, and the 
conserved C-terminal domain. Overall, the human IGFBPs share approximately 36% 
similarity, although alignment of e.g. the conserved N-terminal domain shows significantly 
higher similarities, namely 56% (Hwa et al. 1999). In the 80-93 amino acid containing N-
terminal region of IGFBP1-5 all the 12 cysteines are fully conserved, whereas in IGFBP-6, 10 
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of the 12 cysteines are invariant. The high number of cysteines within such a small domain 
suggests that this domain is highly structured, with a maximum of 6 disulfide bonds formed (5 
in the case of IGFBP-6)(Hwa et al. 1999). Additionally to the conserved cysteines, the N-
terminal domain contains a local motif (GCGCCxxC) that is highly conserved among all 
IGFBPs and only present in vertebrates. However, the function of this motif is unknown. 
From its high degree of conservation, it is assumed to be important for the interactions with 
IGFs, though (Hwa et al. 1999). The midregion of human IGFBPs shares less than 15% 
similarity, is believed to act structurally as a hinge between the N- an C-terminal domains, 
and contrary to those domains contains posttranslational modification (phosphorylation, 
glycosylation) sites. The C-terminal domain of the IGFBPs is again highly conserved and 
shares approximately 34% similarity. It contains six cysteines, which are all strictly 
conserved. To efficiently bind IGF with high affinity, the presence of both the N- and the C-
terminal domains are essential (Hwa et al. 1999).  
Recently, an additional ten potential members of the IGFBP superfamily have been identified 
through computer analysis of GenBank sequence data, on the basis of the presence of the 
IGFBP motif, GCGCCxxC (Rosenfeld and Oh 1998; Burger et al. 2005). These proteins have 
considerably reduced binding affinities for the IGFs and are named as IGFBP-related proteins 
(IGFBP-rPs-1 to -10). IGFBP-rP-1, the first of these proteins to be found, was originally 
identified as a cDNA, termed mac25 (later also IGFBP-7/T1A12/TAF/AGM/PSF/PGI2), that 
was overexpressed in normal leptomeningeal cells compared to meningiomas (Murphy et al. 
1993). In IGFBP-rP-1 the first 112 amino acids show approximately 50% identity to IGFBP-
1, but distally, the sequence diverges completely. Interestingly, the conserved region spans 
exactly the first two exons. IGFBP-rP-1 is distinct from other IGFBP-rPs in that it can bind, 
additionally to binding IGF, strongly to insulin (Yamanaka et al. 1997). Although the affinity 
of IGFBP-rP-1 to IGFs and insulin is similar, its insulin:IGF binding ratio is 500-fold higher 
than that of IGFBP-1 to 6 (Yamanaka et al. 1997). Thus, IGFBP-rP-1 can compete with the 
InRs for binding of insulin, whereas for example IGFBP-3 cannot. In addition to binding 
insulin, IGFBP-rP-1 has also been shown to bind to activin, a member of the TGF-β 
superfamily of growth factors (Kato 2000). A study examining IGFBP-rP-1 protein 
expression in 60 primary breast cancers using immunohistochemistry revealed that 12 normal 
and benign breast tissues had strong IGFBP-rP-1 expression, 16 ductal carcinomas in situ 
showed weak IGFBP-rP-1 levels, and the invasive carcinomas were all negative for IGFBP-
rP-1 (Burger et al. 1998). This is indicating that IGFBP-rP-1 acts as a tumor suppressor.  
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Apart from its function in mediating cellular proliferation, IGFBP-rP-1 also regulates 
adhesion, angiogenesis, and stimulates prostacyclin synthesis (Burger et al. 2005). 
Additionally, IGFBP-rP-1has been found to be one of the major genes implicated in human 
endometrial (the endometrium is the inner uterine membrane, which is developed in 
preparation for the implantation of a fertilized egg, upon its arrival in the uterus) receptivity, 
folliculogenesis, as well as growth development and regression of the corpus luteum in higher 
mammals (Wandji et al. 2000; Dominguez et al. 2003; Casey et al. 2004). The role of IGFBP-
rP-1 in le reproductive system is further supported by the knock-out mouse of IGFBP-rP-1 
(Burger et al. 2005). Mice lacking IGFBP-rP-1 are viable, but at the age of 5-8 months, 
significant changes in the histology of the ovaries, muscle tissue, and the liver have been 
observed (Burger et al. 2005). In particular, gross abnormalities in the corpus luteum have 
been described (Burger et al. 2005).  
 
 
The acid-labile subunit (ALS) 
 
As already mentioned above, in adult animals, plasma IGFs form higher molecular weight 
complexes with specific IGFBPs (IGFBP-1 to -6). These complexes are referred to as ∼50kD 
binary complexes consisting of IGF-1 or IGF-2 and one IGFBP, or as 150kD ternary 
complexes consisting of one molecule each of IGF-1 or IGF-2, IGFBP-3 or IGFBP-5, and a 
85kD glycoprotein, the acid-labile subunit (ALS) (Boisclair et al. 2001; Domene et al. 2005). 
ALS has no affinity for free IGF-1 or IGF-2, and very low affinity for uncomplexed IGFBP-3. 
However, it readily binds to binary complexes of IGF and IGFBP-3 (Baxter and Martin 1989; 
Twigg and Baxter 1998). Virtually no free (unbound) IGFs are present in the circulation of 
vertebrates (Jones and Clemmons 1995; Stewart and Rotwein 1996). Unlike free IGFs and 
IGFs bound to the ∼50kD binary complexes, which can cross the vascular endothelium, 
formation of the ternary complexes restricts the IGFs to the circulation, prolongs their half-
lives and allows them to be stored at high concentration in plasma to facilitate their endocrine 
actions and to minimize their local effects due to their intrinsic insulin-like activities such as 
hypoglycemia (Zapf 1995). In adult animals, serum IGFs reach concentrations that are 1000 
fold that of insulin (Boisclair et al. 2001), which would be high enough for free IGFs to also 
stimulate the InR. Thus, ALS is a critical component that contributes to the development of 
this large IGF reservoir by extending its half-live from 10min when in free form, and 30-
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90min when in binary complexes, to more than 12h when bound in ternary complexes (Guler 
et al. 1989; Zapf 1995). Under acidic conditions, the ternary complex is irreversibly 
dissociated and free IGF is liberated (Martin and Baxter 1986). Neutralization after 
acidification allows for the re-association of IGF and IGFBP, but does not reconstitute the 
ternary complex (Murphy 1998).  
ALS, synthesized exclusively by the liver, is predominantly stimulated by growth hormone 
(GH), as are both IGF-1 and IGFBP-3 (Boisclair et al. 2001). The ALS protein contains 578 
amino acids with seven potential N-glycosylation sites. Further it has an unique structure with 
20 leucine-rich repeats of 24 amino acids, each with a similar consensus sequence. This 
structure is a general mediator of protein-protein interactions, and probably accounts for the 
high affinity of ALS for the binary IGFBP-IGF complexes (Clemmons 1999). A variety of 
conditions have been shown to reduce serum ALS in rats and humans. They include fasting, 
undernutrition, and catabolic diseases such as diabetes, burn injury and cirrhosis (Boisclair et 
al. 2001). Negative regulation of ALS synthesis occurs at both transcriptional and post-
transcriptional levels. Ablation of ALS has no effect on fetal growth in both the ALS-KO 
mice and the ALS-deficient patients. However, a modest reduction in post-natal growth in the 
null ALS mice (13%) and in the ALS-deficient patients was observed (Domene et al. 2005). 
Interestingly, ALS deficiency results in a dramatic reduction in circulating IGF-1 and IGFBP-
3 concentrations (without affecting their synthesis) compared to the wild-type situation (in 
mice the reductions are 62% and 88% respectively)(Boisclair et al. 2001). In contrast to the 
ALS-KO mice, human patients lacking ALS develop insulin resistance (Domene et al. 2005). 
All in all, ALS plays a major role in generating the large IGF pool in the circulation, which 
seems to be partly necessary for post-natal growth.  
Recently, an ALS ortholog has also been identified in Drosophila (dALS)(Colombani et al. 
2003). dALS is expressed in the Drosophila liver analog, fat body, and in seven distinct 
median neurosecretory cells (m-NSCs) of both larval brain hemispheres, that also express four 
of the Drosophila insulins (see below). Like in vertebrates, the expression of dALS is highly 
sensitive to starvation and amino acid restrictions (Colombani et al. 2003). Whether dALS 
functions in a similar way to vertebrate ALS, remains to be tested.  
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Insulin signaling in Drosophila 
 
The presence of an insulin-like hormone in insects has been already proposed 30 years ago 
(Seecof and Dewhurst 1974; Normann 1975; Duve et al. 1979). Since then, molecular and 
genetic analysis in Drosophila has demonstrated that the IIS system is not only present in 
insects, but also extremely well conserved. IIS in Drosophila controls growth, metabolism, 
reproduction, and longevity (Garofalo 2002). While vertebrates contain four different receptor 
tyrosine kinases for the insulin family peptides, the insulin receptor (InR), the IGF-1 receptor 
(IGF-1R), the IGF-2 receptor (IGF-2R), and the insulin related receptor (IRR), in the 
Drosophila genome only a single insulin receptor is present (Fernandez et al. 1995; Chen et 
al. 1996). The Drosophila insulin receptor (dInR), like its mammalian counterparts, 
comprised two α and two β subunits, with a tyrosine kinase domain in its β subunit that is 
activated upon insulin binding (Fernandez-Almonacid and Rosen 1987). Albeit the 
evolutionary distance between flies and humans, the InRs are, especially around the kinase 
domain, highly conserved, and dInR also binds mammalian insulin with reasonably high 
affinity (Garofalo 2002). However, the signaling mechanism of dInR may differ slightly from 
that of its mammalian homologs, as it possesses a carboxy-terminal extension adjacent to its 
kinase domain that contains various tyrosine phosphorylation sites. Autophosphorylation of 
this carboxy-terminal extension is predicted to allow dInR to recruit downstream signaling 
molecules directly without the need for intermediate adaptor proteins. dInR has an essential 
function during normal insect development, because strong dInR mutations are recessive 
embryonic lethal (Fernandez et al. 1995; Chen et al. 1996). Hypomorphic dInR combinations 
produce viable adults that show a dramatic reduction in overall body size, and display 
increased longevity (Chen et al. 1996; Brogiolo et al. 2001; Tatar et al. 2001). Ablation of the 
InR in mice leads to only a slight growth retardation (10% weight decrease), but to the 
development of severe hyperglycemia accompanied by an extreme elevation of insulin levels 
(Accili et al. 2001). In addition to the control of size and metabolism in vertebrates, the 
insulin receptor family, comprising InR, IGF-1R, and IRR, is required for the appearance of 
the male gonads and thus for male sexual differentiation (Nef et al. 2003). XY mice that are 
mutant for all the three receptors develop ovaries and show a completely female phenotype 
(Nef et al. 2003). So far there are no hints about an implication of dInR in the development of 
the male sexual differentiation in Drosophila, but viable combinations of dInR alleles display 
female sterility (Chen et al. 1996).  
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Recently, seven putative ligands, the Drosophila insulin-like peptides (Dilps), of the dInR, 
with homology to human insulin have been identified in Drosophila (Brogiolo et al. 2001). 
When overexpressed ubiquitously, all dilps promote growth (Ikeya et al. 2002). However, 
direct binding of any of the Dilps to the dInR has not been demonstrated yet, although Dilp2, 
the closest ortholog of mammalian insulin and the most potent growth inducing insulin in 
Drosophila, has been shown to genetically interact with the dInR (Brogiolo et al. 2001). The 
different dilp genes have distinct expression patterns, suggesting distinct functions (Brogiolo 
et al. 2001). Four of the seven dilps are expressed in seven cells of each hemisphere of the 
larval brain that might correspond to neurosecretory cells (Brogiolo et al. 2001; Cao and 
Brown 2001; Rulifson et al. 2002). Targeted ablation of these median neurosecretory cells (m-
NSC) causes growth retardation, developmental delay and elevated carbohydrate levels in the 
larval hemolymph (the insect equivalent of blood)(Rulifson et al. 2002). All these effect can 
be reversed by the ectopic expression of a dilp2 transgene (Rulifson et al. 2002). Thus, like its 
mammalian counterpart, dilp2 regulates growth and carbohydrate levels of the hemolymph. 
Since no mutants for any of the dilps exist, the m-NSC ablation phenotype provides the only 
hint at how a dilp loss-of-function phenotype could look like.  
 Figure 1: The insulin signaling pathway in Drosophila.  
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Intracellular insulin signaling 
 
Upon binding of the ligand, the InR undergoes a conformational change, which results in the 
autophosphorylation on several of its cytosolic tyrosine residues in the β-subunit (Ullrich and 
Schlessinger 1990). Once activated, the receptors transduce signals downstream by 
phosphorylating various intracellular substrates, including insulin receptor substrate (IRS) 
proteins. IRS proteins bind via their phosphotyrosine-binding (PTB) domains to 
autophosphorylated tyrosine residues in the juxtamembrane regions of the activated receptors 
(Leevers and Hafen 2004). IRS proteins lack intrinsic catalytic activities but are composed of 
multiple interaction domains and phosphorylation motifs. At least three IRS proteins occur in 
humans and mice, including IRS-1 and IRS-2, which are widely expressed, and IRS-4, which 
is limited to the thymus, brain, and kidney and possibly β-cells (Uchida et al. 2000). Rodents 
also express IRS-3, which is largely restricted to adipose tissue and displays activity similar to 
IRS-1. However, this short ortholog might not occur in humans (White 2002). Drosophila 
contains just a single ortholog of the IRS proteins termed chico. Like its mammalian 
homologs chico contains, in addition to the PTB domain, an N-terminal pleckstrin homology 
(PH) domain and several phosphotyrosine motifs that serve as docking sites for Src-homology 
2 (SH2) domain containing proteins. Two of these motifs (YxxM motifs) fit, after 
phosphorylation by the dInR, the SH2 binding site of the p60 (p85 in mammals) 
adaptor/regulatory subunit of the class IA Phosphoinositide 3-kinase (PI3K). Through the 
binding of PI3K to chico, its catalytic subunit Dp110 gets activated (Weinkove et al. 1997; 
Weinkove et al. 1999). In Drosophila, it has also been shown that p60 is also able to directly 
bind to the InR, circumventing the chico adaptor protein (Oldham and Hafen 2003). Another 
phosphotyrosine motif of chico corresponds to the consensus binding site (YxN) of the 
GRB2/DRK protein, which activates the Ras-mitogen-activated protein kinase (MAPK) 
pathway in mammals (White 2002). In vertebrates, this binding of GRB2/DRK to chico 
represents a connection between the InR and the Ras-MAPK pathways. However, in 
Drosophila at the level of the IRS protein, no connection between insulin and the 
RAS/MAPK pathways could be established so far.  
Conversely to mammals, which contain four class IA PI3Ks, p110α, p110β, p110γ, and p110δ 
(Vanhaesebroeck et al. 2001), Drosophila possesses a single copy, dp110. Through the 
association with the phosphorylated chico, but also dInR, dp110/p60 heterodimers are 
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recruited to the plasma membrane, where dp110 gets access to its phosphoinositide substrate, 
phosphatidylinositol-4,5 bisphosphate (PIP2). Via its lipid kinase domain, dp110 converts 
PIP2, via phosphorylation of the 3’ hydroxyl group of its inositol ring, to the critical second 
messenger phosphatidylinositol-3,4,5 trisphosphate (PIP3) (Leevers and Hafen 2004). 
Elevated levels of PIP3 transduce signals downstream by binding to molecules with PIP3-
binding pleckstrin-homology (PH) domains, thereby inducing their re-localization to the 
plasma membrane and/or conformational changes.  
The activity of class IA PI3Ks is counteracted by the phosphoinositide phosphatase PTEN 
(phosphatase and tensin homolog deleted on chromosome 10). PTEN is a lipid phosphatase 
that specifically removes phosphates at the D3 position of the PIP3 inositol ring (Maehama 
and Dixon 1998; Goberdhan et al. 1999; Huang et al. 1999; Gao et al. 2000). Through the 
dephosphorylation of PIP3, PTEN has a very important role in limiting growth. Immortalized 
embryonic fibroblasts or embryonic stem cells lacking PTEN display a two to three-fold 
increase in PIP3 levels (Hafen 2004). Loss of the tumor suppressor PTEN is a frequent event 
in the development of a wide variety of human cancers. PTEN germline mutations cause 
hereditary cancer predisposition syndromes like the Cowden-, Lhermitte-Duclos-, Bannayan-
Zonana-, and the Proteus syndrome, which are all diseases associated with increased cancer 
incidence (Sulis and Parsons 2003). Thus, the levels of PIP3 are under tight control, because 
any deregulation results in abnormal growth behavior.  
In mammals, a number of signaling molecules possess PIP3-binding PH domains, and hence 
have the potential to be regulated by PI3K. However, in Drosophila, two serine/threonine 
kinases have emerged as key downstream targets: the Drosophila homologs of 
phosphoinositide-dependent kinase 1 (dPDK1) and its substrate, the protein kinase B (PKB, 
also known as Akt)(Leevers and Hafen 2004). PKB is mainly cytosolic in unstimulated cells, 
but upon IIS activity is recruited to the plasma membrane by binding with its PH domain to 
PIP3. Phosphorylation of two sites, Thr308 and Ser473, is required for rendering PKB fully 
active. Once recruited to the cell membrane, PKB co-localizes with PDK1, which has a 
significantly higher affinity for phosphoinositides (PIs). However, the PIs themselves have no 
effect on the catalytic activity of PDK1 (Currie et al. 1999). PDK1 is the kinase, which 
phosphorylates Thr308 in PKB after its translocation to the membrane. Binding of PKB to 
PIP3 induces a conformational change in PKB, exposing its activation loop. This event makes 
Thr308 in PKB accessible for phosphorylation by PDK1. The responsible kinase 
phosphorylating Ser473 has remained elusive for a long time. However, it has been recently 
shown that in Drosophila and human cells, a complex consisting of the TOR kinase and its 
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associated proteins rictor and GβL (see also below) are not only directly phosphorylating 
PKB at Ser473, but also facilitate Thr308 phosphorylation by PDK1 (Sarbassov et al. 2005). 
Activated PKB then detaches from the membrane and translocates to the cytosol and nucleus, 
where it phosphorylates target proteins. In addition to phosphorylating PKB, PDK1 also 
directly activates the p70 S6 kinase (S6K, see also below)(Rintelen et al. 2001; Radimerski et 
al. 2002).  
 
 
Downstream of PKB 
 
PKB is one of the key effectors of the IIS signaling pathway, regulating growth, cell cycle, 
survival and nutrient metabolism. While vertebrates contain three copies of PKB proteins 
(Akt1-3), Drosophila contains a single one. The fact that reduced PKB activity is sufficient to 
rescue PTEN-induced lethality in Drosophila underscores its importance in transducing the 
insulin signal (Stocker et al. 2002). Therefore, most, if not all pathway activity is mediated 
through PKB in Drosophila. In vertebrates, over 50 proteins have been identified as putative 
PKB targets (Whiteman et al. 2002; Hanada et al. 2004). Amongst this growing list of 
substrates phosphorylated by PKB are the metabolic enzymes glycogen synthase kinase 3 
(GSK-3) and 6-phospho-2-kinase, proteins involved in cell survival such as BAD, 
transcription factors of the Forkhead family, especially forkhead box O (FoxO), and the tumor 
suppressor protein Tuberous sclerosis 2 (TSC2)(Hafen 2004). In Drosophila, genetic and 
biochemical studies have identified two critical targets of PKB, namely the FoxO subfamily 
and TSC2. By phosphorylating TSC2, PKB stimulates the TOR pathway (see below). FoxO 
factors are insulin sensitive transcription factors regulating a variety of processes including 
differentiation, metabolism, stress resistance, proliferation, and survival. FoxO proteins 
contain an N-terminal DNA-binding domain and a C-terminal trans-activation domain. The 
FoxO DNA-binding domain is flanked by several conserved PKB phosphorylation sites, and 
its function is antagonized by PKB phosphorylation (Leevers and Hafen 2004). While 
Drosophila contains a single FoxO ortholog, the mammalian genome comprises four members 
of the FoxO subfamily, all of which contain several conserved PKB phosphorylation sites. 
PKB-mediated phosphorylation of FoxO inhibits their function by generating 14-3-3 protein-
binding sites, thereby leading to the accumulation of 14-3-3-bound FoxO in the cytoplasm 
(Brunet et al. 1999). In the absence of PKB activity, FoxO is dephosphorylated, enters the 
 19 
nucleus, and activates target genes (Hafen 2004). Although FoxO is the only known 
transcriptional read-out for insulin signaling so far, its function, unlike PTEN, is not essential 
for development and organismal growth control under normal culture conditions in 
Drosophila (Junger et al. 2003). The use of microarrays to identify putative FoxO targets 
revealed genes involved in the stress response, such as cytochrome P450, and the gene 
encoding the translational inhibitor, Drosophila 4E-BP (for eukaryotic translation initiation 
factor 4E (eIF4E) binding protein)(Junger et al. 2003). The 4E-BP gene encodes a 
translational repressor and was initially identified in Drosophila as the immune-compromised 
Thor mutant in a genetic screen for genes involved in the innate immune response to bacterial 
infection (Rodriguez et al. 1996; Bernal and Kimbrell 2000). 4E-BP binds and inactivates the 
translation initiation factor eIF4E, which participates in the formation of a functional 
translation initiation complex. Positive transcriptional regulation of 4E-BP by FoxO, which 
corresponds to negative transcriptional regulation by insulin, would be a complementary 
mechanism of translational regulation.  
Recently, also another member of the forkhead transcription factor family, Foxa2, has been 
found to be strongly regulated by insulin signaling in vertebrates (Wolfrum et al. 2004). Like 
FoxO, Foxa2 is inactivated by insulin and feeding, but surprisingly, Foxa2 is far more 
sensitive to insulin signals than FoxO, and consequently is turned off even in insulin resistant 
states, whereas FoxO is not (Wolfrum et al. 2004). Additionally, a mutant form of Foxa2, that 
is no longer regulated by IIS, expressed in the livers of diabetic mice reversed the hepatic 
steatosis (abnormal accumulation of certain fats in the liver) and improved insulin sensitivity, 
both phenotypes associated with insulin resistance and diabetes (Wolfrum et al. 2004). To 
date, the Drosophila ortholog of Foxa2 has not yet been identified. However, the only known 
forkhead family member containing, like Foxa2, a putative PKB phosphorylation site is the 
forkhead (fkh) protein. It remains to be tested, if fkh is a true target of PKB, and if it functions 
in a similar way as Foxa2.  
TSC2 (tuberin, first named gigas in the fly), the second target of PKB, forms a complex with 
TSC1 (hamartin) and acts as a negative regulator of growth in Drosophila, and as a tumor 
suppressor in mammals. Mutations in human TSC1 and TSC2, which affects 1 in 6000 
individuals at birth (Cheadle et al. 2000; Li et al. 2004), are associated with heritable forms of 
tuberous sclerosis, a disease characterized by benign tumors (hamartomas) in the brain and 
other tissues (Montagne et al. 2001; Kandt 2002). In Drosophila, mutations in dTSC1 and 
dTSC2 have been identified in screens for genes that suppress growth. Loss of dTSC1 or 
dTSC2 accelerates growth and cell division, whereas co-expression of these two genes slows 
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growth and cell-cycle progression in a cell-autonomous fashion (Gao and Pan 2001; Potter et 
al. 2001; Tapon et al. 2001). Activated PKB phosphorylates TSC2 and thereby disrupts the 
TSC1/2 complex both in Drosophila and mammalian cells (Inoki et al. 2002; Potter et al. 
2002). However, the significance of TSC2 phosphorylation by PKB may vary depending on 
the physiological context. In Drosophila, a TSC2 variant that cannot be phosphorylated 
rescues the lethality of a TSC2 mutant (Dong and Pan 2004), indicating that during fly 
development, PKB phosphorylation of TSC2 is not essential. Recent genetic and biological 
evidence suggests that TSC1/2 regulates growth by acting as a GTPase-activating protein 
(GAP) for the small GTPase Rheb (Ras homolog enriched in brain) (Garami et al. 2003; 
Saucedo et al. 2003; Stocker et al. 2003; Zhang et al. 2003). By acting as GAP toward Rheb, 
TSC2 decreases the GTP-bound, and thus active form of Rheb. Active Rheb stimulates 
growth and translation by binding directly to the kinase domain in TOR and activates TOR in 
a GTP-dependent manner (Long et al. 2005). However, it is still unclear whether GTP-loading 
of Rheb is required for TOR binding or for a subsequent TOR-activation step (Wullschleger 
et al. 2006).  
 
 
The dual role of TOR 
 
TOR was originally identified in yeast by mutations that are resistant to the growth inhibiting 
effects of the antifungal and immunosuppressant drug rapamycin (Heitman et al. 1991). This 
study also demonstrated that rapamycin inhibits the function of TOR by forming a complex 
with FK506-binding protein-12 (FKBP-12), which binds to a conserved region located 
immediately upstream of TOR’s kinase domain. TOR is a member of the PI kinase-related 
kinase (PIKK) family of proteins that structurally resemble PIKs but possess Ser/Thr rather 
than lipid kinase activity (Leevers and Hafen 2004). To date, every eukaryote genome 
examined (including yeast, algae, slime mold, plants, worms, flies, and mammals) contains a 
TOR gene. Except yeast, which in some cases contains two different TOR genes, higher 
eukaryotes possess only a single copy of TOR (Wullschleger et al. 2006). The fact that TOR 
is a large protein containing multiple HEAT repeats suggests that it may function in a 
complex with other proteins. Indeed, it has been shown that TOR is present in two different 
complexes, TOR-complex 1 and 2 (TORC1 and TORC2 respectively), with distinct functions 
(Guertin et al. 2004). While TORC1 is sensitive to rapamycin treatment, TORC2 is not (see 
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more about TORC2 below)(Loewith and Hall 2004). In both complexes, TOR is associated 
with the protein GßL (Lst8 in yeast), which binds to the kinase domain of TOR and acts as a 
positive regulator of mammalian and yeast TOR signaling (Wullschleger et al. 2006). 
However, the precise role of GβL is not known. In TORC1, TOR and GβL are associated 
with a third binding partner, the 150kD protein raptor (KOG1 in yeast), which contains 
several HEAT repeats and seven WD40 domains (Wullschleger et al. 2006). Albeit it is 
known that raptor and TOR interact directly, the domains where this interaction takes place 
still remains elusive, which suggests multiple contact sites between these two proteins. As 
mentioned above, TORC1 is sensitive to rapamycin treatment. Although the exact mechanism 
is unknown, the FKBP12-rapamycin complex binds directly to TORC1 and thereby 
downregulates its activity (Wullschleger et al. 2006).  
TOR is an integrator of a big variety of different signals that influence growth of a cell. Four 
major inputs have been implicated in TOR signaling: growth factors, nutrients, energy, and 
stress. TOR is one of the principal control elements in the regulation of growth and energy 
metabolism. Although it still remains elusive, how and on which level the different signals 
influence TOR activity, it seems that most of them affect TOR by regulating the TSC1/2 
complex (Wullschleger et al. 2006). As mentioned above, the integration of the growth 
signals is likely to function via the PKB dependent phosphorylation of TSC2. Also the energy 
status of a cell is transmitted by the TSC1/2 complex. The energy “sensor” AMP-activated 
protein kinase (AMPK) is activated in response to low cellular energy (high AMP/ATP ratio). 
Activated AMPK directly phosphorylates TSC2 and thereby enhances its GAP activity, 
leading to the inhibition of TORC1 signaling (Inoki et al. 2003). Further, cellular stresses, 
such as hypoxia, downregulate TOR activity, and thereby inhibit protein synthesis 
(Wullschleger et al. 2006). Hypoxia is transduced to TORC1 via the two homologous proteins 
REDD1 and REDD2 (scylla and charybdis in Drosophila)(Brugarolas et al. 2004; Reiling and 
Hafen 2004). REDD, whose expression is induced by the hypoxia inducible factor-1 (HIF-1), 
acts downstream of PKB and upstream of the TSC1/2 complex to inhibit TORC1 signaling 
(Reiling and Hafen 2004). Finally, nutrients, especially amino acids, regulate TORC1 activity. 
Amino acid deprivation results in rapid dephosphorylation of TORC1 downstream targets. 
This dephosphorylation is strictly TORC1 dependent (Wullschleger et al. 2006).  
To current knowledge, the TORC2 consists of TOR, GβL, and a third binding partner named 
rictor (also known as AVO3 from yeast) but not raptor (Jacinto et al. 2004; Sarbassov et al. 
2004). Rictor is a large protein (∼200kDa) that contains no obvious catalytic motifs. In 
contrast to raptor, knockdown of TOR and rictor results in both actin polymerization and cell 
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spreading (Jacinto et al. 2004; Sarbassov et al. 2004). Besides its role in cytoskeleton 
reorganization, TORC2 has been found to phosphorylate and activate PKB (see also 
above)(Sarbassov et al. 2005). Thus, TORC2 plays a positive part in the activation of PKB. 
Importantly, PKB is phosphorylated by TORC2 but not by TORC1. The biological 
implications of this phosphorylation of PKB by TORC2, especially the indirect control of 
TORC2 over TORC1, which is activated by PKB, remains elusive. Apart from the effects on 
the cytoskeleton and PKB phosphorylation, the function of TORC2 is unclear. It is important 
to note that, due to the recent finding of TORC2, the effects of most upstream signals on TOR 
have been studied only in the context of TORC1. It is even unknown whether TORC2 is 
similarly influenced by the upstream regulators TSC and Rheb.  
 
 
Downstream of TOR 
 
TOR signaling plays a role in various growth-related processes in yeast and higher 
eukaryotes. The best-studied targets of TOR are the translation regulators S6K and 4EBP.  
S6K is an InR/TOR downstream signaling component with a direct impact on the translational 
machinery. S6K is a Ser/Thr kinase that is activated upon PDK1- and TORC1-dependent 
Ser/Thr phosphorylation (Oldham and Hafen 2003). S6K in turn phosphorylates the ribosomal 
protein S6 of the small ribosomal subunit. Phosphorylated S6 increases the translation of a 
subclass of mRNAs containing a 5’-tract of oligopyrimidines (5’TOPs), including many 
ribosomal proteins, elongation factors, and the poly(A)-binding protein (Leevers and Hafen 
2004). The 5’-TOP mRNAs account for 15-20% of total cellular mRNAs (Wullschleger et al. 
2006). Thus, by regulating S6K activity, TOR increases the translational capacity of a cell by 
selectively increasing the pool of ribosomes and associated factors. However, this model has 
been recently challenged by experiments showing that translation of 5’TOP mRNAs does not 
depend on S6K activity nor on S6 phosphorylation (Pende et al. 2004; Ruvinsky et al. 2005). 
Thus, it remains to be tested how and if TORC1 controls 5’TOP mRNAs. Further, it should 
be noted that S6K has also other biological targets which can affect translation and cell 
growth, including the protein synthesis elongation factor 2 kinase (eEF2K)(Wang et al. 2001) 
and 4EBP (Raught et al. 2001). A second way in which TORC1 activation promotes 
translation is via the direct phosphorylation and inactivation of 4EBP (see also above). 
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Phosphorylated 4EBP no longer binds to eIF-4E, which is than free to associate with eIF-4G 
to stimulate translation initiation.  
Apart from stimulating the onset of translation, it has been shown that TOR also controls 
ribosome biogenesis (Wullschleger et al. 2006). Studies in both yeast and mammalian cells 
have demonstrated that rapamycin blocks the biosynthesis of ribosomes by inhibiting 
transcription of RNA polymerase I (Pol I)-dependent rRNA genes, Pol II-dependent 
ribosomal protein genes, and Pol III-dependent tRNA genes (Martin and Hall 2005). Thus, 
TOR links nutrient availability to the biosynthesis of ribosomes, which accounts for a large 
segment of total energy consumption by the cell. However, the mechanism by which TOR 
controls the activity of all three RNA polymerases in a coordinated manner is not yet 
understood. In addition to the regulation of genes involved in ribosome biogenesis, TORC1 
also controls the transcription of many other genes, particularly genes involved in metabolic 
and biosynthetic pathways. This has been demonstrated by microarray experiments on 
rapamycin-treated mammalian cells (Peng et al. 2002). Further, it has been shown that 
TORC1-mediated phosphorylation regulates the nuclear localization and the activity of 
several nutrient- and stress-responsive transcription factors in yeast (Loewith and Hall 2004). 
All in  all, the role of TOR-controlled transcription in mediating cell growth remains poorly 
understood.  
Another process that is regulated by TOR, but also by the PI3K pathway, depending on the 
nutritional supply, is autophagy. Autophagy is a process by which eukaryotic cells recover 
their own cytoplasmic contents, including organelles, under starvation conditions to recycle 
amino acids and other macromolecules to provide an internal reserve of nutrients. This 
catabolic process involves the enclosure of cytoplasm by a double-membrane structure 
(autophagosome) and its subsequent delivery to the lysosome (Wullschleger et al. 2006). 
While TOR mutant Drosophila larvae display a strong enhancement of autophagy in the fat 
body even under non-starvation conditions, TOR overexpression represses starvation-induced 
autophagy (Scott et al. 2004). Although TOR is an important regulator of autophagy, it is not 
the only one. The control of autophagy is nutritionally, hormonally, and developmentally 
regulated by multiple signaling pathways (Levine and Klionsky 2004; Meijer and Codogno 
2004; Rusten et al. 2004).  
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Feedback loops between the InR and TOR pathway 
 
In Drosophila, the activity of PKB is increased in TOR and S6K mutant larvae, and decreased 
in the absence of a functional TSC complex. These observations suggest that S6K inhibits 
PKB activity via a negative feedback loop (Radimerski et al. 2002; Lizcano et al. 2003). 
Although the existence of this negative regulation could be clearly shown, the molecular 
mechanism in insects is unknown. However, it has been also shown in earlier studies of 
mammalian tissues that amino acid excess inhibits insulin signaling in a rapamycin-dependent 
manner (Tremblay et al. 2005). Further it could be shown in mouse embryonic fibroblasts 
(MEFs) that loss of either TSC1 or TSC2 leads to a strong inhibition of insulin-mediated 
PI3K signaling (Manning 2004). Recently, it has been demonstrated that the negative 
feedback mechanism in vertebrates functions by direct phosphorylation and inactivation of 
IRS proteins. In particular, S6K1 regulates IRS1 both at the transcriptional level and through 
direct phosphorylation, thereby impairing IRS1 adaptor function. Further, S6K1 knockout 
mice are, due to the loss of the IRS inhibition, hypersensitive to insulin (Um et al. 2004). 
Thus, constitutive activation of TOR-S6K signaling induces a negative feedback loop to 
attenuate PI3K via inhibition of IRS. In this light, the rather benign nature of hamartomas 
caused by the loss of either TSC gene in comparison to the malignant PTEN mutant tumors 
might be explained by insufficient PI3K/PKB pathway activity in these tumor cells necessary 
for a malignant conversion.  
 
 
Mutant phenotypes of the IIS pathway in Drosophila 
 
The most obvious role of IIS, uncovered by genetic analysis in Drosophila, is the regulation 
of growth and body size without disturbing patterning. A characteristic of the growth 
differences caused by IIS alterations (at least the pathway components from the InR to PKB) 
is that both cell number and cell size are affected, which is reminiscent of flies reared under 
adverse nutritional conditions. While positive components of the pathway stimulate growth, 
the negative ones restrict it. However, strong mutations in the InR, PI3K, PTEN, and PKB are 
all recessive embryonic lethal, indicating an essential function of those proteins during normal 
development (Garofalo 2002). Viable combinations of hypomorphic alleles of InR, PI3K, and 
PKB lead to the development of small flies with reduced cell sizes and numbers, which show 
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female sterility, a developmental delay, and at least in the case of the InR increased longevity 
(Hafen 2004). The reduction in cell growth and cell number is strictly autonomous, and is 
neither affecting differentiation nor patterning. Loss-of-function mutations in the adaptor 
protein chico are semi-viable, but are also delayed, reduced in size, due to a decrease in cell 
size and number (Bohni et al. 1999), and live significantly longer (Clancy et al. 2001). The 
reason why Chico is the only non-essential protein of the canonical IIS cascade upstream of 
PKB, could be that the InR is able to directly signal to PI3K, thereby circumventing the IRS 
adaptor protein (Leevers and Hafen 2004).  
In Drosophila, cell size and cell number appear to be controlled partly by two separate 
branches of the IIS network. While cell size but not cell number is reduced in mutants lacking 
S6K (Montagne et al. 1999), in chico mutants, only the reduction in cell number is depending 
on dFoxO (Junger et al. 2003). Intriguingly, although dFoxO is necessary for controlling the 
cell number-output of IIS, dFoxO mutants are viable and of normal body size when reared 
under standard culture conditions (Junger et al. 2003; Kramer et al. 2003).  
The role of IIS in the female reproductive system can be divided into two different aspects of 
its function. First, IIS controls the development of the female reproductive system. Female 
flies containing a temperature-sensitive allele of dp110 (dp110ts) become sterile when reared 
close to the restrictive temperature during larval and pupal development, but are kept at the 
permissive temperature during their adult life (Dietz 2003). Thus, IIS is needed for the 
development of the ovaries, and not only for egg production itself. Second, dp110ts/ts females 
reared at the permissive temperature during their whole development display a normal egg 
laying behavior, but when shifted to the restrictive temperature after hatching arrest egg 
laying within four days (Dietz 2003). Shifting the flies back to the permissive temperature can 
reverse this arrest in oogenesis. This reversible block in oogenesis is similar to what can be 
observed in starved and re-fed females (Drummond-Barbosa and Spradling 2001). Thus, 
besides playing a role in the development of the ovaries, IIS presumably regulates egg 
production according to the availability of nutrients.  
In addition to its effects on growth and reproduction in insects, the IIS pathway has also been 
shown to affect energy homeostasis: chico mutants have massively increased fat storages 
compared to wild type flies (Bohni et al. 1999), and PI3K loss-of-function leads to elevated 
glucose levels in the circulation of adult flies (M. Jünger and E. Hafen, unpublished results). 
Thus, not only the regulation of growth, but also the regulation of circulating glucose by 
insulin seems to be evolutionarily conserved between metazoans and vertebrates which 
develop severe hyperglycemia when lacking the InR (Louvi et al. 1997).  
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The similarity of the phenotypes caused by the loss of components in the insulin signaling 
pathway in insects and vertebrates strongly suggests a conserved role of this pathway in the 
control of overall growth during development without impinging on pattern formation. If, and 
to what extent also other functions of the vertebrate insulin family (e.g. ovarian development 
or energy metabolism) are conserved in Drosophila is still unclear.  
 
 
The Drosophila endocrine system 
 
Almost every aspect of an insect’s life is regulated by hormones at various developmental 
timepoints. Although the best-studied endocrine-stimulated events in their life cycle are 
molting and metamorphosis, there is a variety of others, such as metabolism, water-balance, 
reproductive cycle, and diapause, as well as behaviors such as eclosion, pheromone 
production, and migration, which remain largely obscure (the following text about the 
endocrine system is referred to in (Nijhout 1994)).  
 
Figure 2: The Drosophila Brain-Ring Gland Complex 
Structure of the Drosophila brain and ring gland and some of its 
connections (adapted from (Siegmund and Korge 2001)). 
Abbreviations: CA, corpora allata; CC, corpora cardiaca; PG, 
prothoracic gland; SEG, subesophageal ganglion; VG, ventricular 
ganglion.  
 
 
 
 
 
 
 
 
 
Anatomy 
 
The insect endocrine system, as well as the vertebrate system, is composed of two different 
endocrine organs: the conventional glandular tissues and the neurosecretory cells.  
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The two principal endocrine glands in insects are the prothoracic glands (PG), which produce 
and secrete ecdysteroids, and the corpora allata (CA), where juvenile hormone (JH) is 
produced and released. In higher dipterans such as Drosophila, the PG and the CA build 
together with the glandular/neurohemal (see below) organ corpora cardiaca (CC) a compound 
gland (King et al. 1966), which is located anterior to the brain hemispheres in the larva. 
Because of its circular shape, this compound gland is called ring gland (RG, Fig. 2). During 
metamorphosis, the PG (contrary to the CC and the CA) undergoes programmed cell death 
(Dai and Gilbert 1991) in all insects, except in certain Apterygota and the ovaries and the 
testes start to produce and release ecdysteroids.  
The neurosecretory cells (NSC), the second kind of endocrine organ, consist of groups of 
specialized neurons in the central nervous system. NSC are abundant in the brain (but occur 
actually in all ganglia) and have unusually large cell bodies that, instead of neurotransmitters, 
produce small polypeptides, the neurohormones. NSC usually do not secrete their products at 
synaptic endings but send their axons to specialized structures where their secretions are 
released directly into the hemolymph. Such compact release sites are called neurohemal 
organs. The CC serves as the principal, though not the exclusive, neurohemal site for the NSC 
of the brain. The name CC is derived from the fact that in many species it is intimately 
associated with the heart (it is actually connected to the aorta in Drosophila), where it releases 
the secretions into the hemolymph. Besides common neurons, the CC contains a number of 
intrinsic NSC that produce and release their hormones locally, and thus compose the 
glandular part of the CC.  
As in vertebrates, the secretory activity of the conventional endocrine glands in insects is 
controlled by the secretion of tropic or inhibitory neurohormones produced in the NSC. Thus, 
nearly every hormone that is not produced or secreted by NSC, is usually controlled by two 
neurohormones, a stimulating and an inhibiting one. Among other reasons, this is why the 
majority of insect hormones are such neurosecretory products.  
 
 
The primary hormones 
 
Among the first hormone families discovered were the ecdysteroids (EC). EC are steroid 
hormones occurring in both insects and plants. In insects and other arthropods more than sixty 
ecdysteroids have been isolated (Rees 1989), whereas more than hundred “phytoecdysteroids” 
are known in plants (Lafont and Horn 1989). Some of the phytoecdysteroids are identical 
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(have the same molecular structure and composition) to known insect EC, others are so far 
only known from plants. During larval development of Drosophila, as mentioned above, EC 
are the principal product of the large cells at both sides of the ring gland, called PG, whereas 
in adult flies the source of EC synthesis and release are the ovarian follicle cells and the 
gonads. The EC are not believed to be stored by the PG because the hormone is generally not 
detectable in homogenates of the glands even during periods of high activity. Thus, ecdysone, 
the hormone secreted by the PG and a member of the EC family, appears to be released as 
soon as it is synthesized. While ecdysone is relatively inactive and generally believed to be a 
prohormone, 20-hydroxyecdysone (20-HOE) is the active EC in most insects. 20-HOE is 
produced from ecdysone by the action of a P450 monooxygenase that hydroxylates E at 
carbon 20. In Drosophila, it has been shown that the gene shade is responsible for this 
transition from ecdysone to 20-HOE (Petryk et al. 2003). Interestingly, shade is not expressed 
in the ring gland itself, but in peripheral tissues such as epidermis, midgut, Malpighian 
Tubules and fat body (Petryk et al. 2003). Thus, although ecdysone is produced and secreted 
by the PG, the transformation into the active 20-HOE occurs at various other locations 
throughout the body. Because it is secreted prior to each molt, ecdysone is also called the 
“molting hormone”. The direct action of 20-HOE on the epidermal cells causes them to 
undergo apolysis, cell division, digestion of the old cuticle, and secretion of a new cuticle. It 
has to be mentioned that ecdysone, like most of the ring gland hormones, is mainly controlled 
by the brain, namely through prothoracicotropic hormones (PTTH).  
PTTH are neurosecretory polypeptides that are produced by lateral NSC in the anterior brain 
region and are transported via axons into the ring gland. Probably the axons release the PTTH 
directly in the PG, where they stimulate the synthesis and secretion of ecdysone. Thus, during 
larval development, every ecdysone peak is preceded by a PTTH peak. PTTH itself is 
negatively regulated by JH, but surprisingly only in the final larval instar of holometabolous 
insects (Nijhout and Williams 1974; Rountree and Bollenbacher 1986). What regulates PTTH 
in earlier instars is still unclear.  
Another hormone that plays a major role in insect development and reproduction, is the JH. 
According to (Nijhout 1994), JHs are probably the most versatile hormones in the entire 
animal kingdom. They are involved in diverse processes such as metamorphosis, larval and 
adult diapause regulation, vitellogenin synthesis (by the fat body), longevity, ovarian 
development, and various aspects of metabolism. So far, the only known source of JH 
synthesis and release in insects is the CA, a small glandular tissue (see above) that is 
innervated by several axons from the brain and probably the CC. The CA does not store JHs, 
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so that the rate at which JH secretion occurs is determined entirely by the rate of its synthesis. 
The synthesis itself is largely dependent on neuropeptides from the brain. The production of 
JH from the CA is stimulated by allatotropic hormones (ATH, Atn in Drosophila) and 
inhibited by allatostatic hormones (ASH, Ast in Drosophila). Another neuropeptide that has 
just recently been shown in Drosophila to positively regulate JH production is insulin (Tatar 
et al. 2001). JHs are sequiterpenoids, derived from farnesenic acid, with an epoxide group 
near one end and a methyl ester on the other (Röller et al. 1967). The natural JHs are 
extremely unstable and get degraded by sunlight and various esterases in the hemolymph. JH 
is a lipidlike molecule that has two mechanisms of action at the cellular level: in the fashion 
of a steroid hormone, binding to high affinity receptors in the nucleus, and in the manner of a 
peptide hormone, binding to a cell surface receptor activating a phosphatidyl inositol-
mediated second-messenger system. Although a lot about the distinct functions of JH is still 
unclear, it is known that high JH levels prevent metamorphosis and adult differentiation, 
whereas the degree of its absence determines whether the animal molts to a pupal, larval or 
adult form (Harvie et al. 1998).  
 
 
Akh - another insect hormone involved in controlling metabolism 
 
The adipokinetic hormones (AKH) form another important hormone class in insects, of which 
some members play a crucial role in metabolism. The structure of the AKHs is very similar to 
that of the crustacean red-pigment-concentrating hormone (RPCH) family, which regulates 
the expansion of pigment in red chromatophores. Because of this structural relationship, the 
family is called the AKH/RPCH family. It forms a widespread and functionally diverse family 
of small neuropeptides, of which hypertrehalosemic hormone (HTH) is a member in insects. 
HTH was first discovered in CC homogenates of the cockroach Periplaneta americana 
(Steele 1961) as a factor that causes, when injected, a dramatic elevation of trehalose (a 
disaccharide of glucose and the main form of carbohydrate in the hemolymph of most insects) 
in the hemolymph and cardioacceleration. It actually stimulates the breakdown of glycogen 
via activation of the enzyme phosphorylase, which is the rate-limiting enzyme in the 
breakdown pathway of glycogen (Mordue and Goldsworthy 1969; Goldsworthy 1970; Ziegler 
1979; Gäde 1981; Steele 1982; Steele 1985). HTHs are neurosecretory hormones that usually 
contain 8-10 amino acids (aa) and are produced, in all the tested insect species, by the 
intrinsic neurosecretory cells of the CC. HTH, as all the AKHs, does not appear to have 
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species-specific functions (e.g. AKH from the blowfly Phormia is recognized by receptors in 
the fat body of the cockroach Periplaneta, which leads to an elevation of carbohydrate in the 
hemolymph). Considering the function of HTH, it has to be mentioned that there exist a slight 
sequence similarity between AKHs and the N-terminal portion of glucagon (Scarborough et 
al. 1984). Given the fact that all the members of the AKH family show high structural 
similarity, it is not quite clear what accounts for the differences of their biological functions. 
Much of the diverse regulatory functions may be due to differences in the receptor and the 
transduction mechanisms of the target cells.  
In Drosophila, a protein with high homology to the AKH/RPCH family, and thus also to 
HTH, has been discovered: the Drosophila adipokinetic hormone (dAkh)(Schaffer et al. 
1990). The dAkh is produced as a 79 amino acid precursor protein, which is processed into an 
octapeptide with, like most members of the AKH family, a pyroglutamic acid at its N-
terminus and a tryptophan carboxyamide at its C-terminus. Thus the N- as well as the C-
terminus is blocked. dAkh also contains the characteristic phenylalanine residue at position 4 
and the tryptophan residue at position 8. An unusual feature about the sequence of dAkh is, 
that it contains a charged residue, i.e. aspartic acid, at position 7. All the other members of the 
AKH/RPCH family known so far are uncharged, with the exception of a recently discovered 
protein of the blowfly Phormia terraenovae (Diptera), called Phormia terraenovae 
hypertrehalosemic hormone (Pht-HrTH)(Gäde et al. 1990). Pht-HrTH is in sequence and 
structure absolutely identical to the dAkh. It has been shown that dAkh elevates the 
carbohydrate level in the blood in a dose-dependent manner (without an increase of 
hemolymph lipid levels) and accelerates the heartbeat when injected into the blowfly Phormia 
terraenovae and the cockroach Periplaneta americana (Gäde et al. 1990). Additionally, it has 
been shown in Drosophila that the decrease in trehalose levels following targeted ablation of 
the dAkh producing CC cells is partly rescued by expression of a dAkh transgene (Kim and 
Rulifson 2004). Besides its hyperglycemic activity, dAkh also displays cardioaccelerating 
activity in Drosophila prepupae (Noyes et al. 1995). Thus, dAkh is a functional member of 
the HTH superfamily, which holds the ability to increase hemolymph trehalose content and to 
accelerate the heartbeat.  
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• Supplemental results about Imp-L2 
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Abstract 
 
The highly conserved insulin/IGF receptor pathway plays a predominant role in determining 
size, metabolism, reproduction, and longevity. Here we show that a secreted member of the 
immunoglobulin superfamily, Imaginal morphogenesis protein-Late 2 (Imp-L2), which is 
homologous to the potential vertebrate tumor suppressor IGF binding protein-related protein 1 
(IGFBP-rP1), inhibits growth non-autonomously by suppressing insulin signaling in 
Drosophila. Imp-L2 is expressed in parts of the major endocrine tissue, the corpora cardiaca, a 
variety of brain neurons, and the same seven median neurosecretory cells that produce four of 
the seven Drosophila insulin-like peptides (Dilps). While overexpressing Imp-L2 reduces size 
dramatically, loss-of Imp-L2 function increase overall body size to the same extent as weak 
dilp2 overexpression. An increase of Dilp2 levels in an Imp-L2 mutant background results in 
lethality. Thus, Imp-L2 is necessary to compensate hyperinsulinemia in Drosophila. The fact 
that co-overexpression of Imp-L2 rescues the lethality induced by high Dilp2 levels, and that 
Imp-L2 binds Dilp2 in vitro, strongly suggests that Imp-L2 plays a predominant role in 
regulating Dilp2 activity in vivo. Furthermore, we show that under starvation conditions, Imp-
L2 is necessary for larval survival and for efficiently inhibiting insulin signaling.  
 
 
Introduction 
 
In higher organisms, growth is regulated by a variety of intrinsic and extrinsic factors 
throughout development. Dysfunction of the signaling pathways controlling growth results in 
cells of altered size and contributes to a wide variety of pathological conditions, such as 
cancer, diabetes, and inflammation (reference). One of the major pathways controlling growth 
is the evolutionarily conserved insulin/IGF receptor (InR/IGFR) pathway. In mammals, the 
primary role of insulin and the InR is energy homeostasis by regulating blood glucose levels 
(Saltiel and Kahn 2001), but mutations in the InR gene can also cause embryonic growth 
retardation (Taylor 1992; Takahashi et al. 1997). However, the main growth regulatory 
function in mammals is carried out by the insulin-like growth factors (IGF)-1 and -2 and the 
IGFR (Butler and Le Roith 2001).  
Drosophila has a single InR (dInR) that acts via a canonical phosphatidylinositide 3-kinase 
(PI3K)/protein kinase B (dPKB/dAkt) pathway which regulates growth, metabolism, 
reproduction, and longevity (Garofalo 2002). Upon activation, InR phosphorylates adaptor 
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proteins like insulin receptor substrates (IRS1-4, the only homolog in Drosophila is called 
chico), thereby creating a binding site for the SH2-domain containing regulatory subunit of 
class IA PI3K, p85 (dp60 in D.m.). Via its catalytic p110 (dp110 in D.m.) subunit, PI3K 
phosphorylates phosphatidylinositol-(4,5)-bisphosphate (PIP2) to elevate 
phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) levels. This phosphorylation is negatively 
regulated by the tumor suppressor PTEN (phosphatase and tensin homolog on chromosome 
ten). PIP3 serves as binding site for the PH-domain of PKB, recruiting it to the cell membrane, 
where it is phosphorylated by the phosphoinositide-dependent kinase 1 (PDK1) and the target 
of rapamycin complex 2 (TORC2) (Sarbassov et al. 2005). Among others, activated PKB 
phosphorylates the transcription factor FoxO (forkhead box, subgroup “O”) thereby inhibiting 
its function.  
Recently, seven insulin-like peptides (Dilps) serving as putative ligands for the insulin 
receptor have been identified in Drosophila (Brogiolo et al. 2001). Dilps are expressed in a 
highly controlled spatial and temporal pattern, which includes expression in median 
neurosecretory cells (m-NSCs) of both brain hemispheres. The m-NSCs possess axon 
terminals in the larval endocrine gland and on the aorta, where the Dilps are secreted into the 
hemolymph and act in an endocrine fashion to control growth (Brogiolo et al. 2001; Ikeya et 
al. 2002; Rulifson et al. 2002). Ablation of these m-NSCs causes a developmental delay, 
growth retardation, and elevated carbohydrate levels in the larval hemolymph (Ikeya et al. 
2002; Rulifson et al. 2002). These defects mimic the phenotype of starved flies or flies mutant 
for insulin signaling components, and can be rescued by ubiquitous expression of dilp2 
(Rulifson et al. 2002).  
Overexpression of each of the seven dilps is sufficient to increase total body size (Ikeya et al. 
2002). Apart from their effect on size, nothing is known about the specific function of the 
different Dilps. Since no loss-of-function mutations exist in any of the dilp genes, it is 
unknown if the different Dilps carry out distinct functions or if their function is similar but 
exerted on different target tissues. In biological fluids of vertebrates, IGFs are normally bound 
and transported by IGF binding proteins (IGFBP) (Hwa et al. 1999). Having higher affinity 
for IGFs than for the IGFR, IGFBPs not only prolong the half-lives of IGFs, but modulate 
their availability and activity (Jones and Clemmons 1995). Besides the classical IGFBP, a 
related protein named IGFBP-related protein-1 (IGFBP-rP1/IGFBP-
7/mac25/TAF/AGM/PSF) has been identified as a high-affinity insulin binding protein 
(Yamanaka et al. 1997). Thus, extracellular insulin/IGF signaling in vertebrates is controlled 
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by a family of binding proteins that modulates interactions of the ligand with the receptor. In 
Drosophila nothing is known about the control of extracellular Dilp levels.  
In a gain-of-function screen for suppressors of dInR-induced hyperplasia in the eye, we 
identified the secreted protein Imaginal morphogenesis protein-Late2 (Imp-L2) that displays 
some homology to IGFBP-rP1. While overexpression of Imp-L2 results in a non-autonomous 
size reduction, loss-of Imp-L2 function enhances insulin signaling and increases organismal 
size. Since Imp-L2 binds Dilp2 in vitro and antagonizes its function in vivo, we propose that 
Imp-L2 acts as an insulin binding protein in Drosophila necessary to block insulin signaling 
under adverse nutritional conditions.  
 
 
 
Results 
 
Identification of Imp-L2 
 
To identify novel inhibitors of the Insulin signaling pathway, we performed a misexpression 
screen using a double-headed enhancer-promotor (EP) element. We tested 5400 random EP 
insertions for suppression of the overgrowth phenotype caused by the overexpression of wild-
type dInR in the developing eye using GMR-Gal4 (Fig. 1A). It has already been demonstrated 
that this system is sensitive to alterations in insulin signaling both up- (Brogiolo et al. 2001) 
and downstream (Wittwer et al. 2005) of the dInR. Thus, our screening system is likely to 
identify further components of the pathway. 
Among the suppressor lines identified, one contained an EP element (EP5.66) inserted 8.5kb 
upstream of the Imp-L2 coding sequence (Fig. 1F). When driven by GMR-Gal4, EP5.66 
strongly suppressed the dInR induced big-eye phenotype (Fig 1B). The Imp-L2 gene locus 
(Fig. 1F) consists of three different transcripts that differ in the usage of the first exon but 
share the same Imp-L2 protein-coding region. While Imp-L2-RA and Imp-L2-RC contain a 
small non-coding first exon (Fig. 1F), Imp-L2-RB possesses three small upstream open 
reading frames (uORFs) in its first exon. We established two different UAS transgenes 
containing the cDNA of the Imp-L2-RB transcript either with (UAS-long-IMPL2, further 
named UAS-l.IMPL2) or without (UAS-short-IMPL2, further named UAS-s.IMPL2) the first 
exon. While UAS-l.IMPL2 only partially suppresses the InR induced bulging eye phenotype 
(Fig. 1D), UAS-s.IMPL2 entirely reversed the phenotype (Fig. 1E). Additionally, a point 
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mutation in the Imp-L2 coding sequence (see below) abolishes its ability to suppress the InR 
caused overproliferation (Fig. 1C). Thus, Imp-L2 is sufficient to suppress the dInR induced 
eye phenotype. Furthermore, these results indicate that the first exon of the Imp-L2-RB 
transcript has a repressive function on the translation of the Imp-L2 mRNA (see also below). 
Imp-L2 has been previously shown to be upregulated 8-10 hours after ecdysone treatment 
(Osterbur et al. 1988) in a screen for ecdysone-inducible genes (Natzle et al. 1986). It 
represents a secreted member of the immunoglobulin (Ig) superfamily containing two Ig-C2-
like domains. Although there are several orthologs of Imp-L2 in lower organisms as 
arthropods and nematodes (Fig. 1G), no clear structural homolog could be identified in higher 
organisms.  
In vertebrates, insulin and IGFs are part of a tightly controlled network of ligands, receptors 
and binding proteins (for a review see (Hwa et al. 1999)). While the classical IGFBP-1 to -6 
have very high affinities for IGFs, their binding affinity for insulin is very low. On the other 
hand, IGFBP-rP1 binds insulin, IGF-I and -II to about the same extent, but its insulin:IGF 
binding ratio is 500-fold higher than that of IGFBP-1 to -6 (Yamanaka et al. 1997). 
Structurally, the IGFBP1-6 and IGFBP-rP1 show a high degree of similarity in their N-
terminal domain, whereas the C-terminal ends differ considerably. Instead of the classical 
IGFBP C-terminus IGFBP-rP1 contains an Ig-C2 like domain, which shows, especially 
around the cysteins forming the disulfide bridges, similarity to the second Ig domain of Imp-
L2 (Fig. 1G). Additionally, it has been shown by Sloth Andersen and colleagues that Imp-L2 
is also able to bind human insulin, IGF-I, and IGF-II (Sloth Andersen et al. 2000). Thus, it is 
likely that Imp-L2 is the functional homolog of IGFBP-rP1 in lower organisms which lack 
other IGFBP orthologs. 
 
 
The expression of Imp-L2 is highly regulated during development 
 
As shown by Garbe and colleagues, Imp-L2 mRNA can be detected in embryos from the 
cellular blastoderm throughout embryogenesis in a variety of different tissues, including the 
ventral neuroectoderm, the tracheal pits, the pharynx, the esophagus, and specific neuronal 
cell bodies (Garbe et al. 1993). Nevertheless Imp-L2 protein is only localized to specific 
neuronal structures late in embryogenesis (Garbe et al. 1993). To further determine the 
expression pattern of Imp-L2, we performed in situ hybridization and immunohistochemistry 
in larval and adult tissues. In 3rd instar larvae, Imp-L2 mRNA and protein are strongly 
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expressed in the corpora cardiaca (CC, Fig. 2A, D, E), which are part of the ring gland. The 
ring gland is the major neuroendocrine organ of Drosophila larvae, controlling metabolism, 
development and growth. In addition to the staining in the CC, weaker expression of Imp-L2 
can be detected in several neurons of both brain hemispheres, the subesophageal ganglion 
(SOG) and the ventral ganglion (Fig. 2B and E). The seven m-NSC that produce the Dilps 1, 
2, 3 and 5 (Fig. 2G), and project their axons directly to the SOG, the CC and the heart (Cao 
and Brown 2001; Rulifson et al. 2002) also express Imp-L2. Thus, Imp-L2 is expressed in the 
same cells as the Drosophila insulins, thereby having the potential to interact with the Dilps 
directly at their origin. Furthermore, Imp-L2 expression can be detected in 10-20 cells of the 
anterior midgut epithelium (Fig. 2C+F). These cells are much smaller than the surrounding 
cells (Fig. 2C’), and neither their origin nor their function is known.  
In adults, Imp-L2 protein is expressed in distinct neurons of both male and female brains (Fig. 
2I), and early stages of ovary development (Fig. 2H). In oogenesis, Imp-L2 is expressed from 
the germarium until stage 3 oocytes. After stage 3, the dot-like structures containing Imp-L2 
protein disappear gradually. Beyond stage 6, no more Imp-L2 protein can be detected. 
Contrary to the uniform cytoplasmic staining observed in other tissues, Imp-L2 is expressed 
in vesicle-like compartments in the ovary (Fig. 2H).  
In summary, Imp-L2 is expressed in a variety of neuronal and secretory tissues. Amongst 
them are cells controlling food uptake (Melcher and Pankratz 2005), glucose homeostasis, 
energy metabolism (Ikeya et al. 2002; Rulifson et al. 2002; Kim and Rulifson 2004), and 
reproduction. This is further supporting the hypothesis that Imp-L2 is acting as a neuronally 
controlled hormone playing a role in regulating energy balance.  
 
 
Imp-L2 reduces growth non-autonomously by reducing insulin signaling 
 
To further assess the function of Imp-L2 as a secreted inhibitor of insulin signaling, we 
ectopically expressed Imp-L2 by various Gal4 drivers in different tissues. Strong ubiquitous 
overexpression of Imp-L2 by Act-Gal4 led to lethality with both the UAS-l.IMPL2 and the 
UAS-s.IMPL2 transgenes. While driving UAS-s.IMPL2 by the weaker arm-Gal4 driver still 
resulted in lethality, driving UAS-l.IMPL2 generated flies that were decreased in size and 
weight (-15% in males and -29% in females, data not shown). Apart from the size reduction, 
these flies eclosed with Mendelian ratio and had wild-type appearance. By generating 
overexpression flp-out clones in the eye we confirmed that cell specification and patterning of 
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Imp-L2 overexpressing ommatidia were normal (Fig. 3A). However, a reduction of cell size in 
the clones was observed. The reduction in cell size appeared to be non-autonomous since 
wild-type ommatidia close to the clone were also reduced in size. Given the convex nature of 
the eye we were unable to quantify effects of Imp-L2 overexpression on more distantly 
located ommatidia. Thus, to assess the non-autonomous effect, total body size was measured, 
while Imp-L2 was overexpressed in a tissue specific manner. Eye-specific overexpression of 
both UAS-l.Imp-L2 and UAS-s.Imp-L2 by GMR-Gal4 led to a strong reduction in eye size 
(data not shown). While the GMR-Gal4, UAS-l.Imp-L2 flies were of normal size, total body 
weight was reduced by 38.3% in GMR-Gal4, UAS-s.Imp-L2 male flies (Fig. 3B), and 
development was delayed by one day. Because the highly specialized tissue of the Drosophila 
eye imaginal disc is unlikely to secrete sufficient Imp-L2 levels in order to elicit discernible 
effects on the rest of the body, we wanted to assay the effect of high Imp-L2 levels on total 
body size in a tissue better suited for protein secretion. Therefore, we used the ppl-Gal4 driver 
to overexpress Imp-L2 in the fat body. Ppl-Gal4, UAS-s.IMPL2 flies were lethal, whereas ppl-
Gal4, UAS-l.IMPL2 flies showed a dramatic reduction in overall body size (Fig. 3C and D) 
and were developmentally delayed by two days. Both the size decrease and the developmental 
delay are reminiscent of phenotypes observed in mutants for positive components of the 
insulin signaling pathway such as chico (Bohni et al. 1999), further supporting the hypothesis 
that Imp-L2 acts as a negative regulator of this pathway.  
Another characteristic of insulin signaling pathway mutations and nutritional limitation is a 
change in both cell size and  cell number. Overexpressing UAS-l.IMPL2 in the wing using 
C10-Gal4 led to flies with smaller wings (Fig. 3E), which was mainly due to a reduction in 
cell number. The stronger UAS-s.IMPL2 transgene again led to lethality when combined with 
the C10-Gal4 driver. Therefore, we wanted to further investigate the inhibitory role of the 
first exon of the Imp-L2-RB transcript. For this purpose we generated UAS transgenes of both 
the Imp-L2-RA and the Imp-L2-RC transcripts, which lack any uORFs. Both UAS-IMPL2-RA 
and UAS-IMPL2-RC overexpressed in the wing decreased the wing size and cell number  to a 
greater extent than UAS-l.IMPL2 (Fig. 3E). In addition they also decreased cell size. Thus, 
overexpression of Imp-L2 decreases body and organ size due to a reduction in both cell size 
and  cell number.  
To test whether the observed size reduction by Imp-L2 overexpression is accompanied by a 
down-regulation of insulin signaling, we assayed its effect on PIP3 levels. We used a GFP-PH 
domain fusion protein (tGPH) that specifically binds PIP3 and serves as a reporter for PIP3 
levels in vivo (Britton et al. 2002). The amount of membrane bound tGPH reflects PI3K/PKB 
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signaling activity. Overexpression of dInR posterior to the morphogenetic furrow resulted in a 
severe increase of membrane PIP3 levels (Fig. 4A and B). Like dPTEN, co-overexpression of 
Imp-L2 together with dInR reduced PIP3 levels significantly (Fig. 4C and D). This confirms 
that Imp-L2 inhibits PI3K/PKB signaling upstream of PIP3, without affecting dInR levels 
(Fig. 4B’ and 4D’). 
 
To further investigate the function of Imp-L2, we generated loss-of-function mutations in the 
gene. First we performed an EMS mutagenesis screen in which we selected mutated 
chromosomes carrying EP5.66 that were no longer able to suppress the dInR overexpression 
phenotype in the eye (Fig. 1A). Thereby, one revertant allele (Imp-L2MG2) was identified that 
contained a point mutation in its ORF leading to a premature stop at amino acid 232 (Fig. 1F). 
The mutation is close to the C-terminal end of the protein and leads to a truncated version of 
Imp-L2 in which the conserved cysteine bridge of the 2nd Ig domain is destroyed (marked by 
an asterisk in Fig. 1G). Overexpression of this truncated Imp-L2 version had no inhibitory 
effect on size (Fig. 1C). Thus, Imp-L2MG2 is likely to be a functional null allele.  
In addition, we generated further Imp-L2 alleles by imprecise excision of GE24013, a P-
element located 102bps upstream of the transcriptional start site of Imp-L2-RC’s first exon 
(Fig. 1F). We obtained four Imp-L2 deficiencies lacking most (Def35) or the entire (Def20, 
Def42, Def223) coding sequence. All heteroallelic combinations of the mutant alleles 
increased total body size (Fig. 5A) and displayed enhanced insulin signaling (Fig. 7A 
compared with 7C). While homozygous mutant males showed a 27% increase of total body 
weight, mutant females were 64% heavier (Fig. 5B). Introducing one copy of a genomic 
rescue construct (Garbe et al. 1993) into homozygous mutant flies reverted the size to the 
level of Imp-L2+/- flies, which were already heavier (+14% in males, +44% in females, Fig. 
5B). By measuring the cell density in the wing, the increase in size and weight could be 
attributed primarily to higher cell number, since cell size was only slightly affected (Fig. 5C). 
Apart from the size increase, the flies lacking Imp-L2 appeared completely normal, eclosed 
with the expected frequency and were not delayed. Thus, Imp-L2 loss-of-function dominantly 
increases growth by augmenting cell number without perturbing patterning, developmental 
timing or viability.  
Interestingly, the weight difference in mutant females was about two-fold higher than in 
males (Fig. 5B), albeit the increase in wing area and cell number was similar. This is because 
Imp-L2 mutant females had much larger abdomen than control flies (Fig. 5A). This phenotype 
was sensitive to crowding conditions within the vial, and not completely penetrant, which 
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suggests that Imp-L2 plays a role in the control of oogenesis. Although the mutant females 
(virgins or mated females) did not lay more eggs than controls (data not shown), ovaries of 
heterozygous and homozygous Imp-L2 mutants were dramatically increased in size, similar to 
viable dilp2 overexpression situations (Fig. 5D and not shown). Size and structure of the fly 
ovary are dependent on nutrition. The ovaries of females raised on poor food are reduced in 
size, and their ovarioles contain few, if any, vitellogenic stages (Drummond-Barbosa and 
Spradling 2001). This phenotype can be reproduced by inhibiting insulin signaling, since 
viable mutations in either the dInR, chico, dPI3K, dPKB or dS6K, cause female sterility (Chen 
et al. 1996; Bohni et al. 1999; Montagne et al. 1999) by preventing ovarian stages beyond the 
onset of vitellogenesis. Thus, there exists a checkpoint at the beginning of vitellogenesis that 
is sensitive to nutrition and under the control of the insulin signaling pathway. In Imp-L2 
mutant females, although the number of ovarioles is not changed, the amount of mature eggs 
per ovary is increased two-fold (Fig. 5E) and the number of vitellogenic stage10 egg 
chambers increased three-fold (Fig. 5E). Thus, Imp-L2 is necessary for the checkpoint 
controlling the onset of vitellogenesis, without affecting the egg laying behavior.  
 
 
Imp-L2 interacts with Dilp2 and is necessary for blocking insulin signaling under 
starvation 
 
The fact that Imp-L2 is a secreted protein, and that removal of Imp-L2 function does not 
rescue either chico or PI3K mutant phenotypes (data not shown), is consistent with the 
hypothesis that it acts upstream of the intracellular insulin signaling pathway at the level of 
the ligands. Therefore, we wanted to test genetic interactions of Imp-L2 with the dilps. A 
deficiency (Df(3L)AC1) uncovering dilp1-5 dominantly enhanced the small eye phenotype 
caused by eye-specific overexpression of Imp-L2 (supplementary info). Dilp2 is the most 
potent growth regulator of the seven Dilps in Drosophila (Ikeya et al. 2002). Since flies 
lacking Imp-L2 also display an increase in total body size, we further concentrated on the 
interaction between Imp-L2 and Dilp2. Weak ubiquitous overexpression of dilp2 by arm-Gal4 
caused an increase in total body and organ size (Ikeya et al. 2002). Heterozygosity for Imp-L2 
dominantly increased the size of arm-Gal4, UAS-dilp2 flies (Fig. 6A). Further, in 
homozygous Imp-L2 mutants, expression of dilp2 under the control of arm-Gal4 caused 
lethality, which is reminiscent of flies expressing dilp2 at high levels (Ikeya et al. 2002). 
Expressing both Imp-L2 and dilp2 individually at high levels in the fat body also caused 
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lethality, but co-expression resulted in viable flies of wild-type size (Fig. 6B). Thus, Imp-L2 
decreases the sensitivity to high insulin levels and is sufficient to rescue the lethality resulting 
from dilp2-induced hyperinsulinemia. This raised the question whether Imp-L2 is able to 
physically bind Dilp2. Therefore, we constructed a tagged version of Dilp2 that contains an 
N-terminal Flag tag in between the signal peptide and the actual Dilp2 protein. 
Overexpression of Flag-dilp2 in flies resulted in an increase of total body size demonstrating 
the functionality of the construct (not shown or supplementary info). Using in vitro translated, 
35S -labeled Imp-L2 and Flag-Dilp2 extracted from stably transfected S2 cells, we could show 
that Imp-L2 binds Dilp2 in vitro (Fig. 6C). Thus, by binding to Dilp2 and negatively 
regulating its function, Imp-L2 acts as a functional homolog of IGFBPs in Drosophila.  
Imp-L2 is a potent inhibitor of Dilp2 action, but is not necessary for survival under standard 
conditions. Therefore we wanted to test whether Imp-L2 functions as a fast acting inhibitor of 
insulin signaling under stress conditions. We exposed wild-type and Imp-L2 mutant early 3rd 
instar larvae to various starvation conditions and scored for survival. Larvae lacking Imp-L2 
showed a massive increase in lethality when exposed to 1% Glucose or PBS for 24h (Fig. 
6D). To test whether the increased lethality of larvae under starvation was due to an inability 
to adjust insulin signaling, we monitored PIP3 levels under starvation conditions. Whereas 
control flies showed a decrease of PIP3 levels when exposed to complete starvation for 4h 
(Fig. 7B compared with 7A), Imp-L2 mutant larvae still contained PIP3 levels that were 
comparable to control larvae reared on normal food (Fig. 7D compared with 7A), suggesting 
that Imp-L2 is necessary to shut down insulin signaling under starvation conditions. Imp-L2 
could exert its insulin inhibiting effect under starvation either by enhancing the secretion of 
stored protein or by upregulating Imp-L2 levels directly. It has been shown in a microarray 
experiment by Zinke and colleagues that Imp-L2 mRNA is weakly upregulated after exposure 
to 12h complete starvation (Zinke et al. 2002). We could not detect a change in expression of 
Imp-L2 in the brain, the ring gland and the gut after complete starvation for 24h (data not 
shown). However, Imp-L2 was upregulated in vesicular-like structures in fat body cells (Fig. 
7E). 
Taken together, these experiments show that Imp-L2 is upregulated by the fat body under 
adverse nutritional conditions, and that, although not crucial for survival on standard 
conditions, Imp-L2 is necessary for larval survival and blocking insulin signaling upon 
starvation.  
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Discussion 
 
Imp-L2 modulates growth by regulating the insulin signaling pathway 
 
A novel regulator of the insulin signaling pathway has been identified in a screen for 
suppressors of the InR induced hyperplasia in the eye. Imp-L2 regulates growth non-
autonomously by downregulating the insulin signaling pathway activity in vivo. Depending on 
the levels, Imp-L2 overexpression reduces body and organ size to the same extent and in a 
similar fashion as loss-of-function mutations in positive dInR signaling regulators, such as 
chico or dPKB. Like the negative regulator dPTEN, Imp-L2 attenuates PIP3 levels induced by 
increased dInR activity, and releases PKB-dependent inhibition of dFoxO, thus enabling the 
expression of the dFoxO target gene d4EBP (not shown or refer to Franz screen paper). Loss-
of Imp-L2 function is sufficient to increase total body size to an extent that is similar to weak 
dilp2 overexpression situations or viable PTEN loss-of-function alleles. Furthermore, in Imp-
L2 mutants, dInR signaling activity is increased and can no longer be attenuated under adverse 
nutritional conditions. The size increase of both Imp-L2 mutants and viable dilp2 
overexpression is suppressed by removing chico (data not shown) suggesting that Imp-L2, 
like Dilp2, acts upstream of the intracellular insulin signaling pathway. Additionally, by 
genetic interactions and binding studies we showed that Imp-L2 binds Dilp2 directly and 
counteracts its functions. Therefore, we propose that Imp-L2 acts as a modulator of Dilp 
activity and its availability in biological fluids of insects. 
Recently it has been shown that ecdysone, apart from its role as one of the major hormones 
regulating development and metamorphosis, antagonizes insulin signaling in determining 
final body size (Colombani et al. 2005). The larval fat body serves as a key relay element for 
this ecdysone-dependent growth inhibition (Colombani et al. 2005). Since Imp-L2 has been 
originally identified as an ecdysone-inducible protein and it is induced in the fat body upon 
starvation, it is tempting to speculate that the humoral, insulin-inhibiting signal emanating 
from the fat body could be the Imp-L2 protein. Further analysis of the growth inhibiting effect 
of ecdysone in an Imp-L2 mutant background should enlighten this aspect of Imp-L2 function. 
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Is Imp-L2 the insulin binding protein used by lower organisms? 
 
In vertebrates, IGF-1 and -2 are potent growth inducers that are mostly bound and regulated 
by their binding proteins (for review see (Hwa et al. 1999)). When bound to IGFs, IGFBPs 
function by regulating their transport between intra- and extravascular spaces, by interaction 
with their receptors (Zapf 1995), by prolonging their half-life (Stewart and Rotwein 1996) and 
by precluding their mitogenic activity (Rajah et al. 1999). In the vascular system, most of the 
binary IGF/IGFBP complexes are additionally bound to a third binding partner called acid 
labile subunit (ALS), whereby the half-life of the complex is again massively extended 
(Boisclair et al. 2001). While the affinity of IGFBP1-6 for IGF is very high, their ability to 
bind insulin is low. Conversely, IGFBP-rP1 binds IGF specifically with low affinity, but is a 
high-affinity insulin binding protein (Yamanaka et al. 1997). IGFBP-rP1 blocks binding of 
insulin to the InR and thereby inhibits the earliest step in insulin action (Yamanaka et al. 
1997). Additionally, IGFBP-rP1 is a potential tumor suppressor (Burger et al. 1998) and plays 
an important role in the female reproductive system, in processes like endometrial receptivity, 
folliculogenesis as well as growth development and regression of the corpus luteum (Wandji 
et al. 2000; Dominguez et al. 2003; Casey et al. 2004).  
Lower organisms like insects or nematodes, although lacking any clear orthologs of IGFBPs, 
produce various insulin-like proteins. The only known protein that has been implicated in 
insulin binding in invertebrates so far is Imp-L2. There is a single ortholog of Imp-L2 present 
in Caenorhabditis elegans, Apis mellifera, Anopheles gambiae, Spodoptera frugiperda, and 
Drosophila pseudobscura. In vertebrates, only homology between Imp-L2 and the Ig-domain 
containing C-terminus of IGFBP-rP1 could be detected. Although this is not very high, their 
function seems to be conserved. Like IGFBP-rP1, Imp-L2 is potently inhibiting growth, binds 
to and interacts with insulin, and plays a role in female reproduction in Drosophila. Therefore, 
we propose that Imp-L2 acts as the functional homolog of IGFBP-rP1 in Drosophila.  
It is tempting to speculate that the IGFBPs in vertebrates evolved from the Imp-L2-like 
proteins, since in all lower organisms a single ortholog of these two-Ig-domain proteins seems 
to be present, but the characteristic N-terminal IGFBP-motif is missing completely. Thus, 
IGFBP-rP1 could be a chimerical protein that during evolution exchanged its N-terminal Ig-
domain with a newly evolved IGFBP motif.  
Recently, an ortholog of the glycoprotein ALS was also identified in Drosophila (dALS) 
(Colombani et al. 2003). dALS is expressed in the fat body and the dilp-producing m-NSCs, 
and, like in mammals, its expression is sensitive to starvation (Colombani et al. 2003). 
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However, the function of ALS in Drosophila is unknown. Interaction studies of dALS with 
the Dilps and Imp-L2 should clarify whether dALS is part of the network controlling the 
activity of insulin in flies.  
 
 
Imp-L2 and Dilp2 interaction under starvation 
 
In Drosophila, dInR/PI3K signaling coordinates nutritional status with growth and cell 
metabolism of endoreplicative tissues (ERT) like the fat body. Ectopic induction of dInR or 
PI3K is sufficient to drive cell growth in ERTs even in starved animals (Britton et al. 2002). 
Additionally, PI3K activity is modulated in response to starvation (Fig. 7A+B). In larvae, 
hyperactivation of the dInR pathway leads to increased accumulation of nutrients, while 
inhibiting PI3K activity depletes stored nutrients from the fat body (Britton et al. 2002). Thus, 
like in mammals, insulin acts as a strong anabolic inducer in the Drosophila fat body, an 
organ that resembles the mammalian liver as the principal site of stored glycogen 
(Wigglesworth 1949). Even under adverse nutritional conditions dInR/PI3K expressing cells 
continue stockpiling nutrients and grow, which induces hypersensitivity to starvation of the 
whole larva (Britton et al. 2002). Like dInR overexpressing larvae, Imp-L2 mutants display 
enhanced dInR signaling activity and show a massive increase in lethality when nutrients 
become limiting (Fig. 6D). Hence, we propose that Imp-L2 is necessary to block insulin 
signaling under starvation conditions by regulating Dilp activity. Whereas the expression of 
dilp3 and 5 is directly suppressed at the transcriptional level in the m-NSCs by starvation 
(Ikeya et al. 2002), it is not known how Dilp2, the most potent inducer of growth, is regulated 
under starvation. Imp-L2 provides a new way of controlling Dilp2 activity under adverse 
nutritional conditions, as it is induced and necessary under starvation, and by binding to Dilp2 
counteracts its function.  
The fact that the lethality of Imp-L2 mutant larvae is not much increased when raised on an 
amino acid- (aa) free sugar source (20% glucose in Fig. 6D) suggests that the insulin 
inhibiting effect of Imp-L2 is mainly subject to sugar availability. When the glucose 
concentration is lowered to 1%, Imp-L2 mutant larvae die to the same extent as if raised on 
PBS only. Thus, lacking sugar triggers a response that downregulates insulin signaling in an 
Imp-L2-dependent manner.  
It has been shown that the CC cells, unlike the m-NSCs or any other group of cells known to 
regulate hemolymph glucose, express Drosophila cognates of sulphonylurea receptor (Sur) 
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and potassium channel (Ir) proteins (Kim and Rulifson 2004). Sur and Ir comprise ATP-
sensitive potassium channels regulating hormone secretion by islets and other mammalian 
glucose sensing cells (Aguilar-Bryan et al. 1995; Miki et al. 2001; Seino and Miki 2003). 
Blocking the KATP channels of the CC by the drugs glyburide and tolbutamide results in 
enhanced hormonal secretion and an up to 40% increase in hemolymph glucose levels (Kim 
and Rulifson 2004). The increase in hemolymph glucose has so far believed to be solely due 
to enhanced secretion of the adipokinetic hormone (Akh), a polypeptide with glucagon-like 
functions that is produced and secreted exclusively by CC cells in Drosophila (Van der Horst 
2003; Kim and Rulifson 2004; Lee and Park 2004). Since ectopic expression of Akh only 
partly rescues the hypoglycemic effects of CC ablation (Kim and Rulifson 2004), we propose 
that the lack of CC-produced Imp-L2 accounts for the rest of the hypoglycemia. Through its 
negative regulation of Dilp2 activity, which itself is sufficient to rescue the hyperglycemia 
induced by m-NSC ablation (Rulifson et al. 2002), Imp-L2 possesses the ability to exert an 
additional effect on the control of hemolymph glucose levels. Further studies about the 
changes of hemolymph glucose levels in genetic backgrounds with varying Dilp2 and Imp-L2 
levels should clarify the role of Imp-L2 in glucose metabolism.  
 
 
 
Materials and Methods 
 
Fly stocks 
 
The following fly stocks and transgenes have been used for this study: y w ; w1118 ; GMR-
Gal4 (gift of M. Freeman, MRC Laboratory of Molecular biology, Cambridge, UK); C10-
Gal4 (corresponds to C765-Gal4, (Nellen et al. 1996)), arm-Gal4, Act5C-Gal4, , UAS-GFP, 
UAS-lacZ (all from the Bloomington Drosophila stock center); ppl-Gal4 (gift from M. 
Pankratz, Institut für Genetik, Karlsruhe, Germany); UAS-dInR (Brogiolo et al. 2001); 
Df(3L)AC1 (Brogiolo et al. 2001); tGPH (Britton et al. 2002); GMR>w+>Gal4 (Brogiolo et 
al. 2001); UAS-dPTEN (Huang et al. 1999); UAS-dilp2 (Brogiolo et al. 2001); GE24013 
(GenExel Inc.).  
All crosses were performed at 25°C if not stated otherwise.  
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EP-screen and isolation of Imp-L2 alleles 
 
The EP screen that led to the identification of Imp-L2 will be described elsewhere (F. 
Wittwer, W. Brogiolo, H. Stocker, D. Nellen, K. Basler, E. Hafen, unpublished data). An EP 
element was identified in the Imp-L2 locus suppressing the GMR-Gal4, UAS-InR induced big 
eye phenotype. Plasmid rescue of EP5.66 revealed that it was inserted 6’969bps upstream of 
the first exon of the Imp-L2-RB (CG15009-RB) transcript.  
To obtain loss-of-function alleles of Imp-L2, we performed an EMS mutagenesis screen in 
which we selected mutated chromosomes carrying EP5.66 that were no longer able to 
suppress the dInR overexpression phenotype in the eye. Therefore, EP5.66 males were fed 
with 25mM EMS (ethylmethansulfonate) and subsequently crossed to GMR-Gal4, UAS-dInR 
virgins. 39’000 F1 flies were screened for a reversion of the suppressive effect of EP5.66 on 
the growth phenotype caused by GMR-Gal4, UAS-dInR. Only one of the identified revertant 
lines, Imp-L2MG2, could be confirmed. By sequencing the genomic DNA of Imp-L2MG2, a 
point mutation that resulted in an amino acid exchange (Trp232Stop) was found.  
In order to generate further Imp-L2 mutants, we mobilized the P-element GE24013 (w+ 
marked) inserted 102bp’s upstream of the first exon of the Imp-L2-RC transcript by supplying 
Δ2-3 transposase. Jump starter males were mated with balancer females, and single F1 w- 
males were recrossed to balancer virgins. 350 stocks were established and molecularly tested 
for deletions by single-fly PCR using several primer pairs revealing the alleles Imp-L2Def42, 
Imp-L2Def20, Imp-L2Def35, Imp-L2Def223, and Imp-L2Def29. Because GE24013 contained various 
polymorphisms in Imp-L2, of which several resulted in amino acid substitutions compared to 
the published Imp-L2 sequence, a precise jump-out line of GE24013 could not be used as a 
control in the loss-of-function experiments.  
 
 
Construction of plasmids 
 
In order to generate the UAS-l.IMPL2 construct, a BglII/XhoI fragment of Imp-L2 was cut out 
of the Imp-L2-RB containing cDNA clone LP06542 and inserted into the pUAST vector 
(Brand and Perrimon 1993). To obtain UAS-s.IMPL2, we PCR amplified the second and third 
exon of Imp-L2 from genomic DNA, a region shared by all three Imp-L2 transcripts (primer 
sequences available on request). The fragment was subcloned into the pCRII-Topo vector 
(Invitrogen). The insert was then cut out by EcoRI and cloned into the pUAST vector (Brand 
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and Perrimon 1993). UAS-IMPL2-RA was constructed by inserting a SalI/EcoRI fragment of 
the cDNA clone SD10052 into the pUAST vector. To generate UAS-IMPL2-RC, an 
EcoRI/XhoI fragment from the cDNA clone SD23735 was inserted into the pUAST vector.  
For the generation of the genomic rescue construct, we used a genomic fragment, L2G314 
kindly provided by J. Natzle (Department of Molecular and Cellular Biology, University of 
California, Davis, US). The fragment contains 5kb of genomic sequence upstream of the first 
exon of the Imp-L2-RB transcript, and 1kb downstream of the third exon that was excised by 
BamHI/Asp718 and inserted into a pCaSpeR-4 vector (Thummel 1992).  
The Flag-dilp2 construct was created by PCR amplifying the dilp2 coding region without the 
signal peptide sequence from the full-length cDNA clone, EST GH11579 (obtained from 
Research Genetics), introducing a single flag tag at the 5’ end (primer sequences available on 
request). Further, the primers contained EcoRI and XhoI restriction sites. The resulting PCR 
product was then cloned as an EcoRI/XhoI fragment into an PS261 vector containing the 
hemagglutinin signal peptide sequence. From PS261, the Flag-dilp2 with the signal peptide 
was PCR amplified to introduce BglII and XbaI restriction sites. The BglII/XbaI fragment 
was inserted into a pUAST vector (Brand and Perrimon 1993).  
 
 
Cell culture 
 
Drosophila embryonic S2 cells were grown at 25°C in Schneider’s Drosophila medium 
(Gibco/Invitrogen) supplemented with 10% heat-inactivated fetal-calf serum (FCS), as well as 
Penicillin and Streptomycin.  
For the construction of the stably expressing Flag-dilp2 cell line, S2 cells were co-transfected 
with UAS-Flag-dilp2, Act-Gal4, and a third vector containing a Blasticidin resistance gene, 
using effectene transfection reagent (Qiagen). Two days after the transfection, the selection 
medium (Schneider’s containing 10% FCS and 1:200 5mg/ml Blasticidin) was added to the 
cells. After ten days the selection medium was replaced by Schneider’s containing 10% FCS 
and 1:500 5mg/ml Blasticidin.  
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In vitro pulldown assay 
 
S2 cells expressing Flag-dilp2 were grown to confluency on 175 cm2 culture flasks, washed 
with ice-cold PBS and extracted in IP buffer (120mM NaCl, 50mM Tris, pH 7.5, 20mM NaF, 
1mM benzamidine, 1 mM EDTA, 6mM EGTA, 15mM Na4P2O7, 0.5% Nonidet P-40, 30mM 
β-Glycerolphosphate, 1x Complete Mini Protease Inihibitor (Roche)). After incubation for 15 
min on an orbital shaker at 4°C, solubilized material was recovered by centrifugation at 
13.000 rpm for 15 min and supernatants were collected. 5µg of anti-flag-Antibody (Sigma 
M2, F3165) was added and incubated over night at 4°C while rotating. Protein G sepharose 
beads (Amersham Biosciences) were added for 2 h and the beads washed 4x with IP buffer. 
To verify the immunoprecipitation, a fraction of the beads was incubated with SDS loading 
buffer (62,5mM Tris-HCl, pH 6,8, 20mM DTT, 2% SDS, 25% glycerol, 0,02% bromophenol 
blue) for 5 min at 90°C and the proteins were separated by SDS PAGE. The presence of Flag-
Dilp2 was confirmed by immunoblotting.  
For the in vitro translation the Imp-L2-RC cDNA (SD23735) was cloned into the pCRII.1 
vector (Invitrogen) downstream of the SP6 polymerase promoter. Imp-L2 was translated in 
vitro using the TNT Quick coupled Transcription/Translation System (Promega) according to 
the manufacturer’s protocol. Briefly, 2µg of DNA was incubated with 20µCi [35S]methionine 
and 20µl TNT Quick Master Mix in a total volume of 25µl for 90 min at 30°C. 2.5µl of the 
product was used in the in vitro pulldown assay together with Flag-Dilp2 bound to beads or 
Protein G beads alone in IP buffer containing 0.05% NP-40. The reaction was rotated over 
night at 4°C, the beads were washed 6x with IP buffer (0.05% NP-40) and incubated with 
SDS loading buffer containing 100mM DTT for 10 min at 80°C. The dissociated proteins 
were separated using SDS-PAGE and detected by autoradiography.  
 
 
Phenotypic analyses 
 
Freshly eclosed flies were collected, separated according to sex, placed on normal fly food for 
72h, and anesthetized for 1 minute with ether prior to weighing. Weight was determined using 
a Mettler Toledo MX5 microbalance.  
Wing size was analyzed as described earlier (Reiling and Hafen 2004). ImageJ 1.32j software 
was used to determine the pixels of the wing area.  
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Scanning electron microscope pictures were taken from adult flies that were critical-point 
dried and coated with gold.  
Heat-shock induced overexpression clones (y, w, hs-Flp; GMR>w+>Gal4) were induced 24-
48h after egg laying by a 1h heat-shock at 37°C. Adult fly heads were cut in half using a razor 
blade and briefly stored on ice. Eyes were then fixed as described (Basler et al. 1991).  
For the analysis of the ovaries, freshly eclosed, non-virgin females were collected, and placed 
for 72h on normal fly food. The ovaries of ten females of each genotype were dissected in 
PBS, whereby the ovarioles, mature eggs, and stage 10 egg chambers were counted for each 
ovary separately.  
 
 
Starvation experiments 
 
For all starvation experiments, eggs were collected for 2h on apple agar plates supplemented 
with yeast. After 72h larvae were quickly washed in PBS, and transferred either to a new 
apple agar plate with yeast (“normal food” or “yeast”), a solution containing 20% glucose in 
PBS, or a filter paper soaked with 1% glucose in PBS or PBS only. After 24h, dead larvae 
were counted or dissected for immunohistochemistry.  
For the tGPH reporter analysis under starvation, the “PBS” or “yeast” conditions were used 
(see above). After 4h starvation larvae were dissected in PBS, fixed, and stained with 
Hoechst. Pictures were taken using a Leica SP2 confocal laser scanning microscope.  
 
 
Immunohistochemistry and in situ hybridization 
 
The antibody (Ab) against Imp-L2 was described earlier (Garbe et al. 1993), and kindly 
provided by J. Natzle (Department of Molecular and Cellular Biology, University of 
California, Davis, US). Antibody staining against Imp-L2 was performed using the following 
dilutions: rat-anti-Imp-L2 (1:200), donkey-anti-rat-FITC (1:400, Jackson). Other Abs used 
were: anti-β-Galactosidase (1:, ), an Ab against the C terminus of dInR (INRcT, 
1:10’000)(Fernandez et al. 1995). Nuclei were either stained with DAPI or Hoechst. Pictures 
were taken using a Leica SP2 confocal laser scanning microscope.  
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RNA in situ hybridization using DIG-labeled probes was performed as described (Brogiolo et 
al. 2001). The probes against Imp-L2 were derived from the s.Imp-L2 in a pBluescript SK+ 
vector.  
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Figures 
 
Figure 1.  Imp-L2 overexpression suppresses dInR induced growth 
 
(A-E) Shown are SEMs of female fly eyes (magnification=300x). Overexpression of Imp-L2 
by EP5.66 (B) suppresses the dInr dependent big eye phenotype (A). Flies carrying a point 
mutation in the Imp-L2 gene that leads to a premature stop (Imp-L2MG2) , identified in an EMS 
reversion mutagenesis, no longer suppressed the dInR induced phenotype (C). UAS 
transgenes containing either the full-length Imp-L2-RB transcript (UAS-l.IMPL2, D) or one 
lacking the first exon (UAS-s.IMPL2, E), are also able to rescue the overgrowth caused by 
overexpression of dInR. Genotypes: y, w; GMR-Gal4, UAS-dInR/UAS-GFP (A), y, w; GMR-
Gal4, UAS-dInR/+ ; EP5.66/+ (B), y, w; GMR-Gal4, UAS-dInR/+ ; EP5.66, Imp-L2MG2/+ (C), 
y, w; GMR-Gal4, UAS-dInR/+ ; UAS-l.IMPL2/+ (D), y, w; GMR-Gal4, UAS-dInR/+ ; UAS-
s.IMPL2/+ (E). (F) Genomic organization of the Imp-L2 locus. Indicated are the mutant 
alleles and used P-elements. MG2 marks the point mutation in the EMS allele Imp-L2MG2. (G) 
Alignment of Imp-L2, its orthologs in lower organisms and the putative human ortholog. Dark 
and grey boxes indicate amino acid identity and similarity, respectively. The triangle marks 
the tryptophan mutated to a stop in Imp-L2MG2. Asterisks mark the cysteins forming the two 
disulfide bridges. Dm: Drosophila melanogaster Imp-L2, Ag: Anopheles gambiae CP2953, 
Sf: Spodoptera frugiperda IBP, Ce: Caenorhabditis elegans zig-4, Hs: Homo sapiens IGFBP-
rP1. 
 
 
Figure 2.  Tissue specific overexpression of Imp-L2 reduces growth non-autonomously 
 
(A) Tangential section through an eye containing an Imp-L2 overexpression clone, marked by 
the lack of red pigment. While differentiation and patterning of the Imp-L2 overexpressing 
cells seems completely normal, cell size is reduced, with the cells being bigger the farther 
away from the clone they are. (B) Eye-specific overexpression of UAS-s.IMPL2 reduces total 
body weight (-38.3%). The graph shows male body weight. (C) Overexpression of UAS-
l.IMPL2 by the fat body specific ppl-Gal4 driver results in a 56.1% weight reduction in male 
flies (D). (E) Overexpression of different Imp-L2 UAS transgenes in the wing reduces total 
wing area due to a decrease in cell number and, except for UAS-l.IMPL2, also cell size. 
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Shown are female wings. All experiments were repeated at least twice (*p<0.0001 when 
compared to the “GFP” controls).  
Genotypes: (A) y, w, hs-flp/y, w; GMR>w+>Gal4/+; UAS-l.IMPL2/+, (B) “white” bar y, w; 
GMR-Gal4/+; UAS-s.IMPL2/+, “black” bar y, w; GMR-Gal4/UAS-GFP, (C+D) left fly and 
“white” bar: y, w; ppl-Gal4/+; UAS-l.IMPL2/+, right fly and “black” bar: y, w; ppl-
Gal4/UAS-GFP, (E) “GFP”: y, w; UAS-GFP/+; C10-Gal4/+, “l.IMPL2”: y, w;; C10-
Gal4/UAS-l.IMPL2, “l.IMPL2-3T”: y, w; UAS-l.IMPL2-3T(34)/+; C10-Gal4/+, “IMPL2-
RA”: y, w; UAS-IMPL2-RA(10)/+; C10-Gal4/+, “IMPL2-RC”: y, w;; C10-Gal4/UAS-IMPL2-
RC(4).  
 
 
Figure 3.  Imp-L2 reduces PIP3 levels 
 
Shown are eye imaginal discs of 3rd instar larvae. Green displays the localization of the tGPH 
reporter (in A-D). Expression of dInR protein is shown in red (A’-D’), and nuclear DNA 
staining (DAPI) in blue (A’-D’).  
(A) In wild-type eye imaginal discs, dInR/PI3K signaling is low inhibiting tGPH reporter 
recruitment to the membrane. (B) Overexpression of dInR posterior to the morphogenetic 
furrow causes a strong membrane relocation of tGPH. (C) Simultaneous overexpression of 
dInR and dPTEN reduces membrane-bound tGPH partially. (D) Like dPTEN, Imp-L2 
overexpression reduces the dInR induced membrane localization. Although PIP3 levels are 
strongly reduced when dPTEN or Imp-L2 is co-overexpressed together with dInR, dInR 
protein levels are unaffected (B’-D’).  
Genotypes: (A, A’) y, w; tGPH/+, (B, B’) y, w; UAS-dInR, tGPH/+; GMR-Gal4/+, (C, C’) y, 
w; UAS-dInR, tGPH/+; GMR-Gal4/UAS-dPTEN, (D, D’) y, w; UAS-dInR, tGPH/+; GMR-
Gal4/UAS-s.IMPL2.  
 
 
Figure 4.  Imp-L2 is expressed in a specific pattern throughout development 
 
(A) In situ hybridization with Imp-L2 antisense probes in 3rd instar larvae strongly stains cells 
of the CC (filled arrowheads). (B) When stained longer, also several neurons of both brain 
hemispheres and the subesophagal ganglion show expression of Imp-L2 mRNA. (C) A cluster 
of cells with unknown function in the anterior midgut epithelium expresses Imp-L2. A higher 
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magnification shows that the Imp-L2 expressing cells are much smaller than the surrounding 
cells of the epithelium (C’). (D-I) Antibody (Ab) staining of larval and adult tissues with an 
Ab against Imp-L2 (green). (D+E) The CC (filled arrowheads) expresses Imp-L2 protein 
specifically at high levels. The corpora allata (CA) is innervated by Imp-L2 expressing axons 
(D). In the larval brain, specific neurons of both brain hemispheres and the sub-esophagal 
ganglion (white arrow) express Imp-L2 (D). Axon projections of the brain neurons expressing 
Imp-L2 could be followed to central brain regions as well as the ring gland. Also larval 
midgut cells express Imp-L2 protein at high levels (F). In larvae carrying a copy of a dilp2-
lacZ transgene, co-staining with an Imp-L2-Ab and an Ab against β-galactosidase revealed 
that the seven m-NSCs expressing four dilps also produce low levels of Imp-L2 (G). In the 
ovaries of adult females, in early stages of oogenesis, Imp-L2 is expressed in vesicle-like 
structures (H). Like in larvae, Imp-L2 is expressed in distinct neurons of both brain 
hemispheres of adult males and females (I).  
 
 
Figure 5.  Imp-L2 controls body and organ size 
 
(A) Complete loss-of-Imp-L2 function increases body size in males and females. (B) Total 
body weight is increased 27.5% in males and 63.9% in females. Introducing one copy of a 
genomic rescue construct reduces the size increase to the level of heterozygous Imp-L2 
mutants, which are also heavier (males 13.9% and females 43.6%) than control flies. Imp-
L2+/- flies containing a copy of the genomic rescue construct are of nearly wild-type size. (C) 
The size increase of Imp-L2-/- flies is mainly due to an increase in cell number. (D) The 
additional size increase observed in Imp-L2-/-  and Imp-L2+/- females is due to an increase in 
ovary size. Shown are the ovaries of non-virgin females. (E) While the amount of ovarioles is 
not changed in Imp-L2 mutants, the number of mature egg chambers per ovary is increased 
135% in homozygous and 59% in heterozygous mutants when compared with controls. Apart 
from the mature eggs, Imp-L2-/- ovaries also display a 204% increased amount of stage 10 
oocytes. (*p<0.00001).  
Genotypes: “control” y, w/w, “Imp-L2-/-“ y, w;; Imp-L2Def42/Imp-L2Def20, “Imp-L2+/- in (B)“ y, 
w;; Imp-L2Def20/+, “Imp-L2+/-in (C, D, E)“ y, w;; Imp-L2Def42/+, “Imp-L2-/-, gen. rescue“ y, w;; 
Imp-L2Def42/Imp-L2Def20, Imp-L2genomic construct(57), “Imp-L2+/-, gen. rescue “y, w;; Imp-L2Def20, 
Imp-L2genomic construct(57)/+,  
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Figure 6.  Imp-L2 binds Dilp2 and counteracts its activity 
 
(A) The size increase of flies weakly overexpressing dilp2 by arm-Gal4 is enhanced 
dominantly by reducing Imp-L2 levels (*p<0.001). In a an Imp-L2 loss-of-function 
background weak overexpression of dilp2 results in lethality, which can be rescued by 
introducing a copy of the Imp-L2 genomic rescue construct. (B) While overexpression of 
dilp2 as well as Imp-L2 at high levels by the fat body specific ppl-Gal4 driver causes lethality, 
co-overexpression of dilp2 and Imp-L2 give rise to flies of wild-type size. (C) Imp-L2 binds 
Dilp2. Flag tagged Dilp2, extracted from stably transfected S2 cells, was bound to beads and 
incubated with in-vitro-translated, 35S-labeled Imp-L2. Empty beads were used as a control. 
Imp-L2 could only be pulled down in the presence of Dilp2. (D) The survival rate of Imp-L2 
mutant 3rd instar larvae is highly decreased under starvation. Larvae were subjected for 24 
hours to different starvation conditions. While lethality of Imp-L2-/- larvae is only slightly 
increased when raised on 20% glucose, most of the larvae lacking Imp-L2 die on 1% glucose 
and PBS.  
Genotypes: (A) from left to right: (1) y, w; arm-Gal4/+; UAS-dilp2/+, (2) y, w; arm-Gal4/+; 
UAS-dilp2/Imp-L2Def42, (3) y, w; arm-Gal4/+; UAS-dilp2, Imp-L2Def20/Imp-L2Def42, (4) y, w; 
arm-Gal4/UAS-dilp2; Imp-L2Def42/Imp-L2Def20, Imp-L2genomic construct(57), (5) y, w;; Imp-
L2Def42/Imp-L2Def20, (6) y, w; arm-Gal4/UAS-GFP; Imp-L2Def42/+, (7) y, w/w, (B) from left to 
right: (1) y, w; ppl-Gal4/+; UAS-s.IMPL2/UAS-lacZ, (2) y, w; ppl-Gal4/UAS-dilp2; UAS-
lacZ/+, (3) y, w; ppl-Gal4/UAS-dilp2; UAS-s.IMPL2/+, (1) y, w; ppl-Gal4/+; UAS-lacZ/+, 
(D) “Imp-L2-/-“ y, w;; Imp-L2Def42/Imp-L2Def20, “Imp-L2-/-, gen. rescue“ y, w;; Imp-L2Def42/Imp-
L2Def20, Imp-L2genomic construct(57), “Imp-L2+/-“ y, w;; Imp-L2Def42/+, “control” y, w/w.  
 
 
Figure 7.  Imp-L2 is necessary for blocking dInR signaling under starvation 
 
(A-D) tGPH fluorescence (green) in the fat body of feeding 3rd instar larvae under different 
nutrient conditions. (A’-D’) Nuclear staining (Hoechst) is shown in blue.  
While under normal conditions (“yeast”) insulin signaling is already high in wild-type feeding 
3rd instar larvae (A+A’), Imp-L2 mutants display a further increase in PIP3 localized to 
membranes of fat body cells (B+B’’). After 4h on PBS, dInR signaling is reduced in wild-
type controls (C+C’’). In Imp-L2-/- larvae, although PIP3 levels are slightly reduced upon 
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starvation (D+D’’ compared with B+B’’), PIP3 levels remain higher than in starved control 
larvae (compare D+D’’ with A+A’’).  
(E+F) In starved control larvae (yw), Imp-L2 expression (green) is induced in fat body cells 
after 24h PBS-starvation. Imp-L2 is localized to vesicular-like structures not detectable under 
normal nutritional conditions.  
Genotypes: (A, C, E, and F) y, w, (B+D) y, w;; Imp-L2Def42/Imp-L2Def20.  
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Supplemental results about Imp-L2 
 
This chapter describes findings that were either mentioned as “data not shown” in the 
manuscript but will also cover experiments and results that have not been reported in 
(Honegger et al. 2006).  
 
 
Imp-L2 gain-of-function analysis 
 
Overexpression effects of different Imp-L2 constructs 
 
As we have already shown in (Honegger et al. 2006), overexpression of UAS-l.Imp-L2(1724) 
by the fat body specific ppl-Gal4 leads to a size reduction that is comparable to homozygous 
chico mutants. Ppl-Gal4 driven overexpression of UAS-s.IMPL2(1726) causes lethality, 
though. To compare the overexpression phenotype of l.Imp-L2 with the EP insertion in the 
Imp-L2 locus, both EP5.66 and UAS-l.IMPL2 were expressed under ppl-Gal4 control (Fig. 
S1A). Surprisingly, even though the EP element contained the double amount of UAS sites, 
its effect on size, when driven by ppl-Gal4, was much weaker than with UAS-l.IMPL2(1724). 
Ppl-Gal4 was the only driver line with which EP5.66 led to weaker phenotypes than UAS-
l.IMPL2. With all the other drivers tested, EP5.66 had stronger effects on size (Fig. S2A) 
(Honegger et al. 2006). Although the size decrease was weaker it could be fully attributed to 
the expression of Imp-L2, because driving the truncated version of Imp-L2, Imp-L2MG2 (which 
still contained the EP5.66), with ppl-Gal4 had no longer any effect on total body weight (Fig. 
S1A). The reason for this discrepancy between EP5.66 and UAS-l.IMPL2 when driven in the 
fat body has so far remained elusive.  
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Figure S1: Analysis of different fat body specific Imp-L2 overexpression.  
Weights of 3 day-old adult flies, reared at 25°C. Males to the left, females to the right. (A) Imp-L2 expression in 
the fat body by ppl-Gal4 using EP5.66, leads to a weaker size decrease than by UAS-l.IMPL2. Driving the 
truncated mutant version of Imp-L2, EP5.66, Imp-L2MG2, by ppl-Gal4 has no longer any effect on total body 
weight. (B) Overexpression of the different insertions of the UAS-l.IMPL2 and UAS-s.IMPL2 constructs in the 
fat body by ppl-Gal4.  
 
For both, UAS-l.Imp-L2 and UAS-s.IMPL2, exist additional insertions, namely UAS-l.Imp-
L2(1725) and UAS-s.IMPL2(1727), that have not been tested yet (Galic 2001). 
Overexpression of both 1725 as well as 1727 by ppl-Gal4 resulted in weaker phenotypes than 
observed with 1724 and 1726 respectively (Fig. S1B). Between the two UAS-l.IMPL2 
transgenic insertions 1724 and 1725 only a narrow difference could be observed, which was 
even weaker, when the C10-Gal4 driver was used (Fig. S2). However, a major discrepancy 
could be observed between the two UAS-s.IMPL2 transgenic insertions 1726 and 1727 with 
various Gal4 driver lines (Fig. S1B+S2A). This difference between the two s.IMPL2 
insertions challenges the hypothesis, that overexpressing s.Imp-L2 has stronger effects than 
l.Imp-L2 because it lacks the first exon of Imp-L2-RB, and thereby the negative effect on 
translation of this exon. However, because expression of three different insertions of the 
UAS-IMPL2-3T transgene (Honegger et al. 2006) all showed a stronger inhibition on body 
weight than UAS-l.IMPL2 when driven by the C10-Gal4 driver line (Fig. S2A), we conclude 
that the weak effect of UAS-s.IMPL2(1727) was just due to its unfavorable insertion place.  
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Figure S2: Comparative analysis of the size effects of different UAS-IMPL2 constructs in the wing.  
(A) Weights of 3 day-old adult males reared at 25°C that express different UAS-constructs under the control of 
the C10-Gal4 driver line. All flies contain one copy of the driver and one of the UAS-construct. 1724 and 1725 
are different insertions of the UAS-l.IMPL2 transgene. 1726 and 1727 are different insertions of the UAS-
s.IMPL2 transgene. “22-23, 22-3, 22-18” are different insertions of the UAS-l.IMPL2-3T transgene. “21-1, 21-5” 
are different insertions of the UAS-l.IMPL2 transgene in which the 2nd and the 3rd ATG of the 3 uORFs in exon1 
are mutated to TTG. “20-27, 20-13, 20-22” are different insertions of the UAS-l.IMPL2 transgene in which the 
1st and the 3rd ATG of the 3 uORFs in exon1 are mutated to TTG. “19-1, 19-12” are different insertions of the 
UAS-l.IMPL2 transgene in which the 1st and the 2nd ATG of the 3 uORFs in exon1 are mutated to TTG. “18-12” 
is an UAS-l.IMPL2 transgene in which the 3rd ATG of the 3 uORFs in exon1 are mutated to TTG. (B, C, D) 
Wing analysis of UAS-s.IMPL2 (on the X-chromosome), UAS-l.IMPL2, UAS-IMPL2-3T (pBH22), UAS-
IMPL2-RA (pBH27), UAS-IMPL2-RC (pBH28) driven by C10-Gal4. Shown are female wing blade area (B), 
cell size (C), and cell number (D) as percentage of the C10-Gal4, UAS-GFP control. Contrary to the females, 
s.IMPL2(X)-, pBH27-, and pBH28-males did not survive when combined with the C10-Gal4 driver.  
 
In the process of generating the UAS-IMPL2-3T  transgene, we also constructed versions of 
UAS-l.IMPL2 in which either a single ATG of the three uORFs is mutated to TTG (pBH16, 
pBH17, pBH18) or two out of three ATGs are mutated (pBH19, pBH20, pBH21). A 
comparative weight analysis of these different UAS-constructs (except pBH16+17) is shown 
in (Fig. S2A), where they were driven by the C10-Gal4 driver displaying low ubiquitous 
expression and relatively high expression in the developing wing. All the constructs tested 
showed a decrease in body weight when compared to the GFP control. Though, the extent of 
the inhibitory effect was variable (see e.g. pBH20 in Fig. S2A).  
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In addition to the weight measurements, we conducted an analysis about how different UAS-
IMPL2 constructs affect cell size and cell number in the wing. While the size reduction of the  
two UAS-l.IMPL2 (1724+1725) and the UAS-IMPL2-3T (pBH22) constructs was mainly due 
to a decrease in cell number (Fig. S2B, C, and D), a third insertion of UAS-s.IMPL2 
(s.IMPL2(X)) as well as insertions of UAS-IMPL2-RA (pBH27) and UAS-IMPL2-RC 
(pBH28) reduced size by decreasing both cell size and cell number (Fig. S2B, C, and D).  
 
In summary, it is difficult to conclude much about the strength of different transgenes because 
they are inserted in completely different surroundings in the genome, which greatly influences 
transcription. Thus, in order to make a clear statement about the differences of the constructs, 
Imp-L2 mRNA levels of the various transgenes should be assayed by quantitative real-time 
PCR (qRT-PCR). This would allow the comparison of insertions with similar expression 
levels. An alternative would be to generate new transgenic fly lines using the attB/attP-system 
(Groth et al. 2004), which allows insertion of the transgenes at the very same molecular 
location, thereby excluding position effects on transgene expression.  
 
 
Non-autonomous effects of Imp-L2 overexpression 
 
In (Honegger et al. 2006) we showed that overexpressing Imp-L2 in clones (marked by the 
absence of the red pigment) decreases cell size in the eye without affecting patterning. Since 
Imp-L2 is a secreted protein we expected this inhibitory effect on cell size to be non-
autonomous. Therefore, by measuring the areas taken up by the photoreceptors (black areas in 
Fig. S3A), we tried to quantify if the cells in the vicinity of the Imp-L2 source also display 
altered cell sizes. Even though no significant changes could be observed when one row of 
photoreceptor clusters was compared with the adjacent one, we saw a tendency to become 
bigger the farther away from Imp-L2 clone the clusters are (Fig. S3B).  
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Figure S3: Tissue specific overexpression of Imp-L2 reduces growth non-autonomously. 
(A) Tangential section through an eye containing an Imp-L2 overexpression clone, which can be recognized by 
the lack of red pigment. While differentiation and patterning of the Imp-L2 overexpressing cells appears to be 
completely normal, cell size is reduced. (B) When the black areas surrounding the photoreceptor cells in (A) is 
measured, a tendency towards a size increase can be observed the farther away from the clone the photoreceptors 
are. The clone border was defined as photoreceptor cell clusters that consist of mixed of Imp-L2 overexpressing 
and control cells. Genotype: (A) y, w, hs-flp/y, w; GMR>w+>Gal4/+; UAS-l.IMPL2/+.  
 
In order to show the non-autonomous effect on size of Imp-L2 expression in alternative tissue, 
we expressed it in a wing-specific manner. Overexpression of Imp-L2 in the posterior 
compartment by en-Gal4 not only decreases the size of the posterior wing half, but also of the 
total wing (Fig. S4A+B). The total wing blade area is reduced by 10% (Fig. S4C). Thus, Imp-
L2 expression clearly leads to a non-autonomous decrease in size.  
 
Figure S4: Imp-L2 decreases 
wing size non-autonomously 
when expressed in the posterior 
compartment by en-Gal4.  
(A, B) Overexpression of UAS-
l.IMPL2 by en-Gal4 not only 
decreases the size of the posterior 
compartment but of the whole wing 
blade. Both are right wings from 
female flies, as control served y w-
flies. (C) The total wing blade area 
of en-Gal4, UAS-l.IMPL2 is 
reduced by 10% compared to the 
control.  
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Imp-L2 expression changes metabolism 
 
We have already shown that Imp-L2 is not essential for survival under standard conditions 
(Honegger et al. 2006). However, under adverse nutritional conditions, Imp-L2 is necessary 
for larvae to survive, and to properly shut down insulin signaling. Next we wanted to assay if 
Imp-L2 expression protects against lethality caused by starvation. Therefore, three day-old 
adult flies were subjected to a water-only diet. Overexpression of Imp-L2 by ppl-Gal4 
prolongs lifespan of flies under complete starvation (Fig. S5A). Since a resistance to 
starvation is often caused by elevated body fat levels, we next assayed the fat content of Imp-
L2-overexpressing flies. While in Imp-L2 loss-of-function backgrounds no consistent changes 
in total fat content could be observed (data not shown), flies overexpressing l.IMPL2 in the fat 
body disposed of more fat than controls (Fig. S5B). This is consistent with the fact that chico 
mutants, which display a similar size phenotype as ppl-Gal4, UAS-l.IMPL2 flies, possess 
double amounts of fat when compared to wild-type flies (Bohni et al. 1999).  
Ablating the CC by driving UAS-rpr by Akh-Gal4 results in a strong decrease in the levels of 
trehalose in the larval hemolymph (Kim and Rulifson 2004). This reduction can be partially 
rescued by restoring the levels of the functional fly ortholog of glucagon, dAkh, which is 
exclusively produced by the CC cells (Kim and Rulifson 2004). Since Akh only accounts for 
part of the decrease in circulating trehalose levels, and since dilp2 has been shown to be 
sufficient to increase sugar levels in the hemolymph (Rulifson et al. 2002), it is tempting to 
speculate that CC-produced Imp-L2 is, through inhibiting dilp2, able to increase trehalose 
levels. Therefore, we tested if Imp-L2 is sufficient to increase trehalose levels of the 
hemolymph. Overexpression of Imp-L2 in the fat body by ppl-Gal4 increased trehalose 
content in the hemolymph of adult females by 12% (Fig. S5C). Contrary to the gain-of-
function situation, no consistent changes could be observed in Imp-L2 mutant combinations.  
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Figure S5: Overexpression of Imp-L2 in the fat body changes energy metabolism.  
(A) Imp-L2 expression is sufficient to increase survival (males +15%, females +42%) rate under complete 
starvation in 3 day-old adult flies (of each genotype n=100). Flies were separated after hatching and placed for 3 
days on normal food before transferring them to empty vials sealed with a water-soaked foam plug. (B) 
Overexpression of UAS-l.IMPL2 in the fat body by ppl-Gal4 increases the fat content of 3 day-old adult flies 
(+31% in males, +14% in females). (C) Circulating trehalose and glucose levels are elevated in 3 day-old adult 
females overexpressing Imp-L2 in the fat body (males were not assayed). 
 
 
Additional Imp-L2 loss-of-function data 
 
Comparison of different Imp-L2 alleles 
 
Mutations in the Imp-L2 gene were generated by two different strategies. First, an EMS-
reversion mutagenesis was performed, in which we selected mutant chromosomes carrying 
EP5.66 that were no longer able to suppress the dInR overexpression phenotype in the eye 
(Honegger et al. 2006). Thereby, one mutant allele was identified, Imp-L2MG2, which 
contained a point mutation in the genomic Imp-L2 sequence resulting in a premature stop at 
amino acid 232.  
Second, small deletions in the Imp-L2 locus were obtained by imprecise excision of GE24013 
(the line has not been isogenized prior to the screen). Four out of the five deletions obtained, 
deleted most (Def35) or all (Def20, Def42, Def223) of the Imp-L2 coding sequence. The fifth 
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deletion (Def29, not tested) lacks the first exon and part of the following intron of the Imp-L2-
RB transcript (Honegger et al. 2006). In the process of this jump-out screen we also collected 
several lines in which GE24013 was precisely excised (named 36, 43, 52). Unfortunately, 
these precise jump-out lines, as well as the original GE24013 line, contained several point 
mutations, of which some also resulted in amino acid exchanges in the protein sequence. 
Therefore, the precise jump-out lines were only used in preliminary experiments as controls.  
To analyze the different Imp-L2 alleles, we assayed the weights of various Imp-L2 mutant 
combinations (Fig. S6A+B). Interestingly, Imp-L2MG2 showed no dominant weight increase, 
which hints at the fact that Imp-L2MG2 is a hypomorphic allele. However, when combined 
with a null allele (Imp-L2Def20), Imp-L2MG2 displays the same weight increase as Imp-L2Def223 
(Fig. S6A). Thus, it was not possible to clearly state if Imp-L2MG2 is a hypomorphic or a null 
allele, although it behaves rather like a strong hypomorph than a complete null.  
To further characterize the Imp-L2 loss-of-function phenotype, we surveyed the 
developmental timing of the Imp-L2 mutants. No differences could be observed between the 
developmental timing of various Imp-L2 mutant combinations and the controls (Fig. S6C).  
 
Figure S6: All Imp-L2 alleles increase total body size without affecting developmental timing.  
Different combinations of Imp-L2 mutant alleles all cause a body weight increase of 3 day-old adult flies (A+B). 
Flies were reared at 25°C. Males are represented by the white bars, females by the black ones. In a control 
experiment it could be shown that the TM3 Balancer itself had no effect on total body weight under these 
conditions (not shown), therefore, it was used as a control. 43 and 36 are precise jump-out alleles of GE24013, 
containing several point mutations in its Imp-L2 sequence, some of which resulting in amino acid changes. (C) 
Imp-L2 mutants are not developmentally delayed. Of each genotype the hatching flies of two independent tubes 
were counted. (D) There is no weight difference between 3 day-old virgin and non-virgin females reared at 18°C. 
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After collecting the hatching flies, they were placed for 3 days in a tube at room-temperature either with (non-
virgins) or without (virgins) males. Genotypes: “Def223” is Imp-L2Def223, “Def35” is Imp-L2Def35, “Def20” is 
Imp-L2Def20, “Def42” is Imp-L2Def42, “MG2” is Imp-L2MG2, “43” and “36” see above.  
 
 
Effects of Imp-L2 on oogenesis and oviposition 
 
The relative size increase of Imp-L2 mutant females is much bigger than of mutant males. 
This difference is mainly due to massively enlarged ovaries, which consist of more mature 
eggs and more stage 10 oocytes in Imp-L2 mutant females, when compared to controls 
(Honegger et al. 2006). However, the structure of the ovaries is unchanged in Imp-L2 mutants 
(Fig. S7A-D). In order to test if the weight increase we observed in mutant females is due an 
enhanced oocyte production triggered by copulation, we weighed virgin and mated females 
simultaneously. No difference could be observed between the weights of either control or 
Imp-L2 mutant virgins and non-virgins (Fig. S6D). Thus, mating had no effect on the weight 
of female flies.  
 
 
Figure S7: Loss-of-Imp-L2 function has no 
obvious effect on the structure of the 
ovary. 
(A-D) Ovaries of Imp-L2 mutant females, 
stained with DAPI to highlight the nuclei. 
Neither in early, intermediate (A-C), nor in 
late stages of oogenesis (D), a difference in 
the structure of the ovaries could be observed. 
Genotype: y w;; Imp-L2Def42/Imp-L2Def20.  
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Although we could show that the size increase of the ovaries in Imp-L2 mutants is due to the 
presence of more mature eggs, it was possible that the accumulation is not solely caused by an 
increased rate of oogenesis (more stage10 oocytes) but also by a defect in oviposition. 
Therefore, we assayed oviposition under different nutritional conditions and in different 
genetic backgrounds. No obvious differences in egg laying could be observed when virgin 
females were placed together with males on rich food (apple agar plates supplemented with 
yeast, Fig. S8A). When shifted to poor food conditions (apple agar only), wild-type females 
downregulate their oogenesis rate by 60-fold and oviposition is blocked (Fig. S8A) 
(Drummond-Barbosa and Spradling 2001). Imp-L2 mutants display a lag in shutting down 
oviposition compared to the control when nutrients become limiting (Fig. S8A). However, 
after three days on poor food conditions they lay the same amount of eggs as the control. 
When the flies were placed under poor nutritional conditions right after hatching, neither Imp-
L2 mutants nor heterozygous animals containing a copy of the genomic rescue construct lay 
more eggs than virgin flies would (Fig. S8B). Also in the shift from poor to rich food, no 
difference could be observed between Imp-
L2 mutants with or without the rescue 
construct. Thus, the only difference in 
oviposition observed was the inability of 
Imp-L2 mutants to rapidly block 
oviposition when shifted from rich to poor 
food.  
 
 
Figure S8: Imp-L2 has no obvious function in the 
female egg laying behavior 
Females (N=15) were collected right after hatching 
and placed in small egg laying cages (5 females 
each) together with males. Each day the laid eggs 
were counted. Two different nutritional conditions 
were used. “Poor food” confers to just apple agar, 
whereas “rich food” stands for apple agar 
supplemented with yeast paste. (A) The egg laying 
behavior of Imp-L2 mutants is similar to the 
controls, except when the food was changed from 
rich to poor Imp-L2 mutants were not able to stop 
egg laying as fast as the wild-type control (compare 
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red bar of day 5 with the light blue bar). The experiment was repeated twice. (B) When nutrients are limiting 
Imp-L2 mutants and controls lay similar amounts of eggs. There was also no difference observed, when the food 
conditions were changed from “poor” to “rich”. (C) Loss-of-Imp-L2 function is not sufficient to rescue the block 
in oogenesis observed when PI3K signaling is stalled. PI3Kts (also named 5W3iso) is a temperature sensitive 
mutant that displays nearly wild-type PI3K activity at 18°C, but at 25°C displays the characteristics of a strong 
hypomorphic PI3K allele. Genotypes are: “Imp-L2-/-“ y w;; Imp-L2Def42/Imp-L2Def20, “Imp-L2-/-, gen. rescue“ y w;; 
Imp-L2Def20, pBH5-57/Imp-L2Def42, “Imp-L2-/+, gen. rescue“ y w;; Imp-L2Def20, pBH5-57/+, “control” y w/w, 
“PI3Kts/ts” y w;; 5W3iso/5W3iso, “PI3Kts/ts, Imp-L2-/-” y w;; 5W3iso, Imp-L2Def42/5W3iso, Imp-L2Def20, “PI3Kts/+, Imp-
L2-/+” y w;; 5W3iso, Imp-L2Def20/82-1.  
 
In addition to the nutritional requirements, oogenesis is also mediated by the insulin signaling 
pathway. Genes encoding for its components, namely dInR, chico, dPI3K, dPKB, and dS6K, 
mutate to female sterility and block oogenesis at pre-vitellogenic stages (Chen et al. 1996; 
Bohni et al. 1999; Montagne et al. 1999; Dietz 2003). Further it has been shown by using a 
temperature-sensitive allele of PI3K, PI3Kts (also named 5W3iso), that the block in oogenesis 
caused by the lack of insulin signaling activity is reversible in adults (Dietz 2003). Like in 
starved females, defects in insulin signaling results in an arrest of oogenesis prior to 
vitellogenesis. However, it was not surprising, that the activity of the insulin signaling 
pathway was highest around stage 10 of oogenesis (Fig. S9A+B). Since in Imp-L2 mutants 
oogenesis is stimulated, we wanted to test if this stimulation is strong enough to overcome the 
block in oogenesis caused by loss-of-PI3K function. Imp-L2 mutations were not sufficient to 
overcome the effects of dp110ts mutants when shifted to the restrictive temperature, though 
(Fig. S8C). Thus, PI3K is epistatic over Imp-L2.  
 
 
Figure S9: The activity of the insulin signaling pathway in oogenesis peaks during vitellogenesis. 
Through localization of the PH-GFP (tGPH) fusion construct, PIP3 levels can be monitored. The highest activity 
of insulin signaling was observed during vitellogenesis. Especially stage 10 oocytes display strong membrane 
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localization of the tGPH reporter (A+B). Shown are projections of a series of confocal pictures. The pictures 
were taken at the same magnification, and the same exposure time was applied. Shown are fixed samples of 3 
day-old female ovaries, with the genotype y w; tGPH/+.  
 
 
Stress conditions and Imp-L2 expression 
 
Effects of starvation on Imp-L2 expression and mutant survival 
 
In (Honegger et al. 2006) we showed that loss-of-Imp-L2 function massively increases 
starvation sensitivity of 3rd instar larvae. Additionally, Imp-L2 expression was upregulated in 
the fat body of starved larvae. To assay if also overall levels (including the protein in the 
hemolymph) of Imp-L2 are increased upon starvation, we extracted protein of starved and 
non-starved wild-type and Imp-L2 mutant larvae and compared Imp-L2 protein levels on a 
Western blot (Fig. S10A+B). Because the loading controls showed different results, no clear 
statement about a change in Imp-L2 levels could be made in wild-type flies. However, in 
larvae that were heterozygous for Imp-L2, Imp-L2 was upregulated upon starvation in two 
independent experiments (Fig. S10A+B). Thus, Imp-L2 is required at a certain level when 
larvae are forced to deal with sparse nutritional conditions.  
While Drosophila larvae are constant feeders, which take up and process nutrient incessantly, 
adult flies only feed occasionally. Therefore, a different response of adults and larvae to 
starvation could be expected. Conversely to Imp-L2 mutant larvae which have a shortened 
lifespan under starvation, adults display no increased lethality but live slightly longer than 
control animals when exposed to complete starvation (water only, Fig. S10C).  
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Figure S10: Imp-L2 levels under starvation conditions.  
 (A+B) 73-76h old larvae of the indicated genotypes were either transferred to a filter paper soaked with PBS 
containing 1% glucose or an apple agar plate supplemented with yeast for 24h. In both (A+B) 10µl of larval 
extracts were loaded in each lane. (C) Adult flies (N=100 of each sex per genotype) were collected right after 
hatching and placed on normal food. After 3 days the flies were separated according to sex and placed in empty 
culture vials sealed with water-soaked foam stoppers. Every 4-8h the dead flies were counted. For the blots, the 
following antibodies were used: rat-anti-Imp-L2, rabbit-anti-JnK, mouse-anti-actin. Genotypes: (A+B) “Imp-L2-/-
“: y w;; Imp-L2Def42/Def20, “Imp-L2+/-“: y w;; Imp-L2Def42/+, “Imp-L2-/-“: y w/w, (C) “pBH5-18” genomic rescue 
construct of Imp-L2, “Def20” is the Imp-L2Def20 allele, “Def42” is the Imp-L2Def42 allele.  
 
To test if Imp-L2 expression is uprepulated cell-autonomously upon starvation, we 
downregulated the amino acid transporter slimfast (slif) specifically in single cell clones of the 
fat body. For this purpose we made use of a P-element in the slif locus (slifAnti), that produces, 
when combined with a Gal4 driver line, slif anti-sense RNA (Colombani et al. 2003). This 
leads to a specific downregulation of slif in the Gal4 expressing cell, which causes an amino 
acid starvation phenotype in the affected cell. Spontaneous fat body clones driving slifAnti by 
Act-Gal4 did not show a clear upregulation of Imp-L2 (Fig. S11A, A’, A’’ and B, B’, B’’). 
But since also the expression of Imp-L2 could not be detected when l.IMPL2 was 
overexpressed in fat body clones (Fig. S11C, C’, C’’), either the detection of Imp-L2 in the fat 
body is difficult under these conditions or the protein is rapidly secreted.  
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Figure S11: The size decrease resulting 
from amino acid depletion can be 
partially overcome in an Imp-L2 loss-of-
function background.  
(A, B) Spontaneous clones (marked by 
GFP) in the fat body of wandering 3rd instar 
larvae overexpressing the amino acid 
transporter slif anti-sense RNA, produced 
by a P-element inserted 3’ to the slif gene. 
(C) Spontaneous fat body clones 
overexpressing Imp-L2 by driving UAS-
l.IMPL2 in the GFP marked cells. (A’, B’, 
C’) Staining with an Ab against Imp-L2 
shows no clear upregulation of Imp-L2 in 
the Imp-L2 overexpressing (C’) or amino 
acid-starved cells (A’, B’). (A’’, B’’, C’’) 
GFP in green, Imp-L2 in red. (D) Loss-of-
Imp-L2 function partially rescues the size 
decrease caused by a downregulation of slif 
in the fat body induced by ppl-Gal4 driven 
slifAnti. Shown are weights of 3 day-old adult 
flies, males to the left, females to the right. 
Genotypes: (A, A’, A’’, B, B’, B’’) y w, hs-
flp; Act>CD2>Gal4; slifAnti, (C, C’, C’’) y 
w, hs-flp; Act>CD2>Gal4; UAS-l.IMPL2, (D) from left to right: y w; ppl-Gal4/TM3. Sb, Ser, y w; ppl-Gal4; 
slifAnti, y w; ppl-Gal4; slifAnti, IMPL2MG2/genomic rescue (57), y w; ppl-Gal4; slifAnti, IMPL2MG2, y w; ppl-Gal4; 
slifAnti, IMPL2MG2/IMPL2MG2.  
 
Downregulating slif not solely in single cells but in the whole fat body causes a global growth 
defect similar to that seen in flies raised under poor nutritional conditions (Colombani et al. 
2003). Ppl-Gal4, slifAnti flies reared at 25°C mostly die during the pupal stage, but some 
escapers did hatch that are small and lean. At 18°C most flies hatch but are still slightly 
smaller than the control animals. It has been shown that this size reduction of ppl-Gal4, slifAnti 
flies is due to a humoral mechanism by which the fat body controls overall body size. 
Therefore, we speculated if Imp-L2 could be a fat body induced humoral signal controlling 
total body size by inhibiting Dilp2 activity. Indeed, driving slifAnti by ppl-Gal4 in an Imp-L2 
mutant background (Imp-L2MG2/MG2) slightly ameliorates the size decrease (Fig. S11D). 
However, the experiment should be repeated with the small Imp-L2 deletions to verify this 
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result. To assess if Imp-L2 is the humoral signal emanating from the fat body, we assayed 
insulin signaling activity in the epidermis of wild-type or Imp-L2 mutant wandering 3rd instar 
larvae, in which slif was downregulated specifically in the fat body. Because the signal 
intensity of the tGPH reporter displayed a great amount of variability (Fig S12), we were 
neither able to reproduce the published downregulation of tGPH in the periphery of ppl-Gal4, 
slifAnti 3rd instar larvae (Colombani et al. 2003), nor to answer the question if this 
downregulation is Imp-L2 dependent. The observed variability was presumably caused by the 
fact that it was not possible to determine if the used wandering 3rd instar larvae already ceased 
feeding or not. Depending on the food uptake, the insulin signaling activity varies a lot. 
Therefore, the experiment should be repeated with early 3rd instar larvae which are constantly 
feeding.  
 
 
Figure S12: The downregulation of insulin signaling in the periphery induced by fat body starvation could 
not be reproduced.  
(A-C) Shown are tGPH reporter stainings of the epidermis of four independent living 3rd instar wandering larvae 
of each genotype. Driving the slifAnti P-element in the fat body by ppl-Gal4 produces slif anti-sense RNA. 
Genotypes: (A) y w; tGPH/ppl-Gal4, (B) ) y w; tGPH/ppl-Gal4; slifAnti, (C) y w; tGPH/ppl-Gal4; 
slifAnti/IMPL2MG2.  
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Effects of hypoxia on Imp-L2 expression  
 
Since Imp-L2 is a starvation induced inhibitor of insulin signaling, we wanted to test if it also 
acts as a general response to stress conditions that require a downregulation of Dilp2 activity. 
Recently it has been shown in a microarray experiment that Imp-L2 mRNA is upregulated 
4.39 fold when flies are exposed to severe hypoxia (0.5%O2) for 6h (Liu et al. 2006). By 
immunohistochemistry we could show that it is again the fat body and no other tissue that 
induces Imp-L2 expression under hypoxia (Fig. S13, compare A, A’, A’’ with B, B’, B’’). 
Similar to starved larvae, Imp-L2 expression after hypoxic treatment could be detected in 
small vesicles unequally distributed among fat body cells. Thus, Imp-L2 is not only expressed 
under starvation conditions but is presumably also needed as an inhibitor of insulin signaling 
when oxygen becomes limiting.  
 
 
Figure S13: Under hypoxic conditions, Imp-L2 is upregulated by the larval fat body.  
73-76h old y w 3rd instar larvae were either placed in a hypoxia chamber for 6h at 0.5% O2 (A, A’, A’’) or kept 
under normoxic conditions as controls (B, B’, B’’).  Imp-L2 could be detected in vesicular-like compartments in 
the cytoplasm of fat body cells. The control fat body, at the same exposure, showed no such Imp-L2-vesicles. 
The grainy structures in the control were be also observed in Imp-L2 null mutant larvae.  
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Genetics interactions of Imp-L2 
 
Interaction of Imp-L2 and chico 
 
We stated in our paper (Honegger et al. 2006) that loss-of-Imp-L2 function is not sufficient to 
rescue the size effect of chico mutants (Fig. S14A). Since mild dilp2 overexpression results in 
a similar size increase as Imp-L2 loss-of-function, we also wanted to test if expression of 
dilp2 by arm-Gal4 is able to overcome the size reduction of chico mutants. Equally to Imp-L2 
mutants, also in an arm-Gal4, UAS-dilp2 background the size of chico mutants is not altered 
(Fig. S14B). Thus, chico is epistatic over dilp2 as well as Imp-L2.  
 
 
Figure S14: Imp-L2 acts upstream of the insulin signaling pathway 
Shown are total body weights of 3 day-old adult flies. The left group within each chart are males and the group 
on the right side are females. (A) Loss-of-Imp-L2 function was not sufficient to rescue the size effect of chico 
mutants. In accordance with that, chico dominantly suppress the size increase of Imp-L2 mutants (compare bars 
3 and 4, respectively 8 and 9, p<0.00001). (B) Weak overexpression of dilp2 by arm-Gal4 is also not able to 
rescue the size reduction of chico mutant flies. Genotypes in (A) are from left to right: y w; chico2/chico1; UAS-
lacZ/arm-Gal4, y w; chico2/chico1; Imp-L2Def42/Imp-L2Def20, y w; chico2/CyO.y+; Imp-L2Def42/Imp-L2Def20, y w;; 
Imp-L2Def42/Imp-L2Def20, y w; arm-Gal4/UAS-GFP. Genotypes in (B) are from left to right: y w; chico2/chico1; 
UAS-dilp2/arm-Gal4, y w; chico2/chico1; UAS-lacZ/arm-Gal4, y w;; UAS-dilp2/arm-Gal4, y w; arm-Gal4/UAS-
GFP. 
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Interaction of Imp-L2 and the dilps 
 
We described in our paper the finding, that the deficiency Df(3L)AC1, which uncovers dilp1-
5, dominantly enhanced the small eye phenotype caused by eye specific overexpression of 
Imp-L2 (Fig. S15). Since flies heterozygous for Df(3L)AC1 are already slightly reduced in 
size, it was important to compare the size decrease between the wild-type situation (Fig. 
S15C) and the heterozygous Df(3L)AC1 situation (Fig. S15D). This size decrease is enhanced 
when Imp-L2 is ectopically expressed in the eye (compare Fig. S15A+B with C+D).  
 
Figure S15: Heterozygosity for dilp1-5 
dominantly enhances the Imp-L2 
overexpression phenotype.  
(A) A deficiency uncovering dilp1-5 
(Df(3L)AC1) is dominantly enhancing the 
reduced eye size of GMR-Gal4, UAS-l.IMPL2 
flies. Shown are SEM pictures of female eyes 
taken with the same magnification. 
 
 
 
 
 
 
 
We further showed in our paper that expression of dilp2 by arm-Gal4 in an Imp-L2 mutant 
background results in lethality (see also Fig. S16). To assay if Imp-L2 also regulates the 
function of any of the other Dilp or if it is Dilp2-specific, we tested all the available UAS-dilp 
insertions in the same assay. None of the other dilps showed an interaction with Imp-L2 when 
expressed under the control of the arm-Gal4 driver line (Fig. S17A). Since dilp2 was in our 
hands the only dilp that showed a clear size increase when driven by arm-Gal4, we wanted to 
test if a putative size increase generated by a stronger driver line like i.e. Act-Gal4, could be 
used for a detailed interaction study. Act-Gal4, UAS-dilp2 flies are lethal at larval stages. 
Conversely, dilp1, 3, 4, and 7 showed no effect at all on total body size if driven by Act-Gal4 
(Fig. S17B). However, dilp5+6 displayed a size increase when combined with the Act-driver 
line. Therefore, we wanted to test the effects of strong dilp5 or 6 expression in an Imp-L2 
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loss-of-function background. Driving either dilp5+6 by Act-Gal4 results in lethality in an 
Imp-L2 mutant background (Fig. S17C, from the weaker insertion of dilp6 - UAS-dilp6(4) - 
two escapers hatched). While overexpressing dilp5 by Act-Gal4 had no effect on size in a 
heterozygous Imp-L2 mutant background, overexpressing the stronger line of dilp6 slightly 
increases total body size in Imp-L2+/- flies. Thus, Imp-L2 seems to interact at least with dilp2, 
5, and 6. Due to the lack of a clear overexpression phenotype for all the other dilps, an 
interaction with Imp-L2 could neither be excluded nor confirmed.  
 
 
Figure S16: Elevating dilp2 levels in an Imp-L2 loss-of-function background results in lethality.  
Body weights of 3 day-old adult flies reared either on 18°C (A) or 25°C (B). (A) White bars correspond to the 
weights of males, black bars to females respectively. All flies contained a copy of the arm-Gal4 transgene. 
pBH5-57 and pBH5-18 are two independent insertions of the Imp-L2 genomic rescue construct. (B) 
Overexpression of both UAS-dilp2 lines, on the 2nd (white) and the 3rd (grey) chromosome, by arm-Gal4 results 
in lethality only in an Imp-L2 mutant background. Shown are only male weights.  
Genotypes are in (A) from left to right: y w; arm-Gal4/UAS-GFP; Imp-L2Def42/+, y w; arm-Gal4/UAS-dilp2; 
Imp-L2Def42/+, y w; arm-Gal4/+; Imp-L2Def20, UAS-dilp2/Imp-L2Def42, y w; arm-Gal4/UAS-dilp2; Imp-L2Def20, 
pBH5-57/Imp-L2Def42, y w; arm-Gal4/UAS-dilp2; Imp-L2Def20, pBH5-18/Imp-L2Def42, (B) from left to right: y w; 
arm-Gal4/+; Imp-L2Def42/UAS-dilp2, y w; arm-Gal4/+; Imp-L2Def20, UAS-dilp2/Imp-L2Def42, y w; arm-Gal4/UAS-
dilp2; Imp-L2Def42/+, y w; arm-Gal4/UAS-dilp2, y w; arm-Gal4/UAS-dilp2; Imp-L2Def42/Imp-L2MG2, y w; arm-
Gal4/UAS-dilp2; Imp-L2Def20, pBH5-57/Imp-L2Def42, y w; arm-Gal4/UAS-dilp2; Imp-L2Def20, pBH5-18/Imp-
L2Def42, y w;; Imp-L2Def20/Imp-L2Def42, y w; arm-Gal4/UAS-GFP; Imp-L2Def42/+, y w; arm-Gal4/UAS-GFP.  
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Figure S17: Interaction of the 
different dilps with Imp-L2.  
(A) Weights of male flies 
expressing all available dilp 
transgenes by arm-Gal4 either in a 
hetero- or homozygous Imp-L2 
mutant background. Each color 
represents a different dilp 
construct. The red line corresponds 
to the average weight of Imp-L2 
homozygous mutants, while the 
black line corresponds to the 
weight of wild-type flies. Both 
dilp2 transgenes result in lethality 
when combined with arm-Gal4 in 
an Imp-L2 loss-of-function 
background. (B) Only in the case 
of dilp5+6 high levels of dilp 
expression, induced by Act-Gal4, 
led to heavier flies. All the other 
dilp transgenes display no size 
difference compared to the GFP 
control. (C) High levels of either 
dilp5 or 6 also results in lethality in 
an Imp-L2 mutant background. In 
the case of dilp5, the 
overexpression by Act-Gal4 is 
nearly lethal in an Imp-L2+/- 
background. However, several 
escapers do hatch. The stronger 
insertion of dilp6 (UAS-dilp6.1) was totally lethal when driven by Act-Gal4 in an Imp-L2 loss-of-function 
situation, while in the case of UAS-dilp6(4) two escapers hatched. Flies in which dilp1 is expressed by Act-Gal4 
in an Imp-L2 loss-of function background, are semi-viable and vary greatly in size. The overexpression of dilp3, 
4, and 7 by Act-Gal4 was completely viable in Imp-L2-/- flies.  
Shown are total body weights of 3 day-old male adults. Imp-L2-/- always corresponds to Imp-L2Def42/Def20 (except 
in the 5th column of chart A, where Imp-L2Def42/MG2 was used as Imp-L2-/-. The crosses in C were repeated twice, 
except the ones with dilp1, 3, 4, and 7. (*p<0.0001, in A+C are compared to Imp-L2-/-, whereas in B the 
comparison was made against the GFP control).  
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Interaction of Imp-L2 and dALS 
 
Recently an ortholog of the glycoprotein ALS was identified in Drosophila (dALS) 
(Colombani et al. 2003). dALS is expressed only in the fat body and the dilp-producing m-
NSCs, and like in mammals its expression is sensitive to starvation (Colombani et al. 2003). 
In vertebrates, ALS acts as a binding partner of IGF/IGFBP complexes in the vascular system, 
whereby the half-life of the complex is massively extended (Boisclair et al. 2001). However, 
the function of ALS in Drosophila is unknown. We received several insertions of two 
unpublished transgenic lines from the Léopold lab in Nice, namely UAS-dALS and UAS-
dALS-RNAi. While the RNAi lines have not been tested yet, we assayed the effects of dALS 
overexpression by different driver lines on total body size in combination with elevated dilp2 
and/or Imp-L2 levels. Driving UAS-dALS by ppl-Gal4 had no effect on body size of wild-type 
flies or flies with elevated dilp2 and/or Imp-L2 levels (Fig. S18A). Further, the Imp-L2 levels 
produced by ppl>l.IMPL2 were not high enough, to compensate the hyperinsulinemia induced 
by overexpressing the weaker UAS-dilp2(II) construct by ppl-Gal4. In a second experiment, 
we used the weaker but ubiquitous arm-Gal4 driver in conjunction with the same 
overexpression transgenes. While overexpression of dALS by arm-Gal4 in males already led 
to a significant size increase, it additionally increased the size of flies with higher insulin 
levels (Fig. S18B). However, this effects could not be observed in females. Therefore, since 
the effects are rather weak and could only be observed in one sex, the experiment should be 
repeated before a conclusion can be drawn. In a preliminary experiment, UAS-dALS was also 
driven by the strong Act-Gal4 driver line. Because driving dALS at high levels had no effect 
on size (Fig. S18C), it is likely that the size increase observed in arm>dALS males was only 
an artifact.  
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Figure S18: Interaction of dALS with 
Imp-L2 and dilp2 
Shown are total body weights of 3 day-
old flies, males are to the left and 
females’ weights to the right. (A) Fat 
body specific overexpression of UAS-
dALS alone or in combination with 
either Imp-L2 or dilp2 has no effect on 
total body size. (B) Expression of 
UAS-dALS by arm-Gal4 resulted in a 
significant size increase in males but 
not in females. Co-expression of dALS 
enhances the dilp2-induced size 
increase and the Imp-L2-caused size 
decrease significantly (*p<0.0001, if 
not otherwise stated the p-value always 
referred to the GFP control). (C) Strong 
overexpression of two different 
insertions of the UAS-dALS transgene 
by Act-Gal4 had no impact on size. 
Genotypes in (A) are: y w; ppl-
Gal4/UAS-dilp2; UAS-l.IMPL2, UAS-
ALS/+, y w; UAS-dilp2/+; UAS-
l.IMPL2/+, y w; ppl-Gal4/UAS-dilp2; 
UAS-l.IMPL2/+, y w; ppl-Gal4/UAS-
dilp2; UAS-ALS/+, y w; ppl-
Gal4/UAS-dilp2, y w; ppl-Gal4/+; 
UAS-l.IMPL2/+, y w; ppl-Gal4/+; UAS-ALS/+, y w; ppl-Gal4/+; UAS-l.IMPL2, UAS-ALS/+, y w; ppl-
Gal4/UAS-GFP, in (B) are: y w; arm-Gal4/UAS-dilp2; UAS-l.IMPL2, UAS-ALS/+, y w; UAS-dilp2/+; UAS-
l.IMPL2/+, y w; arm-Gal4/UAS-dilp2; UAS-l.IMPL2/+, y w; arm-Gal4/UAS-dilp2; UAS-ALS/+, y w; arm-
Gal4/UAS-dilp2, y w; arm-Gal4/+; UAS-l.IMPL2/+, y w; arm-Gal4/+; UAS-ALS/+, y w; arm-Gal4/+; UAS-
l.IMPL2, UAS-ALS/+, y w; arm-Gal4/UAS-GFP, in (C) are: y w;; Act-Gal4/UAS-ALS(37), y w;; Act-Gal4/UAS-
ALS(46), y w; UAS-GFP/+; Act-Gal4/+.  
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Human IGFBP-rP1 cannot mimic Imp-L2 expression 
 
In order to test whether the size effects of Imp-L2 overexpression can be mimicked by its 
human ortholog, the IGFBP-rP1 cDNA was cloned into an UAS-vector to allow its 
overexpression. Four independent transgenic insertions (no. 1, 3, 6, and 11) of this construct 
were tested under the control of the ppl-Gal4 and the Act-Gal4 drivers. However, no effect on 
size or development could be observed (Fig. S19A+B). The flies hatched at the expected 
mendelian ratio, without displaying any timing defects. The crosses were performed at 18°C 
and 25°C. Thus, although the negative regulation of insulin activity appears to be conserved 
between the human IGFBP-rP1 and the fly Imp-L2 (Yamanaka et al. 1997; Honegger et al. 
2006), the human protein expressed in Drosophila cannot take over Imp-L2 function.  
 
 
Figure S19: Overexpression of the human IGFBP-rP1 (mac25) is not sufficient to alter growth in 
Drosophila.  
Shown are total body weights of 3 day-old adult flies. Males are on the left side of each chart, and females on the 
right. Driving UAS-IGFBP-rP1 by either Act-Gal4 (A) or ppl-Gal4 (B) had no effect on total body weight. 
Shown are different insertions of a cDNA derived UAS-transgene, driven by the indicated Gal4 driver lines.  
 
 
Is Imp-L2 the “missing link” between Ecdysone and Insulin signaling? 
 
Recently it has been shown that ecdysone (ecd), apart from its role as one of the major 
hormones regulating development and metamorphosis, antagonizes insulin signaling in 
determining final body size, without affecting developmental timing (Colombani et al. 2005). 
Thereby, the larval fat body serves as a key relay element for this ecdysone-dependent growth 
inhibition. Lowered ecd levels in the hemolymph results in increased insulin signaling in the 
fat body, and thus in an overall size increase of 17% (Colombani et al. 2005). Since Imp-L2 
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has been originally identified as ecdysone-inducible protein, and is induced in the fat body 
upon starvation, it is tempting to speculate that the humoral, insulin-inhibiting signal 
emanating from the fat body is Imp-L2. We therefore wanted to test if the humoral groth 
inhibitory effect is blocked in an Imp-L2 mutant background.  
The effects of ecdysone on body size can only be observed when hormone levels are slightly 
changed. To achieve such a mild alteration in ecdysone levels, the size of the ecdysone-
producing prothoracic gland (PG) has to by manipulated by either overexpressing dp110 or 
dp110DN (dominant negative version of dp110) by P0206-Gal4 (Colombani et al. 2005). 
However, we were only able to reproduce the size increase of P0206-Gal4, UAS-dp110DN 
flies, but not the size decrease of P0206-Gal4, UAS-dp110 flies (Fig. S20A). Our inability to 
reproduce the results of the Léopold group is probably due to the fact that the food used in 
Nice and Zurich differs considerably (Arquier et al. 2005; Reiling et al. 2005). Since the yeast 
content of our food is much higher than in the “Nice”-food the size decrease of P0206-Gal4, 
UAS-dp110 flies could be masked. Therefore, the experiment should be repeated on food 
containing low yeast concentrations before Imp-L2 mutations are crossed in.  
Since P0206-Gal4 is not only active in the PG but also in the corpora allata (CA), it has to be 
excluded that the altered insulin signaling in the CA has no effect on final body size. By 
overexpressing dp110 and dp110DN with the CA-specific Aug21-Gal4 driver any effect of the 
CA on body size in this context could be excluded (Fig. S20B).  
 
 
Figure S20: The published size decrease of P0206>dp110 flies cold not be reproduced 
Shown are total body weights of 3 day-old flies. (A) Overexpression of different UAS transgenes in the PG and 
the CA. While P0206-Gal4, UAS-dp110DN flies display the published size increase, P0206-Gal4, UAS-dp110wt 
flies did not show any size difference when compared to the control. Expressing UAS-l.IMPL2 under the control 
of P0206-Gal4 had no effect, but driving dilp2 led to a significant size increase in both males and females. 
Males’ weights are to the left and females’ weights to the right. (B) With the CA specific Aug21-Gal4 driver, 
dp110wt, l.IMPL2, and dilp2 overexpression had no effect, while Aug21-Gal4, UAS-dp110DN displayed a slightly 
decreased body size. Genotypes are in (A): w/yw; P0206-Gal4/UAS-GFP, w/yw; P0206-Gal4/UAS-dp110wt, 
w/yw; P0206-Gal4/+; UAS-dp110DN/+, w/yw; P0206-Gal4/+; UAS-l.IMPL2/+, w/yw; P0206-Gal4/+; UAS-
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dilp2/+, in (B): w/yw; Aug21-Gal4/UAS-GFP, w/yw; Aug21-Gal4/UAS-dp110wt, w/yw; Aug21-Gal4/+; UAS-
dp110DN/+, w/yw; Aug21-Gal4/+; UAS-l.IMPL2/+, w/yw; Aug21-Gal4/+; UAS-dilp2/+ 
 
 
Generation and testing of cell culture tools 
 
The UAS-IMPL2-HA construct 
 
In order to obtain a tagged version of Imp-L2, which can be used for cell culture and pull-
down experiments with sepharose beads, we added to the C-terminus of s.IMPL2 a 4xHA tag 
and cloned it into the UAS vector. Because a tag can in some cases destroy the original 
function of a protein, lead to its degradation or result in a neomorph, we generated transgenic 
fly lines to test if the tagged version of Imp-L2 is still functional. Ectopic expression of UAS-
IMPL2-HA posterior to the 
morphogenetic furrow of the eye 
imaginal disc by GMR-Gal4 shows that 
the tagged version of Imp-L2 could be 
stably expressed and stained by both 
antibodies against Imp-L2 and the HA 
tag (Fig. S21A-C). Further, driving UAS-
IMPL2-HA either by C10-Gal4 (Fig. 
S21D) or ppl-Gal4 (Fig. S21E) reduced 
total body size to a similar extent as 
UAS-l.IMPL2. Thus, we conclude that 
Imp-L2-HA is a functional version of the 
Imp-L2 protein that did not show 
enhanced degradation or neomorphic 
functions.  
 
 
Figure S21: The UAS-IMPL2-HA (pBH25) 
construct is functional.  
(A-C) Expression of UAS-IMPL2-HA(14) by GMR-Gal4 leads to ectopic expression of Imp-L2 in the 
developing eye disc posterior to the morphogenetic furrow. This expression of Imp-L2 can be either detected by 
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an anti-Imp-L2-Ab (A, green) or an Ab against HA (B, red). (D) C10-Gal4 driven expression of different 
insertions of the UAS-IMPL2-HA results in a decrease in total body size that is comparable to UAS-l.IMPL2. 
Shown are male weights (bar1-3: N=20; bar4+5: N=30). (E) Also expression of UAS-IMPL2-HA in the fat body 
by ppl-Gal4 results in flies of massively decreased size.  
 
Because Imp-L2 could not be detected in the spontaneous fat body clones with UAS-l.IMPL2 
we wanted to test if the protein could be stained better using the HA antibody and the UAS-
IMPL2-HA construct. Neither in IMPL2-HA overexpression clones of the fat body nor in 
clones of the salivary gland a clear signal for Imp-L2 could be detected (Fig. S22A, A’, A’’ 
and B, B’, B’’). However, in overexpression clones of the midgut, Imp-L2 expression could 
be detected with the HA antibody (Fig. S22C, C’, C’’). Thus, it seems as if the protein 
expressed in fat body as well as salivary gland cells is rapidly secreted and therefore difficult 
to detect in overexpression clones.  
 
 
Figure S22: Overexpression of HA-tagged Imp-L2 was not detectable by immunohistochemistry in fat 
body and salivary glands but in midgut clones.  
(A-C) Spontaneous overexpression clones of UAS-IMPL2-HA(11) in different tissues of wandering 3rd instar 
larvae marked by GFP. Shown are clones in the fat body (A, A’, A’’), the salivary gland (B’, B’, B’’), and the 
midgut (C, C’, C’’). Genotype: y w, hs-flp; Act>CD2>Gal4; UAS-IMPL2-HA(11).  
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The UAS-Flag-dilp2 construct 
 
To test if Imp-L2 is physically binding to insulin, we first wanted to assay the best way of 
detecting insulin on a Western Blot. On an acrylamide gel the band corresponding to the B-
chain of human insulin runs below 10kDa (Fig. S23A). The A-chain, which should be around 
3kDa in size was not detectable on this sort of gel (16% acrylamide gel). When blotted 
shortly, the B-chain could be also detected by the human insulin anti-body (Fig. S23B). Next 
we wanted to know if we could also detect Dilp2 on a Western blot. The rabbit-anti-dilp2 
antibody created by P. Belawat of our lab was so far only tested by immunohistochemistry, 
where it worked nicely. To test if the antibody also works on Western blots we loaded 
different amounts of recombinant Dilp2 protein (produced by P. Belawat) on an acrylamide 
gel. Unfortunately, Dilp2 could just be detected as a smear (Fig. S23C), which could not be 
used for a pull-down assay together with Imp-L2.  
 
Figure S23: Detection of insulin on a Western blot.  
Different amounts of human insulin were loaded on a acrylamide 
gel and either stained with commassie blue (A) or blotted for 30min 
with 150mA at 4°C and stained with an Ab against human insulin 
(B). In (C), different amounts of recombinant dilp2 (P. Belawat) 
were loaded, blotted like human insulin, and detected by anti-dilp2-
Ab. All the bands correspond to the B-chain of the insulins.  
 
 
 
 
 
 
Because we could not use the Dilp2 antibody for experiments including Western Blots, we 
wanted to create a tagged version of Dilp2. In a first attempt T. Ikeya of our lab constructed a 
version of Dilp2 that contained a C-terminal 4xHA tag. However, the UAS-dilp2-HA 
construct was not functional (transgenic flies did not show a size increase or any other effect 
when combined with various driver lines). Therefore, in a second attempt we decided to tag 
Dilp2 N-terminally with a single copy of the short flag tag. We introduced the flag tag after 
the predicted signal peptide sequence of dilp2 (Brogiolo et al. 2001), and thereby replaced the 
original Dilp2 signal peptide by the hemagglutinin signal peptide (Fig. S24A). The Flag-
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Dilp2 construct was then cloned into an UAS vector. In S2 cells transiently transfected with 
UAS-Flag-Dilp2 in conjunction with Act-Gal4 expression of Flag-Dilp2 could be detected 
(Fig. S24B). However, why Flag-Dilp2 always appears as a double band is unclear. It ran 
between 15kDa and 20kDa, which is much bigger than the usual band of the insulin B-chain 
(compare with Fig. S23). If the detected protein corresponds to unprocessed pro-Dilp2, or if 
one band is pro-Dilp2 and the other the Flag tagged B-chain (even though it is too big) is 
unknown. It is also remains elusive if S2 cells are capable of processing Dilp2 correctly. A 
way of testing if the S2 cells are able to produce functional and active Dilp2, is to stimulate 
wild-type cells with supernatant of Flag-dilp2 expressing S2 cells, and monitor PKB and S6K 
phosphorylation states.  
 
Figure S24: Construction of a Flag-tagged 
dilp2 construct.  
(A) Overview of the UAS-Flag-dilp2 construct. 
The signal sequence of dilp2 was removed and 
replaced by the hemagglutinin signal peptide 
(SP) sequence (from the PS261 vector). After 
the signal sequence, a single copy of the Flag 
tag was inserted. Thus, the created dilp2 version 
contains a N-terminal Flag tag. (B) Western 
Blot of S2 cell extracts that were transiently 
transfected with either UAS-Flag-dilp2, or Act-
Gal4, UAS-Flag-dilp2, and incubated with an 
anti-Flag antibody. (C) Western of two different 
stable S2 cell lines, expressing either the Flag-
tagged dilp2 alone or together with the Imp-L2-
HA construct. The two top lanes arre the 
supernatants of the stable cell lines, while the 
three lanes at the bottom are cell lysate. These 
cell lines were used for the in vitro pull-down 
assay together with the in vitro-translated Imp-
L2 (Honegger et al. 2006). (D) Western Blot of supernatant from three independent KC cell lines, incubated with 
anti-Flag antibody.  
 
To verify if the UAS-Flag-dilp2 produces functional Dilp2, we generated transgenic fly lines. 
Driving seven different insertions of UAS-Flag-dilp2 by Act-Gal4 resulted in all cases in a 
significant size increase (Fig. S25A). Since UAS-dilp2 driven by Act-Gal4 results in lethality, 
and arm-Gal4 driven overexpression of UAS-Flag-dilp2 only with one insertion led to a size 
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increase (Fig. S25B), we concluded that Flag-Dilp2 is a functional version of Dilp2 with 
slightly decreased activity compared to the wild-type protein. To test this hypothesis, we 
wanted to test if the Flag-dilp2 is also able to interact with Imp-L2. Co-overexpression of 
UAS-Flag-dilp2 is sufficient to rescue the size decrease induced in Act-Gal4, UAS-IMPL2-
HA flies (Fig. S25C). Thus, Flag-Dilp2 is a functional version of Dilp2 that displays slightly 
diminished activity.  
 
Figure S25: The UAS-Flag-dilp2 construct is 
functional but weaker than non-tagged dilp2.  
(A) Overexpression of seven different insertions of 
the UAS-Flag-dilp2 construct by Act5C-Gal4 each 
resulted in an increase of total body weight. (B) The 
weaker arm-Gal4 driver only increased the size of 
the strong insertions like UAS-Flag-dilp2(T26). (C) 
Tagged versions of Imp-L2 and dilp2 still counteract 
each other’s effect on size (the experiment was also 
done with the ppl-Gal4 driver). Genotypes in (C) 
are: y w; UAS-Flag-dilp2(T22.1)/+; UAS-IMPL2-
HA(pBH25-11)/Act5C-Gal4, y w; UAS-Flag-
dilp2(T22.1)/+; Act5C-Gal4/+, y w;; UAS-IMPL2-
HA(pBH25-11)/Act5C-Gal4, y w; UAS-GFP/+; 
Act5C-Gal4/+.  
 
 
 
 
 
 
 
 
 
 
Since we could show that Flag-Dilp2 was functional, we next established stable cell lines that 
express Flag-dilp2 under the control of Act-Gal4. In stable S2 cell lines transfected with 
either Act-Gal4, UAS-Flag-dilp2 or Act-Gal4, UAS-Flag-dilp2, UAS-IMPL2-HA, both Flag-
Dilp2 and Imp-L2-HA could be detected in cellular extracts as well as supernatants (Fig. 
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S24C). Also in stable KC cell lines Flag tagged Dilp2 protein could be detected either in cell 
extracts or the supernatant (Fig. S24D).  
 
 
Stable Imp-L2-HA-expressing cell lines 
 
To further study the interaction of Imp-L2 with Dilp2 we wanted to obtain purified Imp-L2 
protein. Therefore, we generated several stable cell lines that produce and secrete Imp-L2. 
Since it was doubtful that cells constantly overexpressing the growth inhibitor Imp-L2 would 
grow, if stably transfected, we generated cell lines containing an inducible Imp-L2 construct. 
For this purpose we cloned the Imp-L2-HA into a pMT vector which contains an inducible 
metallothionein promotor. The MT-Imp-L2-HA construct can be induced by CuSO4. We 
generated KC as well as clone8 stable cell lines that contained the MT-Imp-L2-HA construct. 
Interestingly, the clone8 cells were more efficient in producing and secreting Imp-L2 (Fig. 
S26A). Thus, for most of the cell culture experiments, the stable MT-Imp-L2-HA clone8 
(named Cl8-1) were used.  
In addition to the cell lines containing the inducible MT-Imp-L2-HA construct, we also 
generated stable clone8 cell lines that constitutively express Imp-L2-HA, containing Act-Gal4 
and UAS-IMPL2-HA (Cl8-7, Fig. S26B). Like the Cl8-1 cells, also the Cl8-7 cells grew and 
were easy to keep.  
To conduct a co-immunoprecipitation (co-IP) with Imp-L2 and dilp2, we also generated cell 
lines expressing both genes. Of the three different transfections, only the Cl8-11 cell line 
stably expressed Imp-L2 and dilp2, although the expression levels are lower than in cells 
transfected with only one of the genes (Fig. S26B). However, the IP of Imp-L2 and Dilp2 out 
of these cell lines never worked.  
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Figure S26: Test of stable Imp-L2-HA cell lines. 
(A) Stable KC cells (except lane 7) expressing MT-
IMPL2-HA starved overnight in serum- and insulin-
free medium (Shields & Sang supplemented with 
Penicillin/Streptomycin only). Expression of Imp-L2 
was either induced (+ CuSO4) overnight or not. The 
same amounts of supernatants of each sample was 
loaded on a gel and blotted. Lanes from left to right: 
1+2: KC-??, 3+4: KC-??, 5+6: KC-??, 7: Cl8-1. (B) 
Test of the stable Clone8 cell lines, which were 
transfected with the indicated constructs.  
 
 
 
 
Cell culture experiments 
 
Imp-L2 RNAi in S2 cells 
 
S2 cell extracts showed, when analyzed on a Western blot, a band of around 30kDa that could 
be stained with the Imp-L2 antibody. To verify that Imp-L2 is expressed by S2 cells we 
treated S2 cells for seven days with double stranded RNA of Imp-L2 to downregulate its 
expression. Imp-L2 expression could be efficiently downregulated in two independent 
experiments by RNAi against it (Fig. S27A+B). This downregulation of Imp-L2 did not 
change the way the cells reacted upon insulin stimulation. Interestingly, Rheb RNAi, which 
served as a positive control, also slightly downregulated Imp-L2 expression (Fig. S27A). But 
since the second RNAi experiment did no longer show such a clear downregulation of Imp-L2 
when the cells were treated with RNAi against Rheb (Fig. S76B), this result should be further 
verified by additional RNAi experiments (also against other pathway members) before any 
conclusions can be made.  
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Figure S27: Imp-L2 downregulation does not affect insulin stimulation in S2 cells.  
Double-stranded RNAs of the indicated genes were added to S2 cells. After 7 days cells were either stimulated 
for 30min with bovine Insulin (lanes 1-3) or not (lanes 4-6). (A+B) No difference in phosphorylation of S6K and 
PKB could be observed between cells containing either high or low levels of Imp-L2 (compare lanes 1 and 3, 
and 4 and 6 respectively). In cells treated with RNAi against Rheb, Imp-L2 levels were, especially when 
stimulated with insulin, slightly decreased. The following antibodies were used: rat-anti-Imp-L2, rabbit-anti-
phospho-S6K, rabbit-anti-phospho-PKB, rabbit-anti-JnK, mouse-anti-tubulin.  
 
 
Insulin stimulation in Imp-L2 expressing cells 
 
As we have shown in the manuscript (Honegger et al. 2006), Imp-L2 expression affects 
growth by regulating insulin signaling activity in flies. We next wanted to study the effect of 
Imp-L2 on insulin stimulation in cell culture. In order to optimize the conditions for the 
insulin stimulation we exposed clone8 cells to various nutritional conditions before 
stimulating with human insulin. Only when the cells were starved in serum-free medium 
(supplemented only with penicillin and streptomycin) over night prior to the stimulation, a 
difference in S6K phosphorylation could be detected between stimulated and non-stimulated 
cells (Fig. S28). Thus, in further experiments (if not stated otherwise) cells were starved 
before stimulated with insulin.  
 
Figure S28: Clone8 cells need to be starved before stimulation.  
Shown is a Western blot of different cell extracts from Clone8 cells. 
The samples loaded in the first two lanes were kept in serum-free 
culture medium (Shields & Sang supplemented with Insulin and 
Penicillin/Streptomycin). In lanes 3+4, cells were starved o/n in 
Shields & Sang supplemented with Penicillin/Streptomycin only. 
The cells of lane 5+6 were kept in full culture medium (Shields & Sang supplemented with fetal calf serum, 
Insulin, and Penicillin/Streptomycin). The Blot was stained with an Ab against phosphorylated dS6K and 
Tubulin as a loading control,.  
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To assay the stimulation of the insulin pathway in cells, phosphorylation levels of dS6K and 
dPKB were analyzed after 30min of insulin stimulation. KC cells transiently transfected with 
Act-Gal4, UAS-IMPL2-HA could be stimulated to the same extent as control cells by human 
insulin (Fig. S29A).  
 
 
Figure S29: The presence of Imp-L2 had no effect on stimulation with human insulin in cell culture.  
(A) Transiently transfected KC cells did not display diminished stimulation when treated with human insulin. 
Cells were either transfected with both Act-Gal4 and UAS-IMPL2-HA or Act-Gal4 alone. After 2 days cells 
were stimulated for 30min with huIns. (B) Stable cell lines containing an MT-Imp-L2-HA vector were starved 
o/n in serum- and insulin-free medium. During this time CuSO4 was added to the samples in lane 1, 3, and 5. The 
cells were then stimulated for 30min with human insulin. The different sizes of the tubulin bands are due to the 
presence of the CuSO4, which was not washed away totally. “pS6K” refers to an Ab against phosphorylated 
dS6K, “pPKB” refers to an Ab against phosphorylated dPKB.  
 
Also in stable clone8 cells (Cl8-1, MT-IMPL2-HA) the stimulation by human insulin was not 
altered by the presence of Imp-L2 in the medium (Fig. S29B). However, since it has been 
shown that Imp-L2 binds human insulin specifically (Sloth Andersen et al. 2000), and that 
Imp-L2 inhibits the insulin signaling pathway (Honegger et al. 2006), we would have 
expected that the stimulation by human insulin would be less efficient in the presence of Imp-
L2 in the medium. Because this was not the case, we wanted to test if the inhibition of Imp-L2 
on human insulin stimulation was not observed due to the low binding affinity to human 
insulin. Therefore, we next tested if Imp-L2 interferes with Dilp2 induced stimulation of the 
insulin pathway. We were not able to stimulate stable Cl8-1 (containing MT-IMPL2-HA) cells 
with 10nM Dilp2 in the presence of Imp-L2, even though this concentration of Dilp2 nicely 
stimulated normal clon8 cells (see pPKB and pS6K phosphorylation in Fig. S30A+B). 
However, not only Cl8-1 cells in which Imp-L2 expression was induced but also the non-
induced Cl8-1 cells displayed insensitivity to Dilp2 stimulation (lane 2 in Fig. S30A+B), 
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which was probably due to the leakiness of the MT-Imp-L2-HA construct. In these 
experiments CuSO4 was added together with fresh media to the cells (lanes 1, 3, and 6). The 
medium of the control cells was exchanged at the same time (lanes 2, 4, and 6). Thus, the 
leaky MT-Imp-L2-HA could express and secrete protein for 14-15h. In an attempt to 
minimize the effect of the leaky Imp-L2 expression we decreased the time of induction. By 
inducing Imp-L2 expression for only 6h we could indeed reduce the levels of extracellular 
Imp-L2 protein beyond detection limits in non-induced control cells (Fig. S30C). However, 
under these condition we could no longer detect the inhibitory effect of Imp-L2 on Dilp2 
stimulation. Therefore, instead of lowering Imp-L2 concentration in the medium we next 
decided to increase the Dilp2 concentration used for stimulation. Indeed, we could only 
stimulate Cl8-1 cells in which Imp-L2 was not induced (Fig. S30D). Strangely, we only 
observed a difference between the phosphorylation of S6K and not PKB (see lanes 1+2 in Fig. 
S30D). Since we were not able to reproduce this result (Fig. S30E), no clear conclusion could 
be drawn if Imp-L2 hinders Dilp2 stimulation in cell culture.  
 
 
Figure S30: Stimulation of stable MT-IMPL2-HA cell lines with dilp2.  
(A-E) For the cell extracts, 100µg of total protein extract was loaded, of the supernatants (SN) 60µl were loaded 
on a different gel. (A, B, D, E) Cells were starved in serum- and insulin-free medium (Shields & Sang 
supplemented with Penicillin/Streptomycin only) overnight. During this time CuSO4 was added to the samples in 
lanes 1, 3, and 5. The cells were then stimulated with the indicated concentrations of dilp2 for 30min. The cells 
in (C) were starved and induced for only 6h, but otherwise treated the same way. The different sizes of the 
tubulin band are due to the presence of the CuSO4, which was sometimes not washed away totally. “pS6K” 
refers to an Ab against phosphorylated dS6K, “pPKB” to an Ab against phosphorylated dPKB, “PKC” to an Ab 
against total PKCα.  
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Next, we wanted to test if addition of Imp-L2-containing supernatant decreases the sensitivity 
of wild-type cells to Dilp2 stimulation. Therefore, we collected supernatant of Imp-L2 
expressing cells and added different amounts of it to wild-type cells 30min prior to Dilp2 
stimulation. Neither in starved (Fig. S31A) nor in non-starved (Fig. S31B) cells did the 
presence of Imp-L2 in the medium influence S6K or PKB phosphorylation. Since it is 
possible that Imp-L2 is diluted too much in the supernatants, we concentrated Imp-L2-
containing supernatant by centrifugation using a Vivaspin6 concentrator (MWCO 10’000). 
But also with these concentrated Imp-L2-containing supernatants, we were not able to detect a 
reproducible effect on Dilp2 stimulation of wild-type cells (Fig. S31C+D).  
Although we performed various different cell culture experiments, no unambiguous 
conclusions could be drawn if the inhibition of Dilp2 activity we saw in genetic experiments 
can be reproduced or studied in cell culture.  
 
 
Figure S31: Addition of Imp-L2 containing medium does not affect insulin stimulation of cells.  
(A+B) The supernatant of MT-IMPL2-HA containing Cl8-1 cells, induced o/n in Shields & Sang supplemented 
with Penicillin/Streptomycin, was added to o/n starved (A) or non-starved cells (B). After one hour, the cells 
were stimulated with indicated concentrations of recombinant dilp2 (P. Belawat). In (C+D) the supernatant of the 
Cl8-1 cells (collected as described above) was concentrated using a Vivaspin 6 concentrator (MWCO 10’000) 
before adding it to the cells. The following antibodies were used: mouse-anti-HA, rabbit-anti-phospho-S6K, 
rabbit-anti-phospho-PKB, rabbit-anti-total PKC, mouse-anti-tubulin. 
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m-NSCs specific expression of shits only mildly affects body size 
 
Recently it has been shown that ablation of the m-NSCs, which produce four of the seven 
dilps, is sufficient to decrease total body size (Ikeya et al. 2002; Rulifson et al. 2002). Using a 
temperature-sensitive dominant negative form of dynamin (UAS-shits; (Kitamoto 2001) to 
reversibly block synaptic vesicle recycling and hence synaptic transmission, we wanted to 
assess if disturbed vesicle cycling in m-NSCs is sufficient to copy this size decrease due to 
inefficient or inexistent insulin secretion. Since this system is fast-responding and controlled 
by temperature it would provide the possibility to block insulin secretion at any time of 
development. We expressed UAS-shits specifically in the m-NSCs by either the dilp2-55-Gal4 
or the dilp2-3-Gal4 drivers and reared the flies either at the restrictive (29°C, red bars in Fig. 
S32) or the permissive temperature (22°C, blue bars in Fig. S32). As controls we expressed 
GFP and reaper in the m-NSCs. Disturbing vesicle cycling in the m-NSCs by shits only 
slightly affected final body size (compare the red bars either with the blue ones or the GFP 
control in UAS-shits, dilp2-3-Gal4 flies, Fig. S32). Thus, secretion of insulin is presumably 
only marginally disturbed by shits expression.  
 
 
Figure S32: Blocking the synaptic transport of dilp-expressing m-NSC by expressing shits is not sufficient 
to reproduce the m-NSC cell ablation phenotype.  
Total body weights of flies expressing UAS-shits in the dilp-producing m-NSCs. For this purpose the flies were 
reared in separate incubators at either 22°C (blue bars) or 29°C (red bars). Flies lacking the m-NSCs served as a 
positive control (dilp2-Gal4, UAS-rpr). The weights for the UAS-shits, dilp2-55-Gal4 cross at 29°C are missing, 
because these females died prior to egg deposition on 29°C.  
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Discussion 
 
The evolutionary conserved insulin/IGF receptor pathway is involved in the control of a 
diverse array of processes such as growth, metabolism, longevity, and reproduction (Oldham 
and Hafen 2003). While insulin is a principal regulator of glucose and lipid metabolism 
(Saltiel and Kahn 2001), IGFs, as major downstream targets of growth hormone, are essential 
for regulating growth and body size (Nakae et al. 2001). Alterations in either insulin or IGF 
signaling are linked to severe disorders such as diabetes, obesity, polycystic ovarian disease, 
hyperlipidemia, hypertension, atherosclerosis, and cancer (Saltiel and Kahn 2001). Mutations 
in the tumor suppressor PTEN for instance, constitutively activates downstream components 
of this pathway such as PKB, leading to overproliferation and enhanced survival of mutant 
cells (Cantley and Neel 1999). Thus, PTEN deletion occurs in multiple tumor types, most 
prominently advanced glial tumors (glioblastoma multiforme/anaplastic astrocytoma), but 
also prostate, endometrial, renal and small cell lung carcinoma, melanoma, and meningioma 
(Li et al. 1997; Steck et al. 1997). The only other known negative regulator in the insulin 
signaling cascade is the TSC1/2 complex, which links the canonical insulin pathway with the 
TOR signaling network. Like PTEN, also the TSC1/2 complex acts as a tumor suppressor. 
The genes TSC1 and TSC2 are mutated in the severe human syndrome called Tuberous 
Sclerosis, which is characteristically associated with large benign tumors composed of large 
cells in the brain of patients (Pan et al. 2004). Because deregulation of the insulin signaling 
cascade is altering cellular growth, and thereby predisposing cells to become tumorigenic, the 
negative regulators of the pathway are all likely to function as tumor suppressors.  
In order to identify novel inhibitors of the insulin signaling pathway, we conducted a gain-of-
function (EP) screen for genes that suppress the InR induced hyperplasia in the Drosophila 
eye. Such an EP screen provides a complementary screening strategy to the general loss-of-
function screens, in which genes lacking any obvious phenotype under standard culture 
conditions are likely to be missed. It is assumed that only one-third of all genes in the 
Drosophila genome can be mutated to an easily scored phenotype (Miklos and Rubin 1996). 
Since genes lacking a visible loss-of-function phenotype often cause a phenotype upon 
overexpression, an EP screen is a useful method to identify novel regulators of a pathway.  
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This PhD thesis describes the functional characterization of Imp-L2, which was found in such 
an EP screen based on its ability to suppress the InR induced big eye phenotype upon 
overexpression.  
 
 
Imp-L2 
 
The Drosophila Imp-L2 gene was previously identified as a 20-hydroxyecdysone-induced 
gene encoding a secreted member of the immunoglobin superfamily (Garbe et al. 1993). We 
have shown that Imp-L2 controls cell size as well as cell number non-autonomously by 
inhibiting insulin signaling at the level of the ligands. Although Imp-L2 is not essential for 
survival under standard culture conditions, it is upregulated and necessary in larvae upon 
starvation to sustain extended periods of low nutrition.  
The Imp-L2 gene consists of three different transcripts (RA, RB, and RC) differing in the 
usage of the first exon, but all comprise the same protein coding region. While Imp-L2-RA 
and Imp-L2-RC have small non-coding first exons, Imp-L2-RB contains three small upstream 
open reading frames (uORFs) in its first exon. We have shown that these uORFs have an 
inhibitory effect on translation, since Imp-L2-RB constructs either lacking the first exon or 
containing mutated ATGs in the uORFs, all have stronger effects on growth than the full-
length and wild-type transcript, when overexpressed. Also overexpression of Imp-L2-RA and 
Imp-L2-RC transcripts displayed stronger growth inhibition than Imp-L2-RB. Since all the 
UAS constructs of the different Imp-L2 variants randomly integrated into the genome, their 
expression is differentially influenced by their surrounding. Therefore, to verify that the 
milder effect of UAS-Imp-L2-RB is really due to less efficient translation and not 
transcription, RNA levels must be measured by transcript-specific quantitative real-time PCR 
(qRT-PCR). Another alternative would be to generate new transgenic fly lines with the 
attB/attP system, which allows targeted integration of constructs at a specific landing site. 
Like this, the influence of the genomic region on transcription is the same for all the 
constructs. Another interesting question that could be addressed, once such transgenic fly 
lines with identical integration places of the UAS constructs is established, is, if like in the 
case of GCN4, whose translation rate is increased upon starvation (Hinnebusch 1997), the 
inhibiting effect of the uORFs on the translation changes under various stress conditions. 
Considering the upregulation of Imp-L2 protein expression under starvation and hypoxic 
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conditions, it is tempting to speculate that the Imp-L2-RB mRNA is transcribed constitutively, 
but only efficiently translated under specific stress conditions. The embryonic expression 
pattern supports such a hypothesis of a translational control mechanism, since mRNA can be 
detected at specific places throughout embryonic development, but Imp-L2 protein is only 
detected late in embryogenesis (Garbe et al. 1993). In such a case, the expression of Imp-L2-
RA and Imp-L2-RC need to be under more restrictive control at the level of transcription, 
since their translation without uORFs would work efficiently. To proof this, the abundance of 
the different transcripts during development and under various conditions should be assayed. 
Another possibility would be to generate reporter constructs of the different transcripts, 
luciferase for cell culture and GFP or lacZ for an in vivo analysis, which would also allow 
monitoring the level of transcript expression under diverse conditions.  
Apart from its function as a regulator of insulin signaling upon unfavorable environmental 
conditions, Imp-L2 might also play a role during development by attenuating insulin 
signaling. It has been shown that ecdysone, besides its role as a hormone controlling 
developmental timing and the onset of metamorphosis, negatively regulates insulin signaling 
(Rusten et al. 2004; Colombani et al. 2005). However, it is unknown, what the connection 
between ecdysone- and insulin signaling is. Therefore, as an ecdysone inducible protein that 
efficiently inhibits Dilp2 signaling, Imp-L2 is a good candidate for being the link between the 
two pathways. Flies overexpressing PI3K in the ring gland (P0206>dp110) display slightly 
increased ecdysone levels, which is sufficient to downregulate insulin signaling in the fat 
body and to decrease total body size (Colombani et al. 2005). Since this phenotype was not 
reproducible on our fly food, it could not be tested if the size decrease of P02026>dp110 flies 
persists in an Imp-L2 null background. Additionally, the Léopold Group could not detect any 
change in Imp-L2 mRNA levels in larvae with such a mildly upregulated ecdysone levels 
(tested by RT-PCR, personal communication P.Léopold, Nice). However, it is still possible 
that ecdysone interacts not only on the transcriptional level with Imp-L2, but affects its 
translation or secretion. Recently, it has been shown that insulin and ecdysone signaling are 
also connected in controlling autophagy. Genetic interaction studies showed that ecdysone 
signaling autonomously downregulates PI3K signaling, which represents the effector 
mechanism for induction of programmed autophagy (Rusten et al. 2004). Since the 
connection between ecdysone and insulin signaling is strictly cell-autonomous it is rather 
unlikely that Imp-L2 relays the ecdysone signal in this context.  
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Comparison of the vertebrate and invertebrate insulin binding 
proteins 
 
Although in insects and other lower organisms, as for example nematodes, the insulin 
signaling pathway and insulin-like proteins are highly conserved, clear orthologs of IGFBPs 
are missing. In this thesis we describe Imp-L2, the first protein in insects not only possessing 
the ability to bind and regulate insulin in vivo, but is in its C-terminus also shows homology to 
IGFBP-rP1, the only insulin binding protein in vertebrates known to bind strongly to insulin. 
Further, Imp-L2, like the putative tumor suppressor IGFBP-rP1, always showed an inhibitory 
effect on growth and interacts with Dilp2, the closest homolog of human insulin in 
Drosophila. Thus, Imp-L2 acts as a functional homolog of IGFBPs in insects. An analysis of 
IGFBP-rP1 expression in 60 primary breast cancers using immunohistochemistry revealed 
that 12 normal and benign breast tissues had strong IGFBP-rP1 expression, 16 ductal 
carcinomas in situ showed weak IGFBP-rP1 levels and the invasive carcinomas were negative 
for IGFBP-rP1, all consistent with its role as a tumor suppressor (Burger et al. 1998). Through 
its role in controlling insulin activity under unfavorable conditions like starvation and 
hypoxia, Imp-L2 also has the potential to be a tumor suppressor, and since the conditions 
inside a tumor are often highly unfavorable for a cell, Imp-L2 activity would have to be 
abolished to sustain growth. However, expression of IGFBP-rP1 in flies was not able to 
mimic the effects of Imp-L2 overexpression. It is possible that the N-terminus of IGFBP-rP1, 
which is highly homologous to the evolutionary non-conserved IGFBPs, disturbs the 
interaction with Drosophila insulins. Thus, it might be possible to mimic the effects of Imp-
L2 by a chimeric protein consisting of the Imp-L2 N- and the IGFBP-rP1 C-terminus.  
The polycystic ovarian syndrom (PCOS), a mammalian disorder, in the course of which 
IGFBPs are assumed to play an important role, is reminiscent of the big ovary phenotype of 
Imp-L2 mutant females. PCOS is a disorder of unknown, probably heterogeneous etiology, 
characterized by chronic anovulation, hyperandrogenism, and enlarged polycystic ovaries (for 
a review see (Poretsky et al. 1999)). PCOS affects between 5-10% of women at reproductive 
state. Although the phenotype of the enlarged ovaries of Imp-L2 mutant females resembles the 
large polycystic ovaries of humans, the cause for these polycystic ovaries is different in both 
situations. While anovulation is a major cause in humans, Imp-L2 mutant females display no 
failure in egg deposition, but rather show enhanced egg production. Thus, the ovulation rate is 
unchanged in Drosophila. Even though the development of the different situations differs 
considerably, it is striking how similar the phenotypes are.  
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Albeit the classical IGFBPs are not present in the Drosophila genome, it contains an ortholog 
of ALS. It has been shown in mammals that in postnatal serum most IGFs are sequestered into 
ternary complexes consisting of one molecule each of IGF, IGFBP-3 or IGFBP-5, and ALS 
(Boisclair et al. 2001). Since insects lack any orthologs of IGFBP-3 and IGFBP-5, and an 
ALS-IGFBP-rP1 binding has never been shown in vertebrates, it is unclear what the binding 
partners of ALS are in Drosophila. However, like in mammals (Dai et al. 1994; Oster et al. 
1996), dALS is expressed mainly by the fat body, the liver analog of insects, and its 
expression is sensitive to starvation (Colombani et al. 2003). It remains to be tested whether 
ALS for the lack of canonical IGFBPs in insects binds insulin directly, whether it binds to 
binary Imp-L2-insulin complexes, or whether it binds Imp-L2 alone. So far, we were not able 
to generate a clear dALS phenotype or interaction in conjunction with either dilp2 or Imp-L2. 
In vitro pull-downs and further genetic interaction studies should enlighten the function of 
ALS in Drosophila and clarify its role in modulating insulin signaling.  
 
 
Interaction of Imp-L2 with the Dilps 
 
We have shown that besides its interaction with dilp2 (Honegger et al. 2006), Imp-L2 interacts 
at least genetically also with dilp5 and dilp6. In conjunction with the other dilps we were not 
able to detect a genetic interaction. This was partly due to the lack of a reproducible 
overexpression phenotype of dilp1, 3, 4, and 7. Their expression was also not sufficient to 
additionally increase the size of Imp-L2 mutants. Thus, we can only conclude, that Imp-L2 
interacts with dilp2, 5, and 6, albeit a putative interaction with the other dilps cannot be 
excluded.  
Since there exist no mutants for the different dilps, it is crucial to test if really all the dilps are 
capable of influencing total body size, as stated before (Ikeya et al. 2002). Although we were 
not able to reproduce this result, the overexpression of dilp1, 3, 4, and 7 could be repeated in a 
sensitized system. Direct constructs overexpressing the InR specifically in the eye under the 
control of the GMR promotor (GMR-InRwt), display weak or no phenotypes. Therefore, 
overexpressing dilp1, 3, 4, or 7 by GMR-Gal4 in a GMR-InRwt background rather shows an 
effect on eye size than in wild-type situations. Further, this experiment may provide a hint, if 
all the dilps signal through the InR. A possible phenotype of one of the dilps could then be 
further tested in an Imp-L2 loss-of-function background to test a possible interaction. 
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Additionally, co-overexpression of Imp-L2 and either dilp1, 3, 4, or 7 might hint at a putative 
interaction.  
Another way of showing a potential interaction of Imp-L2 with the dilps would be to tag 
Dilp1, and 3-7 N-terminally in the same way as Dilp2. In an in vitro pull-down assay the 
physical interaction of Imp-L2 with the different Dilps could then be monitored.  
Obviously, the best environment to study the Imp-L2-Dilp interaction would be directly in the 
hemolymph. Since both proteins are secreted and show non-autonomous effects it is most 
likely that their interaction takes place in this fluid. The limiting parameters of such an 
experiment would be on one hand the scarce amount of hemolymph which can be extracted 
from a single fly/larva, and on the other hand the dilp antibodies, which are presumably not 
good enough for a pull-down experiment. Thus, tagged proteins could be used to perform an 
immunopurification from pooled hemolymph samples of about 100 larvae. Since 
immunohistochemistry is presumably not sensitive enough to see a potential interaction in the 
hemolymph, quantitative proteomics could be used to detect the proteins in the sample. If the 
conditions to conduct such an experiment could be established, this assay could be also used 
to determine the interaction of the dilps with Imp-L2 at different developmental stages and 
under various stress conditions.  
 
 
Nutrient-dependent regulation of growth by Imp-L2 
 
As we have already described in the introduction, growth of an organism is controlled by the 
combination of genetic and environmental means. The basic growth information is stored as 
genetic information that constantly adapts according to environmental changes. Although 
there has lately been made a great amount of progress in understanding both the genetic 
pathways and the environmental cues controlling growth, it has so far remained obscure, how 
an organism orchestrates the different signals to generate a common growth output. It is 
crucial for an animal to be capable of reacting immediately to a changing environment and 
attenuate the genetic programs according to those changes. One of the central pathways in the 
control of metabolism and growth is the IIS cascade. Therefore, IIS is one of the major targets 
which needs to be adjusted following such changes in environmental conditions. One way to 
achieve this, is to change the transcription of the various pathway members. However, 
transcriptional alterations change the activity of the pathway only slowly. Another way is to 
modulate the activity of the pathway directly at the protein level. In vertebrates, the IGFBP 
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superfamily functions that way. By directly binding to the IGFs and/or insulin, these proteins 
possess the ability to regulate the availability, and therefore also the activity of the IIS 
pathway at an extracellular level. Consequently, this provides a fast response to the changing 
environmental conditions.  
In this thesis we provide evidence that Imp-L2 acts as a Drosophila equivalent to the 
vertebrate IGFBPs. Imp-L2 is the first insulin binding protein identified in invertebrates. It 
acts as negative regulator of IIS in Drosophila by controlling the activity of the most potent 
growth-inducing insulin, Dilp2. Although Imp-L2 is not essential for survival of the flies 
under standard culture conditions, it is necessary to restrict the activity of the IIS pathway 
when nutrients become limiting. It is of uttermost importance for an organism to respond 
rapidly to starvation conditions by adapting metabolism and growth, because unconfined 
growth under scarce nutritional conditions swiftly results in lethality (Britton et al. 2002). 
While the transcription of dilp3 and 5 is downregulated upon starvation conditions, dilp2 
mRNA levels are unaffected by nutritional availability. Imp-L2 binding provides the only 
known mechanism so far, that allows the restriction of Dilp2 activity upon unfavorable 
environmental conditions. Thus, the necessity of Imp-L2 under starvation conditions 
presumably emerges from its inhibitory effect on Dilp2 activity. Like this, Imp-L2 acts as a 
link between environmental conditions such as starvation and the IIS cascade to control 
growth and metabolism in Drosophila.  
One of the major challenges faced by all organisms during evolution was to ensure survival of 
periods in which nutrient availability is low. It is therefore not surprising that mechanisms 
evolved early in evolution to meet this challenge. The genetic and biochemical studies 
presented in this thesis highlight the high degree of functional conservation between Imp-L2 
and the IGFBP system used in higher organisms to shuttle and control insulin and IGFs. They 
support the hypothesis that these molecules represent an essential part of the cellular and 
organismal mechanisms that allow the attenuation of cellular and organismal growth in 
response to nutrients.  
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Materials and Methods 
 
Material and Methods used in the course of this study are essentially described in the 
manuscript (Honegger et al. 2006) 
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